EX-99.2 3 d190742dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

 

LOGO


Management report

 

 

Anheuser-Busch InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest natural ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona® and Stella Artois®; multi-country brands Beck’s®, Hoegaarden®, Leffe® and Michelob Ultra®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin® and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 169 000 employees based in nearly 50 countries worldwide. For 2021, our reported revenue was 54.3 billion US dollar (excluding joint ventures and associates).

The following management report should be read in conjunction with our audited consolidated financial statements.

In the rest of this document we refer to Anheuser-Busch InBev as “AB InBev”, “the company”, “we”, “us” or “our”.

Selected financial figures

To facilitate the understanding of our underlying performance, the comments in this management report, unless otherwise indicated, are based on organic and normalized numbers. “Organic” means the financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scopes. Scopes represent the impact of acquisitions and divestitures, the start-up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year-over-year changes in accounting estimates and other assumptions that management does not consider part of the underlying performance of the business.

The tables in this management report provide the segment information per region for the period ended 31 December 2021 and 2020 in the format up to Normalized EBIT level that is used by management to monitor performance.

Whenever used in this report, the term “normalized” refers to performance measures (EBITDA, EBIT, Profit, EPS, effective tax rate) before non-underlying items and discontinued operations. Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the company’s performance, but rather should be used in conjunction with the most directly comparable IFRS measures.

On 1 June 2020, we completed the previously announced sale of Carlton & United Breweries (“CUB”), our Australian subsidiary, to Asahi Group Holdings, Ltd (“Asahi”). Effective 30 September 2019, following the announcement on 19 July 2019 of the agreement to divest CUB to Asahi, we classified the assets and liabilities associated with the Australian operations as assets held for sale and liabilities associated with assets held for sale in accordance with IFRS 5 Non-current Assets Held for Sale and Discontinued Operations. In addition, since the results of the Australian operations represented a separate major line of business, these were accounted for as discontinued operations as required by IFRS 5 and presented in a separate line in the consolidated income statement (“profit from discontinued operations”) up to 31 May 2020. As a result, all the presentations of our underlying performance and organic growth figures do not reflect the results of the Australian operations.

 

AB InBev – Financial Report 2021 | 2


The tables below set out the components of our operating income and operating expenses, as well as the key cash flow figures.

 

 For the year ended 31 December

 Million US dollar

   2021      %     2020      %  
                                    

Revenue¹

     54 304        100%       46 881        100%  

Cost of sales

     (23 097)        43%       (19 634)        42%  
                                    

Gross profit

     31 207        57%       27 247        58%  

SG&A

     (17 574)        32%       (15 368)        33%  

Other operating income/(expenses)

     805        1%       845        2%  
                                    

Normalized profit from operations (Normalized EBIT)

     14 438        27%       12 723        27%  

Non-underlying items

     (614)        1%       (3 103)        7%  
                                    

Profit from operations (EBIT)

     13 824        25%       9 620        21%  
                                    

Depreciation, amortization and impairment

     4 771        9%       4 598        10%  

Non-underlying impairment

     281        1%       2 733        6%  

Normalized EBITDA

     19 209        35%       17 321        37%  

EBITDA

     18 876        35%       16 951        36%  
                                    

 Normalized profit attributable to equity holders of AB InBev

     5 723        11%       3 807        8%  
 Profit from continuing operations attributable to equity holders of AB InBev      4 670        9%       (650)        1%  
 Profit from discontinued operations attributable to equity holders of AB InBev      -        -       2 055        4%  
 Profit attributable to equity holders of AB InBev      4 670        9%       1 405        3%  

 For the year ended 31 December

 Million US dollar

                  2021      2020  

Operating activities

                                  

Profit from continuing operations

 

             6 114        147  

Interest, taxes and non-cash items included in profit

 

             12 693        17 024  
 Cash flow from operating activities before changes in working capital and use of provisions

 

             18 806        17 171  
                             

Change in working capital

 

             2 459        592  

Pension contributions and use of provisions

 

             (375)        (616)  

Interest and taxes (paid)/received

 

             (6 197)        (6 391)  

Dividends received

 

             106        51  

Cash flow from operating activities on Australia discontinued operations

 

             -        84  
 Cash flow from operating activities

 

             14 799        10 891  
                             
 Investing activities

 

                         

Net capex

 

             (5 498)        (3 687)  

Acquisition and sale of subsidiaries, net of cash acquired/disposed of

 

             (444)        (510)  

Net proceeds from sale/(acquisition) of other assets

 

             65      (292)  

Proceeds from Australia divestiture

 

             -        10 838  

Cash flow from investing activities on Australia discontinued operations

 

             -        (13)  

 Cash flow from investing activities

 

             (5 878)        6 336  
                             
 Financing activities

 

                         

Dividends paid

 

             (2 364)        (1 800)  

Net (payments on)/proceeds from borrowings

 

             (8 511)        (8 294)  

Payment of lease liabilities

 

             (531)        (461)  

Sale/(purchase) of non-controlling interests and other

 

             (192)        2 086  

Cash flow from financing activities on Australia discontinued operations

 

             -        (6)  
 Cash flow from financing activities

 

             (11 598)        (8 475)  
                                    

 Net increase/(decrease) in cash and cash equivalents

                      (2 677)        8 752

 

 

1 Turnover less excise taxes. In many jurisdictions, excise taxes make up a large proportion of the cost of beer charged to the company’s customers.

 

AB InBev – Financial Report 2021 | 3


Financial performance

We are presenting our results under five regions: North America, Middle Americas, South America, EMEA and Asia Pacific.

The tables in this management report provide the segment information per region for the period ended 31 December 2021 and 2020 in the format down to Normalized EBIT level that is used by management to monitor performance.

The tables below provide a summary of our performance for the period ended 31 December 2021 and 2020 (in million US dollar, except volumes in thousand hectoliters) and the related comments are based on organic numbers.

 

 AB INBEV WORLDWIDE    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Volumes

     530 644        56        -        50 979        581 678        9.6%  

Revenue

     46 881        (193)        326        7 290        54 304        15.6%  

Cost of sales

     (19 634)        61        (119)        (3 405)        (23 097)        (17.4)%  

Gross profit

     27 247        (132)        207        3 885        31 207        14.3%  

SG&A

     (15 368)        100        (180)        (2 126)        (17 574)        (13.9)%  

Other operating income/(expenses)

     845        (187)        8        139        805        32.3%  

Normalized EBIT

     12 723        (218)        35        1 899        14 438        15.4%  

Normalized EBITDA

     17 321        (207)        96        2 000        19 209        11.8%  

Normalized EBITDA margin

     36.9%        -        -        -        35.4%        -118 bps  

In 2021, our normalized EBITDA increased 11.8%, while our normalized EBITDA margin contracted 118 bps, reaching 35.4%.

Consolidated volumes grew by 9.6%, with own beer volumes up 9.7% and non-beer volumes up 8.7%, driven by a recovery year-over-year as the COVID-19 pandemic negatively impacted our volumes in 2020.

Consolidated revenue grew by 15.6% to 54 304m US dollar, with revenue per hectoliter growth of 5.5% driven by premiumization and revenue management initiatives. Combined revenues of our global brands, Budweiser, Stella Artois and Corona increased by 17.6% globally and 22.9% outside of their respective home markets.

Consolidated Cost of Sales (CoS) increased 17.4%, and increased 7.2% on a per hectoliter basis, driven by anticipated transactional foreign exchange and commodity headwinds.

Consolidated selling, general and administrative expenses (SG&A) increased 13.9% due primarily to higher variable compensation accruals and elevated supply chain costs.

Consolidated other operating income/(expenses) in 2021 increased by 32.3% primarily driven by higher government grants and sales of non-core assets. In the fourth quarter of 2020 and in the second quarter of 2021, Ambev, recognized 481m US dollar and 226m US dollar income in Other operating income respectively related to tax credits in Brazil. The net impact is presented as a scope change and does not impact the presented organic growth. Additionally, Ambev recognized 118m US dollar of interest income in Finance income in 2021 (2020: 315m US dollar) related to these credits. Underlying profit attributable to equity holders and underlying EPS were positively impacted by 165m US dollar after tax and non-controlling interest (30 December 2020: 325m US dollar). Ambev’s tax credits and interest receivables are expected to be collected over a period exceeding 12 months after the balance sheet date. As of 31 December 2021, the total amount of such credits and interest receivables represented 960m US dollar.

 

AB InBev – Financial Report 2021 | 4


VOLUMES

The table below summarizes the volume evolution per region and the related comments are based on organic numbers. Volumes include not only brands that we own or license, but also third-party brands that we brew as a subcontractor and third-party products that we sell through our distribution network, particularly in Europe. Volumes sold by the Global Export business, which includes our global headquarters and the export businesses which have not been allocated to our regions, are shown separately.

 

 Thousand hectoliters    2020      Scope      Organic
growth
     2021      Organic
growth %
 
                                              

North America

     106 846        72        47        106 965        -  

Middle Americas

     120 800        (1)        20 648        141 447        17.1%  

South America

     144 209        (67)        12 480        156 622        8.7%  

EMEA

     76 207        (275)        10 775        86 707        14.2%  

Asia Pacific

     81 649        -        6 730        88 379        8.2%  

Global Export and Holding Companies

     933        326        299        1 558        23.8%  

AB InBev Worldwide

     530 644        56        50 979        581 678        9.6%  

North America total volumes were flat.

In the United States, our sales-to-retailers (“STRs”) declined by 2.3%, estimated to be below the industry, while sales-to-wholesalers (“STWs”) were flattish as inventories normalized following pandemic related volatility. In 2021, our above core portfolio delivered high-single digit volume growth, and now represents over 30% of revenue. Michelob ULTRA, the #2 beer brand in the country by volume, continued to outperform the industry and grew STRs by double digits in 2021. Our seltzer portfolio grew 1.7x the segment in 2021. Within the ready-to-drink cocktail segment, Cutwater once again grew by triple-digits for 2021.

In Canada, our volume was flattish versus in 2021 compared to 2020, as on-premise channel closures were mostly offset by strength in the off-premise channel. We continued to outperform the industry, led by our above core brands. Our Beyond Beer portfolio grew volume by double-digits.

Middle Americas total volumes increased by 17.1%.

In Mexico, in 2021 compared to 2020, our volumes grew by double-digits, below the industry. Our continued momentum is fueled by category and portfolio development, digital transformation, and channel expansion. In 2021, we expanded in the fast-growing Beyond Beer segment through innovations such as Michelob ULTRA Hard Seltzer and Corona Agua Rifada. We launched the next phase of our OXXO rollout, expanding to approximately 3,400 additional stores by January 2022. Our BEES platform continues to expand, with over 70% of our revenues now digital.

In Colombia, our volumes grew over 20% in 2021 compared to 2020, reflecting the power of our enhanced brand portfolio and consistent commercial strategy execution. Led by the implementation of our category expansion levers, the beer category continues to grow, with 2021 marking the highest per capita consumption in Colombia in the last 25 years. We saw growth across all segments of our portfolio this year. In 2021 compared to 2020, our core portfolio grew by double-digits and our super-premium portfolio grew even faster, led by the nearly 40% combined growth of our global brands and local premium brand, Club Colombia. The roll out and adoption of the BEES platform continued with over 85% of our revenues in 2021 through digital channels.

In Peru, fueled by consistent execution of our commercial strategy, we delivered record high volumes in the fourth quarter of 2021. On a full-year basis, our volumes grew by double-digits. Our global and local premium brands delivered particularly strong performances, growing double-digits in 2021. BEES continues to expand and 75% of our revenue is now digital.

In Ecuador, we delivered volume growth of double-digits in 2021 compared to 2020. We continue to focus on expanding the beer category and driving premiumization. Over 90% of our revenue in Ecuador is now digital.

South America total volumes increased by 8.7%.

In Brazil, our total volume grew by 7.3%, with beer volumes up by 7.0% and non-beer volumes up by 8.3%, in 2021 compared to 2020. We continue to execute our consumer and customer-centric strategy focused on innovation and the digital transformation of our business. In 2021, we delivered record high beer volumes and strengthened the health of our portfolio. Innovations represented more than 20% of revenue this year. BEES now covers more than 85% of our active customers across the country and helped contribute to an all-time high Net Promoter Score (“NPS”). Zé Delivery fulfilled more than 61 million orders in 2021, more than doubling versus 2020.

In Argentina, we grew volume by low teens in 2021 compared to 2020. Our premium brands led the way, due to the outperformance of Andes Origen, Corona and Stella Artois.

 

AB InBev – Financial Report 2021 | 5


EMEA total volumes increased by 14.2%.

In Europe, our volumes grew by mid-single digits in 2021 compared to 2020. We continue to drive premiumization across Europe. Premium and super premium brands now make up over 50% of our revenue. In 2021, our global brands and our super premium portfolio grew by double-digits, led by Corona and Leffe. Our DTC solution, PerfectDraft, delivers the ultimate home beer experience, growing 9x as fast as the online beer category in both France and the UK according to our estimates.

In South Africa, our volumes grew by strong double-digits in 2021 compared to 2020. In 2021, strong underlying consumer demand for our products resulted in market share expansion in both beer and total alcohol versus pre-pandemic levels. We saw consistent growth across all segments of our brand portfolio in 2021, led by Carling Black Label, our leading core brand. We continue to accelerate the premium and Beyond Beer segments, both delivering strong double-digit growth. The adoption of the BEES platform continued with almost 90% of our revenues now through digital channels.

In Africa excluding South Africa, we continue to see an improving operating environment and strong consumer demand for our brands. This led to volume and growth across most of our key markets versus 2020. In Nigeria, our volumes outperformed the industry in 2021, despite supply chain constraints.

Asia Pacific total volumes increased by 8.2%.

In China, volumes grew by 9.3% in 2021 compared to 2020. Our market share expanded by an estimated 80bps versus 2020. We remain focused on driving premiumization, digital transformation, and expansion of our business. All segments of our portfolio grew in 2021, led by the double-digit increase of our premium and super premium portfolios, both above pre-pandemic levels. We addressed new consumer trends and occasions through the expansion of Budweiser Supreme as well as the launch of various flavor options, including Hoegaarden Fruity and Corona Sea Salt Guava.

In South Korea, in 2021, COVID-19 restrictions continued to impact the industry resulting in low-single digit volume decline compared to 2020. Our market share momentum accelerated throughout the year delivering an estimated expansion of nearly 130 bps, driven by the continued success of our innovations, the “All New Cass” and our new classic lager HANMAC.

 

AB InBev – Financial Report 2021 | 6


OPERATING ACTIVITIES BY REGION

The tables below provide a summary of the performance of each region, for the period ended 31 December 2021 (in million US dollar, except volumes in thousand hectoliters) and the related comments are based on organic numbers.

 

 AB INBEV WORLDWIDE    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Volumes

     530 644        56        -        50 979        581 678        9.6%  

Revenue

     46 881        (193)        326        7 290        54 304        15.6%  

Cost of sales

     (19 634)        61        (119)        (3 405)        (23 097)        (17.4)%  

Gross profit

     27 247        (132)        207        3 885        31 207        14.3%  

SG&A

     (15 368)        100        (180)        (2 126)        (17 574)        (13.9)%  

Other operating income/(expenses)

     845        (187)        8        139        805        32.3%  

Normalized EBIT

     12 723        (218)        35        1 899        14 438        15.4%  

Normalized EBITDA

     17 321        (207)        96        2 000        19 209        11.8%  

Normalized EBITDA margin

     36.9%        -        -        -        35.4%        -118 bps  
                 
 North America    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Total volumes (thousand hls)

     106 846        72        -        47        106 965        -  

Revenue

     15 622        (16)        144        507        16 257        3.3%  

Cost of sales

     (5 870)        36        (47)        (303)        (6 185)        (5.2)%  

Gross profit

     9 752        20        97        204        10 072        2.1%  

SG&A

     (4 369)        (69)        (52)        (279)        (4 769)        (6.4)%  

Other operating income/(expenses)

     (14)        1        -        59        46        -  

Normalized EBIT

     5 369        (48)        44        (16)        5 349        (0.3)%  

Normalized EBITDA

     6 172        (36)        52        (56)        6 131        (0.9)%  

Normalized EBITDA margin

     39.5%        -        -        -        37.7%        -160 bps  
                 
 Middle Americas    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Total volumes (thousand hls)

     120 800        (1)        -        20 648        141 447        17.1%  

Revenue

     10 032        5        16        2 488        12 541        24.8%  

Cost of sales

     (3 331)        (6)        (21)        (1 070)        (4 428)        (32.1)%  

Gross profit

     6 701        (1)        (5)        1 418        8 113        21.2%  

SG&A

     (2 710)        (3)        (16)        (421)        (3 149)        (15.5)%  

Other operating income/(expenses)

     6        -        -        18        24        -  

Normalized EBIT

     3 997        (4)        (20)        1 015        4 988        25.4%  

Normalized EBITDA

     5 014        (4)        (6)        1 121        6 126        22.4%  

Normalized EBITDA margin

     50.0%        -        -        -        48.8%        -96 bps  
                 
 South America    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Total volumes (thousand hls)

     144 209        (67)        -        12 480        156 622        8.7%  

Revenue

     8 092        (61)        (653)        2 116        9 494        26.3%  

Cost of sales

     (3 786)        4        309        (1 290)        (4 763)        (34.1)%  

Gross profit

     4 306        (58)        (344)        826        4 730        19.4%  

SG&A

     (2 417)        75        194        (615)        (2 762)        (26.2)%  

Other operating income/(expenses)

     522        (189)        (8)        71        397        65.3%  

Normalized EBIT

     2 412        (171)        (157)        282        2 365        14.0%  

Normalized EBITDA

     3 179        (171)        (209)        326        3 125        11.7%  

Normalized EBITDA margin

     39.3%        -        -        -        32.9%        -401 bps  
                 
 EMEA    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Total volumes (thousand hls)

     76 207        (275)        -        10 775        86 707        14.2%  

Revenue

     6 835        (364)        377        1 184        8 032        18.0%  

Cost of sales

     (3 394)        172        (160)        (411)        (3 793)        (12.7)%  

Gross profit

     3 441        (192)        217        774        4 239        23.0%  

SG&A

     (2 696)        198        (143)        (214)        (2 855)        (8.2)%  

Other operating income/(expenses)

     163        -        8        30        200        18.6%  

Normalized EBIT

     907        6        82        590        1 584        64.6%  

Normalized EBITDA

     1 895        4        118        581        2 598        30.6%  

Normalized EBITDA margin

     27.7%        -        -        -        32.4%        308 bps  

 

AB InBev – Financial Report 2021 | 7


 Asia Pacific    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Total volumes (thousand hls)

     81 649        -        -        6 730        88 379        8.2%  

Revenue

     5 648        (46)        420        826        6 848        14.8%  

Cost of sales

     (2 605)        (2)        (184)        (257)        (3 048)        (9.9)%  

Gross profit

     3 042        (48)        236        570        3 800        19.0%  

SG&A

     (2 097)        46        (139)        (140)        (2 330)        (6.8)%  

Other operating income/(expenses)

     146        -        9        (16)        139        (11.1)%  

Normalized EBIT

     1 091        (3)        107        413        1 609        37.9%  

Normalized EBITDA

     1 737        (2)        152        434        2 321        25.0%  

Normalized EBITDA margin

     30.8%        -        -        -        33.9%        277 bps  
                 
 Global Export and Holding Companies    2020      Scope      Currency
translation
     Organic
growth
     2021      Organic
growth %
 
                                                       

Total volumes (thousand hls)

     933        326        -        299        1 558        23.8%  

Revenue

     652        289        22        169        1 133        18.1%  

Cost of sales

     (648)        (142)        (16)        (74)        (880)        (9.5)%  

Gross profit

     4        147        6        95        252        63.8%  

SG&A

     (1 079)        (148)        (25)        (457)        (1 709)        (37.3)%  

Other operating income/(expenses)

     22        1        (1)        (22)        -        (96.6)%  

Normalized EBIT

     (1 053)        1        (20)        (384)        (1 457)        (36.5)%  

Normalized EBITDA

     (677)        2        (11)        (407)        (1 093)        (60.4)%  

REVENUE

Our consolidated revenue grew by 15.6% to 54 304m US dollar with revenue per hectoliter growth of 5.5% driven by premiumization and revenue management initiatives.

COST OF SALES

Our cost of Sales (CoS) increased by 17.4% and increased by 7.2% on a per hectoliter basis, driven by anticipated transactional foreign exchange and commodity headwinds.

OPERATING EXPENSES

Our total operating expenses increased 13.4% in 2021:

 

   

Selling, General & Administrative Expenses (SG&A) increased by 13.9% due primarily to higher variable compensation accruals and elevated supply chain costs.

 

   

Other operating income increased 32.3% primarily driven by higher government grants and sales of non-core assets. In addition, in the second quarter of 2021, Ambev, our subsidiary, recognized 226m US dollar income in Other operating income related to tax credits following a favorable decision from the Brazilian Supreme Court. In the fourth quarter of 2020 Ambev, recognized 481m US dollar related to tax credits in Brazil. The net impact is presented as a scope change.

NORMALIZED PROFIT FROM OPERATIONS BEFORE DEPRECIATION AND AMORTIZATION (NORMALIZED EBITDA)

Our normalized EBITDA increased 11.8% organically to 19 209m US dollar, with an EBITDA margin of 35.4%, representing an EBITDA margin organic contraction of 118 bps.

 

   

North America EBITDA decreased 0.9% to 6 131m US dollar with a margin contraction of (160) bps to 37.7% primarily due to increased selling, general and administrative expenses.

 

   

Middle Americas EBITDA increased 22.4% to 6 126m US dollar with a margin contraction of (96) bps to 48.8%. driven by top-line growth coupled with operational efficiencies.

 

   

South America EBITDA increased 11.7% to 3 125m US dollar with a margin contraction of (401) bps to 32.9% as top-line growth was partially offset by anticipated transactional foreign exchange and commodity headwinds and higher selling, general and administrative expenses.

 

   

EMEA EBITDA increased 30.6% to 2 598m US dollar with a margin enhancement of 308 bps to 32.4%, driven by top-line growth and strong operational leverage.

 

   

Asia Pacific EBITDA increased 25.0% to 2 321m US dollar with a margin enhancement of 277 bps to 33.9% due to top-line growth driven by ongoing premiumization and revenue management initiatives.

 

   

Global Export and Holding Companies EBITDA of (1 093)m US dollar in 2021 (2020: (677)m US dollar).

 

AB InBev – Financial Report 2021 | 8


Differences in normalized EBITDA margins by region are due to a number of factors such as different routes to market, share of returnable packaging in the region’s sales and premium product mix.

RECONCILIATION BETWEEN NORMALIZED EBITDA AND PROFIT ATTRIBUTABLE TO EQUITY HOLDERS

Normalized EBITDA and EBIT are measures utilized by us to demonstrate the company’s underlying performance.

Normalized EBITDA is calculated excluding profit from discontinued operations and the following effects from profit from continuing operations attributable to our equity holders: (i) Non-controlling interest, (ii) Income tax expense, (iii) Share of results of associates, (iv) Net finance cost, (v) Non-underlying net finance cost, (vi) Non-underlying items above EBIT (including non-underlying impairment) and (vii) Depreciation, amortization and impairment.

Normalized EBITDA and EBIT are not accounting measures under IFRS accounting and should not be considered as an alternative to Profit from continuing operations attributable to equity holders as a measure of operational performance or as an alternative to cash flow as a measure of liquidity. Normalized EBITDA and EBIT do not have a standard calculation method and our definition of normalized EBITDA and EBIT may not be comparable to that of other companies.

 

 For the year ended 31 December

 Million US dollar

   Notes        2021        2020  
                                

Profit attributable to equity holders of AB InBev

                4 670          1 405  

Non-controlling interest

                1 444          797  

Profit of the period

                6 114          2 202  

Profit from discontinued operations

     21            -          (2 055)  

Profit from continuing operations

                6 114          147  

Income tax expense

     12            2 350          1 932  

Share of result of associates

     16            (248)          (156)  

Non-underlying net finance cost/(income)

     11            806          1 738  

Net finance cost

     11            4 803          5 959  

Non-underlying items above EBIT (including non-underlying impairment)

     8            614          3 103  

Normalized EBIT

                14 438          12 723  

Depreciation, amortization and impairment (excluding non-underlying impairment)

     10            4 771          4 598  

Normalized EBITDA

                19 209          17 321  

Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the company due to their size or nature. Details on the nature of the non-underlying items are disclosed in Note 8 Non-underlying items.

 

AB InBev – Financial Report 2021 | 9


IMPACT OF FOREIGN CURRENCIES

Foreign currency exchange rates have a significant impact on our financial statements. The following table sets forth the percentage of our revenue realized by currency for 2021 and 2020:

 

      2021        2020   

 US dollar

     29.6%          31.9%   

 Brazilian real

     12.4%          12.7%   

 Chinese yuan

     9.7%          9.1%   

 Mexican peso

     9.4%          8.9%   

 Euro

     6.2%          6.9%   

 Colombian peso

     4.1%          3.8%   

 South African rand

     4.0%          3.3%   

 Canadian dollar

     3.7%          3.9%   

 Argentinean peso¹

     3.0%          2.4%   

 Pound sterling

     2.7%          2.7%   

 Peruvian peso

     2.6%          2.5%   

 Dominican peso

     2.1%          1.9%   

 South Korean won

     2.1%          2.3%   

 Other

     8.1%          7.6%   

The following table sets forth the percentage of our normalized EBITDA realized by currency for 2021 and 2020:

 

      2021        2020   

 US dollar

     32.8%          31.6%   

 Mexican peso

     13.6%          13.0%   

 Brazilian real

     9.8%          14.5%   

 Chinese yuan

     9.4%          7.6%   

 Colombian peso

     5.4%          4.9%   

 Euro

     4.3%          7.1%   

 Peruvian peso

     4.0%          3.6%   

 South African rand

     3.9%          2.6%   

 Dominican peso

     3.0%          2.8%   

 Canadian dollar

     2.9%          2.9%   

 Argentinean peso¹

     2.7%          2.0%   

 South Korean won

     1.7%          1.9%   

 Pound sterling

     0.3%          0.7%   

 Other

     6.2%          5.0%   

In 2021, the fluctuation of the foreign currency rates had a positive translation impact, including hyperinflation accounting impact, of 326m US dollar on our revenue (2020: negative impact of 3 410m US dollar), of 96m US dollar on our normalized EBITDA (2020: negative impact of 1 292m US dollar) and of 35m US dollar on our normalized EBIT (2020: negative impact of 950m US dollar).

Our profit from continuing operations (after tax) has been positively affected by the fluctuation of foreign currencies, including hyperinflation accounting impact, amounted to 41m US dollar (2020: negative impact of 288m US dollar), while the positive translation impact, including hyperinflation accounting impact, on our EPS (profit attributable to our equity holders) was 38m US dollar or 0.02 US dollar per share (2020: negative impact of 174m US dollar or 0.09 US dollar per share).

The impact of the fluctuation of the foreign currencies on our net debt amounted to 1 609m US dollar (decrease of net debt) in 2021, as compared to an impact of 3 426m US dollar (increase of net debt) in 2020. The impact of the fluctuation of the foreign currencies on the equity attributable to our equity holders amounted to 4 320m US dollar (decrease of equity), as compared to an impact of 9 943m US dollar (decrease of equity) in 2020.

 

 

1 Hyperinflation accounting was adopted in 2018 to report the company’s Argentinian operations.

 

AB InBev – Financial Report 2021 | 10


PROFIT

Normalized profit attributable to our equity holders was 5 723m US dollar (normalized EPS 2.85 US dollar) in 2021, compared to 3 807m US dollar (normalized EPS 1.91 US dollar) in 2020. Underlying profit (normalized profit attributable to equity holders of AB InBev excluding mark-to-market gains or losses linked to the hedging of our share-based payment programs and the impact of hyperinflation) was 5 774m US dollar in 2021 (Underlying EPS 2.88 US dollar) as compared to 5 022m US dollar in 2020 (Underlying EPS 2.51 US dollar) (see Note 22 Changes in equity and earnings per share for more details). Profit attributable to our equity holders for 2021 was 4 670m US dollar, compared to 1 405m US dollar for 2020 and includes the following impacts:

 

   

Net finance costs (excluding non-underlying net finance items): 4 803m US dollar in 2021 compared to a net finance cost of 5 959m US dollar in 2020. This decrease was primarily due to mark-to-market adjustment linked to the hedging of our share-based payment programs amounting to a loss of 23m US dollar in 2021, compared to a loss of 1 211m US dollar in 2020 resulting in a change of 1 188m US dollar.

 

   

Non-underlying net finance cost: Non-underlying net finance cost amounted to 806m US dollar in 2021 compared to 1 738m US dollar cost in 2020. 25m US dollar loss resulted from mark-to-market adjustments on derivative instruments entered into to hedge the shares issued in relation to the combination with Grupo Modelo and the restricted shares issued in connection with the combination with SAB (2020: 1 008m US dollar loss) and 741m US dollar loss resulted from the early termination of certain bonds (2020: 795m US dollar loss).

 

   

Non-underlying items: In 2021, we incurred (614)m US dollar of non-underlying costs (2020: (603)m US dollar) mainly comprising of (172)m US dollar of restructuring costs (2020: (157)m US dollar), (247)m US dollar of business and asset disposal costs (including impairment losses), mainly comprising 258m US dollar of non-cash impairment charge associated with Bedford Systems, a joint venture with Keurig Dr. Pepper following the announcement of the cessation of its business in December 2021 (2020: (239)m US dollar of costs mostly related to non-underlying impairment of intangible assets classified as assets held for sale and other intangibles), (105)m US dollar of costs associated with COVID-19 (2020: (182)m US dollar) which mainly relate to personal protection equipment for our colleagues, charitable donations and other costs incurred as a direct consequence of the COVID-19 pandemic, and (72)m US dollar cost related to the Zenzele Kabili scheme. During the second quarter of 2020, we reported a 2.5 billion US dollar non-cash goodwill impairment charge. The goodwill impairment charge was partially offset by a 1.9 billion US dollar gain on the disposal of the Australia operations reported in discontinued operations.

 

   

Income tax expense: 2 350m US dollar in 2021 with an effective tax rate of 28.6% compared to 1 932m US dollar in 2020 with an effective tax rate of 100.4%. The 2021 and 2020 effective tax rates are negatively impacted by the non-deductible losses from derivatives related to the hedging of share-based payment programs and the hedging of the shares issued in a transaction related to the combination with Grupo Modelo and SAB. The effective tax rate for 2020 was also negatively impacted by the non-deductible, non-cash goodwill impairment loss. The normalized effective tax rate excluding mark-to-market gains or losses linked to the hedging of our share-based payment programs was 27.9% in 2021 compared to 26.2% in 2020.

 

   

Profit attributable to non-controlling interest: 1 444m US dollar in 2021 compared to 797m US dollar in 2020.

 

   

Profit from discontinued operations: In 2020, we reported 2 055m US dollar in discontinued operations primarily attributable to an exceptional 1.9 billion US dollar gain on the divestiture of the Australian operations completed on 1 June 2020 (2021: nil).

 

AB InBev – Financial Report 2021 | 11


Liquidity position and capital resources

CASH FLOWS

 

 Million US dollar    2021        2020   

 Cash flow from operating activities

     14 799          10 891   

 Cash flow from investing activities

     (5 878)          6 336   

 Cash flow from financing activities

     (11 598)          (8 475)   

 Net increase/(decrease) in cash and cash equivalents

     (2 677)          8 752   

Cash flow from operating activities

 

 Million US dollar    2021        2020   

 Profit/(loss) from continuing operations

     6 114          147   

 Interest, taxes and non-cash items included in profit

     12 693          17 024   

 Cash flow from operating activities before changes in working capital and use of provisions

     18 806          17 171   

 Change in working capital

     2 459          592   

 Pension contributions and use of provisions

     (375)          (616)   

 Interest and taxes (paid)/received

     (6 197)          (6 391)   

 Dividends received

     106          51   

 Cash flow from operating activities on Australia discontinued operations

     -          84   

 Cash flow from operating activities

     14 799          10 891   

Our cash flow from operating activities reached 14 799m US dollar in 2021 compared to 10 891m US dollar in 2020. The increase primarily results from higher profit and changes in working capital for 2021 compared to 2020 as our results for 2020 were negatively impacted by the COVID-19 pandemic.

Cash flow from investing activities

 

 Million US dollar    2021        2020   

 Net capex

     (5 498)          (3 687)   

 Acquisition and sale of subsidiaries, net of cash acquired/disposed of

     (444)          (510)   

 Net proceeds from sale/(acquisition) of other assets

     65          (292)   

 Proceeds from Australia divestiture

     -          10 838   

 Cash flow from investing activities on Australia discontinued operations

     -          (13)   

 Cash flow from investing activities

     (5 878)          6 336  

Our cash outflow from investing activities was 5 878m US dollar in 2021 compared to a cash inflow of 6 336m US dollar in 2020. The decrease in the cash flow from investing activities was mainly due to the exceptional 10 838m US dollar proceeds from the divestiture of the Australian business reported in 2020 and higher net capital expenditures in 2021 compared to 2020.

Our net capital expenditures amounted to 5 498m US dollar in 2021 and 3 687m US dollar in 2020. Out of the total 2021 capital expenditures approximately 44% was used to improve the company’s production facilities while 41% was used for logistics and commercial investments and 15% was used for improving administrative capabilities and for the purchase of hardware and software.

Cash flow from financing activities

 

 Million US dollar    2021        2020   

 Dividends paid

     (2 364)          (1 800)   

 Net (payments on)/proceeds from borrowings

     (8 511)          (8 294)   

 Payment of lease liabilities

     (531)          (461)   

 Sale/(purchase) of non-controlling interests and other

     (192)          2 086   

 Cash flow from financing activities on Australia discontinued operations

     -          (6)   

 Cash flow from financing activities

     (11 598)          (8 475)   

Our cash outflow from financing activities amounted to 11 598m US dollar in 2021, as compared to a cash outflow of 8 475m US dollar in 2020. The increase is primarily driven by higher dividends paid in 2021 and the issuance of a 49.9% minority stake in our US-based metal container operations to Apollo for net proceeds of 3.0 billion USD in 2020. Proactive deployment of excess cash balances toward gross debt reduction resulted in a cash outflow of 8 294m US dollar and 8 511m US dollar in 2020 and 2021, respectively.

 

AB InBev – Financial Report 2021 | 12


As of 31 December 2021, we had total liquidity of 22.2 billion US dollar, which consisted of 10.1 billion US dollar available under our Sustainability-Linked Loan Revolving Credit Facility (“SLL RCF”) and 12.1 billion US dollar of cash, cash equivalents and short-term investments in debt securities less bank overdrafts. Although we may borrow such amounts to meet our liquidity needs, we principally rely on cash flows from operating activities to fund the company’s continuing operations.

CAPITAL RESOURCES AND EQUITY

Our net debt amounted to 76.2 billion US dollar as of 31 December 2021 as compared to 82.7 billion US dollar as of 31 December 2020. As a result of our business performance and strong cash flow generation in 2021, we reduced gross debt by nearly 10 billion US dollar to 88.8 billion US dollar as of 31 December 2021, leading to a net debt to EBITDA ratio of 3.96x. This ratio is now below 4.0x for the first time since the combination with SAB in 2016.

Net debt is defined as non-current and current interest-bearing loans and borrowings and bank overdrafts minus debt securities and cash. Net debt is a financial performance indicator that is used by our management to highlight changes in the company’s overall liquidity position. We believe that net debt is meaningful for investors as it is one of the primary measures our management uses when evaluating our progress towards deleveraging toward our optimal net debt to normalized EBITDA ratio of around 2x.

Our net debt decreased by 6.5 billion US dollar as of 31 December 2021 compared to 31 December 2020. Aside from operating results that are net of capital expenditures, the net debt is impacted mainly by the payment of interests and taxes (6.2 billion US dollar increase of net debt), dividend payments to shareholders of AB InBev and Ambev (2.4 billion US dollar) and foreign exchange impact on net debt (1.6 billion US dollar decrease of net debt).

Net debt to normalized EBITDA decreased from 4.8x for the 12-month period ending 31 December 2020 to 3.96x for the 12-month period ending 31 December 2021. Deleveraging to around 2x remains our commitment and we will prioritize debt repayment in order to meet this objective.

Consolidated equity attributable to our equity holders as at 31 December 2021 was 68 669m US dollar, compared to 68 024m US dollar as at 31 December 2020. The net increase in equity results from the profit attributable to equity shareholders partially offset by dividends paid and foreign exchange losses on translation of foreign operations primarily related to the combined effect of the weakening of the closing rates of the Colombian pesos, the Peruvian Sol, the South African rand and the Mexican pesos, partially offset by the weakening of the closing rate of the Euro, which resulted in a foreign exchange translation adjustment of 4 320m US dollar as of 31 December 2021 (decrease of equity).

Further details on interest-bearing loans and borrowings, repayment schedules and liquidity risk, are disclosed in Note 23 Interest-bearing loans and borrowings and Note 28 Risks arising from financial instruments.

As of 31 December 2021, the company’s credit rating from Standard & Poor’s was BBB+ for long-term obligations and A-2 for short-term obligations, with a stable outlook, and the company’s credit rating from Moody’s Investors Service was Baa1 for long-term obligations and P-2 for short-term obligations, with a stable outlook.

 

AB InBev – Financial Report 2021 | 13


Research and development

Given our focus on innovation, we place a high value on research and development. In 2021, we spent 298m US dollar in research and development (2020: 296m US dollar). The spent focused on product innovations, market research, as well as process optimization and product development.

Research and development in product innovation covers liquid, packaging and draft innovation. Product innovation consists of breakthrough innovation, incremental innovation and renovation. The main goal for the innovation process is to provide consumers with better products and experiences. This implies launching new liquid, new packaging and new draught products that deliver better performance both for the consumer and in terms of top-line results, by increasing our competitiveness in the relevant markets. With consumers comparing products and experiences offered across very different drink categories and the offering of beverages increasing, our research and development efforts also require an understanding of the strengths and weaknesses of other beverage categories, spotting opportunities for beer and developing consumer solutions (products) that better address consumer need and deliver better experience. This requires understanding consumer emotions and expectations. Sensory experience, premiumization, convenience, sustainability and design are all central to our research and development efforts.

Research and development in process optimization is primarily aimed at quality improvement, capacity increase (plant debottlenecking and addressing volume issues, while minimizing capital expenditure) and improving efficiency. Newly developed processes, materials and/or equipment are documented in best practices and shared across business regions. Current projects range from malting to bottling of finished products.

Knowledge management and learning is also an integral part of research and development. We seek to continuously increase our knowledge through collaborations with universities and other industries.

Our research and development team is briefed annually on the company’s and the business regions’ priorities and approves concepts which are subsequently prioritized for development. The research & development teams invest in both short- and long-term strategic projects for future growth, with the launch time depending on complexity and prioritization. Launch time usually falls within the next calendar year.

The Global Innovation and Technology Center (“GITeC”), located in Leuven, accommodates the Packaging, Product, Process Development teams and facilities such as Labs, Experimental Brewery and the European Central Lab, which also includes Sensory Analysis. In addition to GITeC, we also have Product, Packaging and Process development teams located in each of our geographic regions focusing on the short-term needs of such regions.

 

AB InBev – Financial Report 2021 | 14


Risks and uncertainties

Under the explicit understanding that this is not an exhaustive list, AB InBev’s major risk factors and uncertainties are listed below. There may be additional risks which AB InBev is unaware of. There may also be risks AB InBev now believes to be immaterial, but which could turn out to have a material adverse effect. Moreover, if and to the extent that any of the risks described below materialize, they may occur in combination with other risks which would compound the adverse effect of such risks. The sequence in which the risk factors are presented below is not indicative of their likelihood of occurrence or of the potential magnitude of their financial consequence.

AB InBev’s business, financial condition, cash flows and operating results have been and may continue to be negatively impacted by the COVID-19 pandemic. AB InBev has experienced disruptions to its ability to operate its production facilities in some countries, and in the future, it may experience further disruption to its ability to operate its production facilities or distribution operations as a result of regulatory restrictions, safety protocols, social distancing requirements and heightened sanitation measures. AB InBev has also experienced constraints in its ability to source beverage containers and disruptions in the availability of transportation services and labor in certain markets, and may experience further disruption to its supply chain and distribution operations. Any sustained interruption in AB InBev’s operations or its business partners’ operations, distribution network or supply chain, or any significant continuous shortage of raw materials or other supplies could impact AB InBev’s ability to make, manufacture, distribute or sell its products or may result in an increase in its costs of production and distribution. Sales of AB InBev’s products in the on-premise channel have been significantly impacted by the implementation of social distancing and lockdown measures in most of its markets, including the closure of bars, clubs and restaurants and restrictions on sporting events, music festivals and similar events. Although sales in the on-premise channel improved as a result of the easing of social distancing and lockdown measures in many of these markets, such improvements have been, and may continue to be, impacted by the re-implementation of restrictions in certain markets due to the emergence and spread of new COVID-19 variants. Any future outbreak or recurrence of COVID-19 cases in other markets that have eased social distancing and lock down measures may similarly result in the re-implementation of such measures and a further negative impact on our sales. If the COVID-19 pandemic intensifies and expands geographically, or efforts to curb the pandemic are ineffective, its negative impacts on AB InBev’s sales could be more prolonged and may become more severe. Deteriorating economic and political conditions in many of AB InBev’s major markets affected by the COVID-19 pandemic, such as increased unemployment, decreases in disposable income, declines in consumer confidence, or economic slowdowns or recessions, could cause a further decrease in demand for its products. Furthermore, the ongoing economic impacts and health concerns associated with the COVID-19 pandemic may continue to affect consumer behavior, spending levels and consumption preferences. The impact of the COVID-19 pandemic on global economic conditions has impacted and may continue to impact the proper functioning of financial and capital markets, as well as foreign currency exchange rates, commodity and energy prices and interest rates. A continuation or worsening of the levels of market disruption and volatility seen in the recent past could have an adverse effect on AB InBev’s ability to access, or costs of, capital or borrowings, its business, its liquidity, its net debt to EBITDA ratio, credit ratings, results of operations and financial condition. Compliance with governmental measures imposed in response to COVID-19 has caused and may continue to cause us to incur additional costs, and any inability to comply with such measures can subject AB InBev to restrictions on its business activities, fines, and other penalties, any of which can adversely affect its business. In addition, responses to the COVID-19 pandemic may result in both short-term and long-term changes to fiscal and tax policies in impacted jurisdictions, including increases in tax rates.

Any of the negative impacts of the COVID-19 pandemic (or any future outbreak or recurrence of COVID-19 following the relaxation of social distancing and lockdown measures or the emergence and spread of new COVID-19 variants), including those described above, alone or in combination with others, may have a material adverse effect on AB InBev’s results of operations, financial condition and cash flows.

AB InBev is exposed to the risk of a global recession or a recession in one or more of its key markets, and to credit and capital market volatility and an economic or financial crisis (including as a result of the COVID-19 pandemic), or otherwise. These could result in reduced consumption or sales prices of AB InBev’s products, which in turn could result in lower revenue and reduced profit. AB InBev’s financial condition and results of operations, as well as AB InBev’s future prospects, would likely be hindered by an economic downturn in any of its key markets. Consumption of beer and other alcohol and non-alcohol beverages in many of the jurisdictions in which AB InBev operates is closely linked to general economic conditions and changes in disposable income. A continuation or worsening of the levels of market disruption and volatility seen in the recent past could have an adverse effect on AB InBev’s ability to access capital, its business, results of operations and financial condition, and on the market price of its shares and American Depositary Shares.

AB InBev’s results of operations are affected by fluctuations in exchange rates. Any change in exchange rates between AB InBev’s operating companies’ functional currencies and the U.S. dollar will affect its consolidated income statement and balance sheet when the results of those operating companies are translated into U.S. dollar for reporting purposes as

 

AB InBev – Financial Report 2021 | 15


translational exposures are not hedged. Also, there can be no assurance that the policies in place to manage commodity price and transactional foreign currency risks to protect AB InBev’s exposure will be able to successfully hedge against the effects of such foreign exchange exposure, especially over the long-term. Further, the use of financial instruments to mitigate currency risk and any other efforts taken to better match the effective currencies of AB InBev’s liabilities to its cash flows could result in increased costs.

Following the categorization of Argentina in AB InBev’s results for the third quarter of 2018 as a country with a three-year cumulative inflation rate greater than 100%, the country is considered as a hyperinflationary economy in accordance with IFRS rules (IAS 29), resulting in the restatement of certain results for hyperinflation accounting. If the economic or political situation in Argentina further deteriorates, the South America operations may be subject to additional restrictions under new Argentinean foreign exchange, export repatriation or expropriation regimes that could adversely affect AB InBev’s liquidity and operations, and ability to access funds from Argentina.

AB InBev may not be able to obtain the necessary funding for its future capital or refinancing needs and may face financial risks due to its level of debt and uncertain market conditions. AB InBev may be required to raise additional funds for its future capital needs or to refinance its current indebtedness through public or private financing, strategic relationships or other arrangements and there can be no assurance that the funding, if needed, will be available or provided on attractive terms. AB InBev has incurred substantial indebtedness by entering into a senior credit facility and accessing the bond markets from time to time based on its financial needs, including as a result of the acquisition of SAB. The portion of AB InBev’s consolidated balance sheet represented by debt will remain significantly higher as compared to its historical position. AB InBev’s increased level of debt could have significant consequences for AB InBev, including (i) increasing its vulnerability to general adverse economic and industry conditions, (ii) limiting its flexibility in planning for, or reacting to, changes in its business and the industry in which AB InBev operates, (iii) impairing its ability to obtain additional financing in the future and limiting its ability to fund future working capital and capital expenditures, to engage in future acquisitions or development activities or to otherwise realize the value of its assets and opportunities fully, (iv) requiring AB InBev to issue additional equity (potentially under unfavorable market conditions), and (v) placing AB InBev at a competitive disadvantage compared to its competitors that have less debt. AB InBev’s ability to repay and renegotiate its outstanding indebtedness will be dependent upon market conditions. Unfavorable conditions, including significant price volatility, dislocations and liquidity disruptions in the global credit markets in recent years, as well as downward pressure on credit capacity for certain issuers without regard to those issuers’ underlying financial strength, could increase costs beyond what is currently anticipated. Such costs could have a material adverse impact on AB InBev’s cash flows, results of operations or both. Further, AB InBev may restrict the amount of dividends it will pay as a result of AB InBev’s level of debt and its strategy to give priority to deleveraging toward its optimal net debt to normalized EBITDA ratio of around 2x.

Also, a credit rating downgrade could have a material adverse effect on AB InBev’s ability to finance its ongoing operations or to refinance its existing indebtedness. In addition, a failure of AB InBev to refinance all or a substantial amount of its debt obligations when they become due, or more generally a failure to raise additional equity capital or debt financing or to realize proceeds from asset sales when needed, would have a material adverse effect on its financial condition and results of operations.

AB InBev’s results could be negatively affected by increasing interest rates or the future discontinuance of certain benchmarks. Although AB InBev enters into interest rate swap agreements to manage its interest rate risk and also enters into cross-currency interest rate swap agreements to manage both its foreign currency risk and interest-rate risk on interest-bearing financial liabilities, there can be no assurance that such instruments will be successful in reducing the risks inherent in exposures to interest rate fluctuations.

The ability of AB InBev’s subsidiaries to distribute cash upstream may be subject to various conditions and limitations. The inability to obtain sufficient cash flows from its domestic and foreign subsidiaries and affiliated companies could adversely impact AB InBev’s ability to pay dividends and otherwise negatively impact its business, results of operations and financial condition.

Changes in the availability or price of raw materials, commodities, energy and water, including as a result of currency fluctuations, constraints on sourcing and unexpected increases in tariffs on such raw materials and commodities, like aluminum, could have an adverse effect on AB InBev’s results of operations to the extent that AB InBev fails to adequately manage the risks inherent in such volatility, including if AB InBev’s hedging and derivative arrangements do not effectively or completely hedge against foreign currency risks and changes in commodity prices.

Certain of AB InBev’s operations depend on effective distribution networks to deliver its products to consumers, and distributors play an important role in distributing a significant proportion of beer and other beverages. Generally, distributors purchase AB InBev’s products from AB InBev and then on-sell them either to other distributors or points of sale. Such distributors are either government-controlled or privately owned but independent wholesale distributors for distribution of AB InBev’s products, and there can be no assurance that such distributors will not give priority to AB InBev’s competitors.

 

AB InBev – Financial Report 2021 | 16


Further, any inability of AB InBev to replace unproductive or inefficient distributors, who could engage in practices that harm AB InBev’s reputation as consumers look to AB InBev for the quality and availability of its products, or any limitations imposed on AB InBev to purchase or own any interest in distributors or wholesalers as a result of contractual restrictions, regulatory changes, changes in legislation or the interpretations of legislation by regulators or courts could adversely impact AB InBev’s business, results of operations and financial condition.

The continued consolidation of retailers in markets in which AB InBev operates could result in reduced profitability for the beer industry as a whole and indirectly adversely affect AB InBev’s financial results.

AB InBev relies on key third parties, including key suppliers, for a range of raw materials for its beer, alcoholic beverages and soft drinks, and for packaging material. The termination of or any material change to arrangements with certain key suppliers or the failure of a key supplier to meet its contractual obligations could have a material impact on AB InBev’s production, distribution and sale of beer, alcoholic beverages and soft drinks and have a material adverse effect on AB InBev’s business, results of operations, cash flows or financial condition. Certain of AB InBev’s subsidiaries may purchase nearly all of their key packaging materials from sole suppliers under multi-year contracts. The loss of or temporary discontinuity of supply from any of these suppliers without sufficient time to develop an alternative source could cause AB InBev to spend increased amounts on such supplies in the future. In addition, a number of key brand names are both licensed to third-party brewers and used by companies over which AB InBev does not have control. Although AB InBev monitors brewing quality to ensure its high standards, to the extent that one of these key brand names or joint ventures, companies in which AB InBev does not own a controlling interest and/or AB InBev’s licensees are subject to negative publicity, it could have a material adverse effect on AB InBev’s business, results of operations, cash flows or financial condition.

A portion of the company’s global portfolio consists of associates in new or developing markets, including investments where the company may have a lesser degree of control over the business operations. The company faces several challenges inherent to these various culturally and geographically diverse business interests. Although the company works with its associates on the implementation of appropriate processes and controls, the company also faces additional risks and uncertainties with respect to these minority investments because the company may be dependent on systems, controls and personnel that are not under the company’s control, such as the risk that the company’s associates may violate applicable laws and regulations, which could have an adverse effect on the company’s business, reputation, results of operations and financial condition.

AB InBev may have a conflict of interest with its majority-owned subsidiaries. For example, a conflict of interest could arise if the subsidiary brings a legal claim for an alleged contractual breach, which could materially and adversely affect AB InBev’s financial condition. A conflict of interest may also arise as a result of any dual roles played by AB InBev directors who may also be managers or senior officers in the subsidiary. Notwithstanding policies and procedures to address the possibility of such conflicts of interest, AB InBev may not be able to resolve all such conflicts on terms favorable to AB InBev.

The size of AB InBev, contractual limitations it is subject to and its position in the markets in which it operates may decrease its ability to successfully carry out further acquisitions and business integrations. AB InBev cannot enter into further transactions unless it can identify suitable candidates and agree on the terms with them. The size of AB InBev and its position in the markets in which it operates may make it harder to identify suitable candidates, including because it may be harder for AB InBev to obtain regulatory approval for future transactions. If appropriate opportunities do become available, AB InBev may seek to acquire or invest in other businesses; however, any future acquisition may pose regulatory, antitrust and other risks.

An inability to reduce costs could affect AB InBev’s profitability. Additionally, the Tax Matters Agreement AB InBev has entered into with Altria Group Inc. imposes some limits on the ability of the Combined Group to effect some reorganizations which it may otherwise consider.

Failure to generate significant cost savings and margin improvement through initiatives for improving operational efficiencies could adversely affect AB InBev’s profitability and AB InBev’s ability to achieve its financial goals. AB InBev is pursuing a number of initiatives to improve operational efficiency. If AB InBev fails for any reason to successfully complete these measures and programs as planned or to derive the expected benefits from these measures and programs, there is a risk of increased costs associated with these efforts, delays in benefit realization, disruption to the business, reputational damage or a reduced competitive advantage in the medium term.

AB InBev entered into a consent decree with the U.S. Department of Justice in relation to the combination with SAB, pursuant to which AB InBev’s subsidiary, Anheuser-Busch Companies, LLC, agreed not to acquire control of a distributor if doing so would result in more than 10% of its annual volume being distributed through distributorships controlled by AB InBev in the U.S. AB InBev’s compliance with its obligations under the settlement agreement is monitored by the U.S. Department of

 

AB InBev – Financial Report 2021 | 17


Justice and the Monitoring Trustee appointed by them. Were AB InBev to fail to fulfill its obligations under the consent decree, whether intentionally or inadvertently, AB InBev could be subject to monetary fines or other penalties.

A substantial portion of AB InBev’s operations are carried out in developing European, African, Asian and Latin American markets. AB InBev’s operations and equity investments in these markets are subject to the customary risks of operating in developing countries, which include, amongst others, political instability or insurrection, human rights concerns, external interference, financial risks, changes in government policy, political and economic changes, changes in the relations between countries, actions of governmental authorities affecting trade and foreign investment, regulations on repatriation of funds, interpretation and application of local laws and regulations, enforceability of intellectual property and contract rights, local labor conditions and regulations, lack of upkeep of public infrastructure, potential political and economic uncertainty, application of exchange controls, nationalization or expropriation, empowerment legislation and policy, corrupt business environments, crime and lack of law enforcement as well as financial risks, which include risk of illiquidity, inflation, devaluation, price volatility, currency convertibility and country default. Moreover, the economies of developing countries are often affected by changes in other developing market countries, and, accordingly, adverse changes in developing markets elsewhere in the world could have a negative impact on the markets in which AB InBev operates. Such developing market risks could adversely impact AB InBev’s business, results of operations and financial condition. Furthermore, the global reach of AB InBev’s operations exposes it to risks associated with doing business globally, including changes in tariffs. The Office of the United States Trade Representative has enacted tariffs on certain imports into the United States from China. If significant tariffs or other restrictions are placed on imports from China or any retaliatory trade measures are taken by China, this could have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade, which in turn could have a material adverse effect on AB InBev’s business in one or more of its key markets and results of operations.

Competition and changing consumer preferences in its various markets and increased purchasing power of players in AB InBev’s distribution channels could cause AB InBev to reduce prices of its products, increase capital investment, increase marketing and other expenditures or prevent AB InBev from increasing prices to recover higher costs and thereby cause AB InBev to reduce margins or lose market share. Also, innovation faces inherent risks, and the new products AB InBev introduces may not be successful, while competitors may be able to respond more quickly to the emerging trends, such as the increasing consumer preference for “craft beers” produced by smaller microbreweries. In recent years, many industries have seen disruption from non-traditional producers and distributors, in many cases, from digital only competitors. AB InBev’s business could be negatively affected if it is unable to anticipate changing consumer preference for such platforms. Any of the foregoing could have a material adverse effect on AB InBev’s business, financial condition and results of operations.

If any of AB InBev’s products is defective or found to contain contaminants, AB InBev may be subject to product recalls or other associated liabilities. Although AB InBev maintains insurance against certain product liability (but not product recall) risks, it may not be able to enforce its rights in respect of these policies and, in the event that contamination or a defect occurs, any amounts it recovers may not be sufficient to offset any damage it may suffer, which could adversely impact its business, reputation, prospects, results of operations and financial condition.

In recent years, there has been public and political attention directed at the soft drinks and alcoholic beverage industries, as a result of a rising health and well-being trend. Despite the progress made on AB InBev’s Smart Drinking Goals, AB InBev may be criticized and experience an increase in the number of publications and studies debating its efforts to reduce the harmful consumption of alcohol, as advocates try to shape the public discussions. AB InBev may also be subject to laws and regulations aimed at reducing the affordability or availability of beer in some of its markets. Additional regulatory restrictions on AB InBev’s business, such as those on the legal minimum drinking age, product labeling, opening hours or marketing activities, may cause the social acceptability of beer to decline significantly and consumption trends to shift away from it, which would have a material adverse effect on AB InBev’s business, financial condition and results of operations.

Negative publicity and campaigns by activists, whether or not warranted, connecting us, our supply chain or our business partners with workplace and human rights issues, whether actual or perceived, could adversely impact our corporate image and reputation and may cause our business to suffer. We have made a number of commitments to respect human rights, including our commitment to the principles and guidance contained in the UN Guiding Principles on Business and Human Rights, through our policies. Allegations, even if untrue, that we are not respecting our commitments or actual or perceived failure by our suppliers or other business partners to comply with applicable workplace and labor laws, including child labor laws, or their actual or perceived abuse or misuse of migrant workers could negatively affect our overall reputation and brand image.    

AB InBev could incur significant costs as a result of compliance with, and/or violations of or liabilities under, various regulations that govern AB InBev´s operations or the operations of its licensed third parties, including the General Data Protection Regulation adopted in the European Union, which was fully implemented in May 2018.

 

AB InBev – Financial Report 2021 | 18


A wholly-owned subsidiary of Labatt Breweries of Canada (“Labatt”), the Canadian subsidiary of our subsidiary Ambev, researches non-alcohol beverages containing tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”), both derived from cannabis, and also commercializes a non-alcohol CBD beverage in Canada only, which could lead to increased legal, reputational and financial risks as the laws and regulations governing recreational cannabis are still developing, including in ways that AB InBev may not foresee. For instance, the involvement in the legal cannabis industry in Canada may invite new regulatory and enforcement scrutiny in other markets. Cannabis remains illegal in many markets in which AB InBev operates, and violations of Law could result in significant fines, penalties, administrative sanctions, convictions or settlements arising from civil proceedings or criminal charges. Furthermore, the political environment and popular support for cannabis legalization has changed quickly and remains in flux.

AB InBev is now, and may in the future be, a party to legal proceedings and claims, including collective suits (class actions), and significant damages may be asserted against it. Given the inherent uncertainty of litigation, it is possible that AB InBev might incur liabilities as a consequence of the proceedings and claims brought against it, including those that are not currently believed by it to be reasonably possible, which could have a material adverse effect on AB InBev’s business, results of operations, cash flows or financial position. Important contingencies are disclosed in Note 30 Contingencies of the 2021 consolidated financial statements.

AB InBev may be subject to adverse changes in taxation, which makes up a large proportion of the cost of beer charged to consumers in many jurisdictions. Increases in excise and other indirect taxes applicable to AB InBev’s products tend to adversely affect AB InBev’s revenue or margins, both by reducing overall consumption and by encouraging consumers to switch to other categories of beverages, including unrecorded or informal alcohol products. Minimum pricing is another form of fiscal regulation that can affect AB InBev’s profitability. Furthermore, AB InBev may be subject to increased taxation on its operations by national, local or foreign authorities, to higher corporate income tax rates or to new or modified taxation regulations and requirements (including potential changes in the U.S and Brazil). For example, in response to the increasing globalization and digitalization of trade and business operations, the Organization for Economic Co-operation and Development (OECD) is working on proposals for international tax reform as an extension of its Base Erosion and Profit Shifting project. The proposals are comprised in a two-pillar approach: Pillar One, which is focused on the re-allocation of some of the taxable profits of multinational enterprises to the markets where consumers are located; and Pillar Two, which is focused on establishing a global minimum corporate taxation rate. In June 2021, the finance ministers of the G7 nations announced an agreement on the principles of the two-pillar approach. Subsequently, in October 2021, the OECD/G20 Inclusive Framework announced that 136 countries and jurisdictions had joined an agreement on the two-pillar approach, including the establishment of a global minimum corporate tax rate of 15%. The OECD aims for a multilateral convention on Pillar One to be signed in 2022 and implemented in 2023. The aim for Pillar Two is for domestic legislation to be introduced during the course of 2022 and become effective in 2023 and for treaty changes to be implemented by a multilateral instrument in 2024. Changes in tax treaties, the introduction of new legislation, updates to existing legislation, or changes to regulatory interpretations of existing legislation as a result of these or similar proposals could impose additional taxes on businesses and increase the complexity, burden and cost of tax compliance in countries where we operate. An increase in excise taxes or other taxes could adversely affect the financial results of AB InBev as well as its results of operations.

Antitrust and competition laws and changes in such laws or in the interpretation and enforcement thereof, as well as being subject to regulatory scrutiny, could affect AB InBev’s business or the businesses of its subsidiaries. For example, in connection with AB InBev’s previous acquisitions, various regulatory authorities have imposed (and may impose) conditions with which AB InBev is required to comply. The terms and conditions of certain of such authorizations, approvals and/or clearances required, among other things, the divestiture of the company’s assets or businesses to third parties, changes to the company’s operations, or other restrictions on the company’s ability to operate in certain jurisdictions. Such actions could have a material adverse effect on AB InBev’s business, results of operations, financial condition and prospects. In addition, such conditions could diminish substantially the synergies and advantages which the company expects to achieve from such future transactions.

AB InBev operates its business and markets its products in emerging markets that, as a result of political and economic instability, a lack of well-developed legal systems and potentially corrupt business environments, present it with political, economic and operational risks. Although AB InBev is committed to conducting business in a legal and ethical manner in compliance with local and international statutory requirements and standards applicable to its business, there is a risk that the employees or representatives of AB InBev’s subsidiaries, affiliates, associates, joint ventures/operations or other business interests may take actions that violate applicable laws and regulations that generally prohibit the making of improper payments to foreign government officials for the purpose of obtaining or keeping business, including laws relating to the 1997 OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions such as the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act.

Although AB InBev’s operations in Cuba are quantitatively immaterial, its overall business reputation may suffer or it may face additional regulatory scrutiny as a result of Cuba being a target of U.S. economic and trade sanctions. In addition, in

 

AB InBev – Financial Report 2021 | 19


January 2021, the former Trump Administration designated Cuba as a state sponsor of terrorism. If investors decide to liquidate or otherwise divest their investments in companies that have operations of any magnitude in Cuba, the market in and value of AB InBev’s securities could be adversely impacted. In addition, Title III of U.S. legislation known as the “Helms-Burton Act” authorizes private lawsuits for damages against anyone who traffics in property confiscated without compensation by the Government of Cuba from persons who at the time were, or have since become, nationals of the United States. Although this section of the Helms-Burton Act has been suspended by discretionary presidential action since its inception in 1996, on 2 May 2019, the former Trump Administration activated Title III of the Helms-Burton Act, thereby allowing nationals of the United States that hold claims under the Helms-Burton Act to file suit in U.S. federal court against all persons trafficking in property confiscated by the Cuban government.

As a result of the activation of Title III of the Helms-Burton Act, AB InBev may be subject to potential U.S. litigation exposure beginning 2 May 2019, including claims accrued during the prior suspension of Title III of the Helms-Burton Act. Given the unprecedented activation of Title III of the Helms-Burton Act, there is substantial uncertainty as to how the statute will be interpreted by U.S. courts. AB InBev has received notice of a claim purporting to be made under the Helms-Burton Act. It remains unclear how the activation of Title III of the Helms-Burton Act will impact AB InBev’s U.S. litigation exposure with respect to this notice of claim.

AB InBev relies on the reputation of its brands and its success depends on its ability to maintain and enhance the image and reputation of its existing products and to develop a favorable image and reputation for new products. An event, or series of events, that materially damages the reputation of one or more of AB InBev’s brands could have an adverse effect on the value of that brand and subsequent revenues from that brand or business. Further, any restrictions on the permissible advertising style, media channels and messages used may constrain AB InBev’s brand building potential and thus reduce the value of its brands and related revenues.

AB InBev may not be able to protect its current and future brands and products and defend its intellectual property rights, including trademarks, patents, domain names, trade secrets and know-how, which could have a material adverse effect on its business, results of operations, cash flows or financial condition, and in particular, on AB InBev’s ability to develop its business.

If the business of AB InBev does not develop as expected, or if the adverse economic impacts of the COVID-19 pandemic continue, impairment charges on goodwill or other intangible assets may be incurred in the future that could be significant and that could have an adverse effect on AB InBev’s results of operations and financial condition.

Climate change or other environmental concerns, or legal, regulatory or market measures to address climate change or other environmental concerns, could have a long-term, material adverse impact on AB InBev’s business and results of operations. In addition, social attitudes, customer preferences and investor sentiment are increasingly influenced by environmental, social and corporate governance (“ESG”) considerations, and as a result AB InBev may face pressure from its shareholders, regulators, suppliers, customers or consumers to further address ESG-related concerns, and may be subject to regulatory inquiry or legal action. Further, water scarcity or poor water quality may affect AB InBev by increasing production costs and capacity constraints, which could adversely affect AB InBev’s business and results of operations. Additionally, AB InBev’s inability to meet its compliance obligations under EU emissions trading regulations may also have an adverse impact on AB InBev’s business and results of operations.

AB InBev’s operations are subject to environmental regulations, which could expose it to significant compliance costs and litigation relating to environmental issues.

Further, AB InBev may be exposed to labor strikes, disputes and work stoppages or slowdowns, within its operations or those of its suppliers, or an interruption or shortage of raw materials for any other reason that could lead to a negative impact on AB InBev’s costs, earnings, financial condition, production level and ability to operate its business. AB InBev’s production may also be affected by work stoppages or slowdowns that affect its suppliers, distributors and retail delivery/logistics providers as a result of disputes under existing collective labor agreements with labor unions, in connection with negotiations of new collective labor agreements, as a result of supplier financial distress or for other reasons. A work stoppage or slowdown at AB InBev’s facilities could interrupt the transport of raw materials from its suppliers or the transport of its products to its customers. Such disruptions could put a strain on AB InBev’s relationships with suppliers and customers and may have lasting effects on its business even after the disputes with its labor force have been resolved, including as a result of negative publicity.

AB InBev relies on information and operational technology systems, networks and services to support a variety of business processes and activities, including procurement and supply chain, manufacturing, distribution and consumer marketing, and process, transmit, and store electronic information. Although AB InBev takes various actions to prevent cyber-attacks and to minimize potential technology disruptions, such disruptions could impact AB InBev’s business and expose it to legal claims or regulatory penalties. For example, if outside parties gained access to AB InBev’s confidential data or strategic

 

AB InBev – Financial Report 2021 | 20


information and appropriated such information or made such information public, this could harm AB InBev’s reputation or its competitive advantage, or could expose AB InBev or its customers to a risk of loss or misuse of information. More generally, technology disruptions can have a material adverse effect on AB InBev’s business, results of operations, cash flows or financial condition.

AB InBev may not be able to recruit or retain key personnel and successfully manage them, which could disrupt AB InBev’s business and have an unfavorable material effect on AB InBev’s financial position, its income from operations and its competitive position.

AB InBev’s business and operating results could be negatively impacted by social, technical, natural, physical, public health or other disasters.

Although AB InBev maintains insurance policies to cover various risks, it also uses self-insurance for most of its insurable risks. Should an uninsured loss or a loss in excess of insured limits occur, this could adversely impact AB InBev’s business, results of operations and financial condition.

AB InBev’s ordinary shares currently trade on Euronext Brussels in euros, the Johannesburg Stock Exchange in South African rand, the Mexican Stock Exchange in Mexican pesos and its ordinary shares represented by American Depositary Shares (the “ADSs”) trade on the New York Stock Exchange in U.S. dollars. Fluctuations in the exchange rates between the euro, the South African rand, the Mexican peso and the U.S. dollar may result in temporary differences between the value of AB InBev’s ordinary shares trading in different currencies, and between its ordinary shares and its ADSs, which may result in heavy trading by investors seeking to exploit such differences.

RISKS ARISING FROM FINANCIAL INSTRUMENTS

Note 28 of the 2021 consolidated financial statements on Risks arising from financial instruments contain detailed information on the company’s exposures to financial risks and its risk management policies.

Changes in labels of alternative performance measurements (“APMs”)

Following a report on European Union (EU) issuers’ use of Alternative Performance Measures (i.e., non-IFRS measures, or “APMs”), issued by the European Securities and Markets Authority (ESMA) in December 2019, the company has relabeled “non-recurring” items to “non-underlying” items.

Events after the balance sheet date

Please refer to Note 33 Events after the balance sheet date of the consolidated financial statements.

Corporate governance

For information with respect to Corporate Governance, please refer to the Corporate Governance section, which forms an integral part of our annual report.

 

AB InBev – Financial Report 2021 | 21


Statement of the Board of Directors

 

 

The Board of Directors of AB InBev SA/NV certifies, on behalf and for the account of the company, that, to their knowledge, (a) the financial statements which have been prepared in accordance with International Financial Reporting Standards give a true and fair view of the assets, liabilities, financial position and profit or loss of the company and the entities included in the consolidation as a whole and (b) the management report includes a fair review of the development and performance of the business and the position of the company and the entities included in the consolidation as a whole, together with a description of the principal risks and uncertainties they face.

 

AB InBev – Financial Report 2021 | 22


Independent auditors’ report

 

 

 

LOGO                      

STATUTORY AUDITOR’S REPORT TO THE GENERAL SHAREHOLDERS’ MEETING OF ANHEUSER-BUSCH INBEV NV/SA ON THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

 

 

We present to you our statutory auditor’s report in the context of our statutory audit of the consolidated financial statements of Anheuser-Busch InBev NV/SA (the “Company”) and its subsidiaries (jointly “the Group”). This report includes our report on the consolidated financial statements, as well as the other legal and regulatory requirements. This forms part of an integrated whole and is indivisible.

We have been appointed as statutory auditor by the general meeting d.d. 24 April 2019, following the proposal formulated by the board of directors and following the recommendation by the audit committee and the proposal formulated by the works’ council. Our mandate will expire on the date of the general meeting which will deliberate on the annual accounts for the year ended 31 December 2021. We have performed the statutory audit of the consolidated financial statements of Anheuser-Busch InBev NV/SA for three consecutive years.

Report on the consolidated financial statements

Unqualified opinion

We have performed the statutory audit of the Group’s consolidated financial statements, which comprise the consolidated statement of financial position as at 31 December 2021, the consolidated income statement, the consolidated statement of comprehensive income, the consolidated statement of changes in equity and the consolidated statement of cash flows for the year then ended, and the notes to the consolidated financial statements, including a summary of significant accounting policies and other explanatory information, and which is characterised by a consolidated statement of financial position total of USD 217 627 million and a profit for the year of USD 6 114 million.

In our opinion, the consolidated financial statements give a true and fair view of the Group’s net equity and consolidated financial position as at 31 December 2021, and of its consolidated financial performance and its consolidated cash flows for the year then ended, in accordance with International Financial Reporting Standards as adopted by the European Union and with the legal and regulatory requirements applicable in Belgium.

Basis for unqualified opinion

We conducted our audit in accordance with International Standards on Auditing (ISAs) as applicable in Belgium. Furthermore, we have applied the International Standards on Auditing as approved by the IAASB which are applicable to the year-end and which are not yet approved at the national level. Our responsibilities under those standards are further described in the “Statutory auditor’s responsibilities for the audit of the consolidated financial statements” section of our report. We have fulfilled our ethical responsibilities in accordance with the ethical requirements that are relevant to our audit of the consolidated financial statements in Belgium, including the requirements related to independence. We have obtained from the board of directors and Company officials the explanations and information necessary for performing our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key audit matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements of the current period. These matters were addressed in the context of our audit of the consolidated financial statements as a whole and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

 

AB InBev – Financial Report 2021 | 23


   

 

Key Audit Matter

 

  

 

How our audit addressed the key audit matter

 

   
Impairment of goodwill and intangible assets with indefinite useful life     
   

As described in Notes 4, 14 and 15 to the consolidated financial statements, the Company has recorded goodwill and intangible assets with indefinite useful life for an amount of $115 796 million and $38 320 million, respectively, as of 31 December, 2021. Impairment analyses of goodwill and indefinite-lived intangible assets are performed annually and whenever a triggering event has occurred, in order to determine whether the carrying value exceeds the recoverable amount.

 

Impairment tests are conducted by management, in accordance with IAS 36, in which management applies a discounted cash flow approach based on current acquisition valuation models for its cash-generating units showing an invested capital to EBITDA multiple above 9x and valuation multiples for its other cash-generating units. The Company uses a strategic plan based on external sources in respect of macro-economic assumptions, industry, inflation and foreign exchange rates, past experience and identified initiatives in terms of market share, revenue, variable and fixed cost, capital expenditure and working capital assumptions. Management’s cash flow projections include significant judgement, estimates and assumptions, related to the weighted average cost of capital and the terminal growth rate.

 

The principal considerations for our determination that performing procedures relating to the impairment of goodwill and intangible assets with indefinite useful life is a key audit matter are the following: (i) the high degree of auditor judgment and subjectivity in applying procedures relating to the valuation of the cash-generating units due to the significant amount of judgment by management when developing this estimate, (ii) the audit effort involved the use of professionals with specialized skill and knowledge to assist in evaluating the audit evidence obtained from these procedures and (iii) the significant audit effort necessary in evaluating the significant assumptions relating to the estimate, related to the weighted average cost of capital and the terminal growth rate.

 

  

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill and indefinite-lived asset impairment testing, including controls over the valuation of the Company’s cash-generating units.

 

These procedures also included, among others, testing management’s process for developing the fair value estimates; evaluating the appropriateness of the discounted cash flow model; testing the completeness, accuracy, and relevance of underlying data used in the models; and, with the assistance of professionals with specialized skill and knowledge, evaluating the significant assumptions used by management, related to the weighted average cost of capital and the terminal growth rate.

 

Evaluating management’s assumptions involved evaluating whether the assumptions used by management were reasonable considering (i) the current and past performance of the cash-generating unit, (ii) the consistency with external market and industry data, (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit and (iv) analysis of sensitivities in the Company’s discounted cash flow model.

   

Key Audit Matter

 

  

How our audit addressed the key audit matter

 

   
Uncertain tax positions     
   

As described in Notes 4 and 30 to the consolidated financial statements, significant judgment by management is required in determining the worldwide provision for income tax. There are some transactions and calculations for which the ultimate tax determination is uncertain. Some subsidiaries within the group are involved in tax audits and local enquiries usually in relation to prior years. Investigations and negotiations with local tax authorities are ongoing in various jurisdictions at the balance sheet date and, by their nature, these can take considerable time to conclude. In assessing the amount of any income tax provisions to be recognized in the consolidated financial statements, estimation is made of the expected successful settlement of these matters.

 

The principal considerations for our determination that performing procedures relating to uncertain tax positions is a key audit matter are the following (i) the high degree of auditor judgment and subjectivity in applying procedures related to uncertain tax positions due to the significant amount of judgment by management when developing this estimate, including a high degree of estimation uncertainty relative to the numerous and complex tax laws, frequency of tax audits, and the considerable time to conclude investigations and negotiations with local tax authorities as a result of such audits, and (ii) the involvement of professionals with specialized skill and knowledge to assist in evaluating the audit evidence obtained from these procedures.

  

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to completeness of the uncertain tax positions, as well as controls over measurement of the liability.

 

These procedures also included, among others, (i) testing the information used in the calculation of the income tax provisions, including intercompany agreements, international, federal, and state filing positions, and the related final tax returns; (ii) testing the calculation of the income tax provision by jurisdiction, including management’s assessment of the technical merits of tax positions and estimates of the amount of tax benefit expected to be sustained; (iii) testing the completeness of management’s assessment of both the identification of uncertain tax positions and possible outcomes thereof; and (iv) evaluating the status and results of income tax audits by the relevant tax authorities.

 

Professionals with specialized skill and knowledge were used to assist in the evaluation of the completeness and measurement of the Company’s uncertain tax positions, including evaluating the reasonableness of management’s assessment of the chance of loss related to tax positions and the application of relevant tax laws.

 

 

 

AB InBev – Financial Report 2021 | 24


Responsibilities of the board of directors for the preparation of the consolidated financial statements

The board of directors is responsible for the preparation of consolidated financial statements that give a true and fair view in accordance with International Financial Reporting Standards as adopted by the European Union and with the legal and regulatory requirements applicable in Belgium, and for such internal control as the board of directors determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the board of directors is responsible for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the board of directors either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

Statutory auditor’s responsibilities for the audit of the consolidated financial statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

In performing our audit, we comply with the legal, regulatory and normative framework applicable to the audit of the consolidated financial statements in Belgium. A statutory audit does not provide any assurance as to the Group’s future viability nor as to the efficiency or effectiveness of the board of directors’ current or future business management at Group level. Our responsibilities in respect of the use of the going concern basis of accounting by the board of directors’ are described below.

As part of an audit in accordance with ISAs, we exercise professional judgment and maintain professional scepticism throughout the audit. We also:

 

Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control;

 

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s internal control;

 

Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the board of directors;

 

Conclude on the appropriateness of the board of directors’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our statutory auditor’s report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our statutory auditor’s report. However, future events or conditions may cause the Group to cease to continue as a going concern;

 

Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation;

 

Obtain sufficient and appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the Group audit. We remain solely responsible for our audit opinion.

We communicate with the audit committee regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. We also provide the audit committee with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with the audit committee, we determine those matters that were of most significance in the audit of the consolidated financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor’s report unless law or regulation precludes public disclosure about the matter.

Other legal and regulatory requirements

Responsibilities of the board of directors

The board of directors is responsible for the preparation and the content of the directors’ report on the consolidated financial statements.

 

AB InBev – Financial Report 2021 | 25


Statutory auditor’s responsibilities

In the context of our engagement and in accordance with the Belgian standard which is complementary to the International Standards on Auditing (ISAs) as applicable in Belgium, our responsibility is to verify, in all material respects, the directors’ report on the consolidated financial statements and to report on these matters.

Aspects related to the directors’ report on the consolidated financial statements

In our opinion, after having performed specific procedures in relation to the directors’ report on the consolidated financial statements, this directors’ report is consistent with the consolidated financial statements for the year under audit, and it is prepared in accordance with article 3:32 of the Companies’ and Associations’ Code.

In the context of our audit of the consolidated financial statements, we are also responsible for considering, in particular based on the knowledge acquired resulting from the audit, whether the directors’ report is materially misstated or contains information which is inadequately disclosed or otherwise misleading. In light of the procedures we have performed, there are no material misstatements we have to report to you.

The non-financial information is included in a separate report of the directors’ report which is part of section “2021 AB InBev Environmental, Social & Governance Report” of the annual report. The report of non-financial information contains the information required by virtue of article 3:32, §2 of the Companies’ and Associations’ Code, and agrees with the consolidated accounts for the same year. The Company has prepared the non-financial information, based on reference framework Global Reporting Initiative (GRI) Standards and relevant United Nations Sustainable Development Goals. However, in accordance with article 3:80, §1, 5° of the Companies’ and Associations’ Code, we do not express an opinion as to whether the non-financial information has been prepared in accordance with the said framework as disclosed in the separate report of the directors’ report on the consolidated accounts.

Statement related to independence

 

 

Our registered audit firm and our network did not provide services which are incompatible with the statutory audit of the consolidated financial statements, and our registered audit firm remained independent of the Group in the course of our mandate.

 

The fees for additional services which are compatible with the statutory audit of the consolidated financial statements referred to in article 3:65 of the Companies’ and Associations’ Code are correctly disclosed and itemized in the notes to the consolidated financial statements.

European Uniform Electronic Format (ESEF)

We have also verified, in accordance with the draft standard on the verification of the compliance of the financial statements with the European Uniform Electronic Format (hereinafter “ESEF”), the compliance of the ESEF format with the regulatory technical standards established by the European Delegate Regulation No. 2019/815 of 17 December 2018 (hereinafter: “Delegated Regulation”). The board of directors is responsible for the preparation, in accordance with ESEF requirements, of the consolidated financial statements in the form of an electronic file in ESEF format (hereinafter “consolidated financial statements”) included in the annual financial report.

Our responsibility is to obtain sufficient appropriate evidence to conclude that the format and marking language of the digital consolidated financial statements comply in all material respects with the ESEF requirements under the Delegated Regulation.

Based on the work we have performed, we believe that the format of and marking of information in the digital consolidated financial statements included in the annual financial report of Anheuser-Busch InBev NV/SA per 31 December 2021 comply in all material respects with the ESEF requirements under the Delegated Regulation.

Other statements

This report is consistent with the additional report to the audit committee referred to in article 11 of the Regulation (EU) N°537/2014.

Diegem, 23 February 2022

The statutory auditor

PwC Bedrijfsrevisoren BV / Reviseurs d’Entreprises SRL

Represented by

 

LOGO

Koen Hens

Statutory Auditor

 

AB InBev – Financial Report 2021 | 26


Consolidated financial statements

 

 

Consolidated income statement

 

  For the year ended 31 December

  Million US dollar, except earnings per shares in US dollar

   Notes      2021      2020  
                        

Revenue

          54 304        46 881  

Cost of sales

          (23 097)        (19 634)  

Gross profit

          31 207        27 247  
                        

Distribution expenses

          (5 889)        (5 104)  

Sales and marketing expenses

          (7 292)        (6 861)  

Administrative expenses

          (4 394)        (3 404)  

Other operating income/(expenses)

   7      805      845

Profit from operations before non-underlying items

          14 438        12 723  
                        

COVID-19 costs

   8      (105)        (182)  

Restructuring

   8      (172)        (157)  

Business and asset disposal (including impairment losses)

   8      (247)        (239)  

Acquisition costs business combinations

   8      (17)        (25)  

Zenzele Kabili costs

   8      (72)        -

Impairment of goodwill

   8      -      (2 500)  

Profit from operations

          13 824        9 620  
                        

Finance cost

   11      (5 234)        (6 601)  

Finance income

   11      431        642  

Non-underlying net finance income/(cost)

   11      (806)        (1 738)  

Net finance income/(cost)

          (5 609)        (7 697)  
                        

Share of result of associates and joint ventures

   16      248        156  

Profit before tax

          8 463        2 079  
                        

Income tax expense

   12      (2 350)        (1 932)  

Profit from continuing operations

          6 114        147  
                        

Profit from discontinued operations

   21      -      2 055  
                        

Profit of the period

          6 114        2 202  
                        

Profit/(loss) from continuing operations attributable to:

                      

Equity holders of AB InBev

          4 670        (650)  

Non-controlling interest

          1 444        797  
                        

Profit of the period attributable to:

                      

Equity holders of AB InBev

          4 670        1 405  

Non-controlling interest

          1 444        797  
                        

Basic earnings per share

   22      2.33        0.70  

Diluted earnings per share

   22      2.28        0.69  
                        

Basic earnings per share from continuing operations

   22      2.33        (0.33)  

Diluted earnings per share from continuing operations

   22      2.28        (0.33)  
                        

Basic earnings per share before non-underlying items and discontinued operations¹

   22      2.85        1.91  

Diluted earnings per share before non-underlying items and discontinued operations¹

   22      2.80        1.87  
                        

Underlying earnings per share1

   22      2.88        2.51  

The accompanying notes are an integral part of these consolidated financial statements.

 

 

1 Basic earnings per share and diluted earnings per share before non-underlying items and discontinued operations and Underlying earnings per share are not defined metrics in IFRS. Refer to Note 22 Changes in equity and earnings per share for more details.

 

AB InBev – Financial Report 2021 | 27


Consolidated statement of comprehensive income/(loss)

 

  For the twelve-month period ended 31 December
  Million US dollar
   Notes      2021      2020  
                            

Profit of the period

              6 114        2 202  

Other comprehensive income/(loss): items that will not be reclassified

to profit or loss:

                          

Re-measurements of post-employment benefits

     22        504        (263)  
                504        (263)  

Other comprehensive income/(loss): items that may be reclassified

subsequently to profit or loss:

                          

Exchange differences on translation of foreign operations

     22        (4 681)        (10 951)  

Effective portion of changes in fair value of net investment hedges

              156        479  

Cash flow hedges recognized in equity

              1 060        739  

Cash flow hedges and cumulative translation adjustments reclassified from equity to

profit or loss in relation to Australia divestiture

     22        -      426  

Cash flow hedges reclassified from equity to profit or loss

              (920)        (533)  
                (4 385)        (9 841)  
                            

Other comprehensive income/(loss), net of tax

              (3 881)        (10 104)  
                            

Total comprehensive income/(loss)

              2 233        (7 901)  
                            

Attributable to:

                          

Equity holders of AB InBev

              934        (8 156)  

Non-controlling interest

              1 299        255  

The accompanying notes are an integral part of these consolidated financial statements.

 

AB InBev – Financial Report 2021 | 28


Consolidated statement of financial position

 

  As at

  Million US dollar

   Notes    31 December 2021      31 December 2020  
                        

ASSETS

                      

Non-current assets

                      

Property, plant and equipment

   13      26 678        26 419  

Goodwill

   14      115 796        120 971  

Intangible assets

   15      40 430        41 527  

Investments in associates and joint ventures

   16      5 874        6 143  

Investment securities

   20      161        137  

Deferred tax assets

   17      1 969        2 019  

Employee benefits

   24      5        6  

Income tax receivables

          1 137        869  

Derivatives

   28      48        138  

Trade and other receivables

   19      1 580        1 661  

Total non-current assets

          193 678        199 891  
                        

Current assets

                      

Investment securities

   20      374        396  

Inventories

   18      5 399        4 482  

Income tax receivables

          381        655  

Derivatives

   28      621        827  

Trade and other receivables

   19      5 046        4 833  

Cash and cash equivalents

   20      12 097        15 252  

Assets classified as held for sale

   21      30        74  

Total current assets

          23 949        26 519  
                        

Total assets

          217 627        226 410  
                        

EQUITY AND LIABILITIES

                      

Equity

                      

Issued capital

   22      1 736        1 736  

Share premium

          17 620        17 620  

Reserves

          15 431        17 798  

Retained earnings

          33 882        30 870  

Equity attributable to equity holders of AB InBev

          68 669        68 024  
                        

Non-controlling interests

   32      10 671        10 327  

Total equity

          79 340        78 351  
                        

Non-current liabilities

                      

Interest-bearing loans and borrowings

   23      87 369        95 478  

Employee benefits

   24      2 261        2 970  

Deferred tax liabilities

   17      12 204        12 627  

Income tax payables

          726        808  

Derivatives

   28      100        1 759  

Trade and other payables

   27      1 008        1 522  

Provisions

   26      436        544  

Total non-current liabilities

          104 104        115 707  
                        

Current liabilities

                      

Bank overdrafts

   20      53        5  

Interest-bearing loans and borrowings

   23      1 408        3 081  

Income tax payables

          1 334        1 036  

Derivatives

   28      5 786        5 046  

Trade and other payables

   27      25 434        22 965  

Provisions

   26      169        219  

Total current liabilities

          34 184        32 352  
                        

Total equity and liabilities

          217 627        226 410  

The accompanying notes are an integral part of these consolidated financial statements.

 

AB InBev – Financial Report 2021 | 29


Consolidated statement of changes in equity

 

          Attributable to equity holders of AB InBev        
  Million US dollar   Notes     Issued
Capital
    Share
premium
    Treasury
shares
    Reserves     Share-
based
payments
reserves
    Other
comprehensive
income
reserves
    Retained
earnings
    Total    

Non-

controlling
interest

    Total
Equity
 

As per 1 January 2020

        1 736       17 620       (6 270)       50 104       2 327       (21 279)       31 484       75 722       8 831       84 553  

Profit/(loss) of the period

        -       -       -       -       -       -       1 405       1 405       797       2 202  

Other comprehensive income/(loss)

                                                                                   

Exchange differences on translation of foreign operations (gains/(losses))

  22     -       -       -       -       -       (9 943)       -       (9 943)       (529)       (10 473)  

Cash flow hedges

  22     -       -       -       -       -       198       -       198       8       206  

Cash flow hedges and cumulative translation adjustments reclassified from equity to profit or loss in relation to Australia divestiture

  22     -       -       -       -       -       426       -       426       -       426  

Re-measurements of post-employment benefits

  22     -       -       -       -       -       (243)       -       (243)       (20)       (263)  

Total comprehensive income/(loss)

        -       -       -       -       -       (9 562)       1 405       (8 156)       255       (7 901)  

Dividends

        -       -       -       -       -       -       (1 118)       (1 118)       (804)       (1 923)  

Treasury shares

        -       -       1 359       -       -       -       (974)       385       -       385  

Share-based payments

  25     -       -       -       -       3       -       -       3       17       20  

Hyperinflation monetary adjustments

        -       -       -       -       -       -       160       160       99       259  

Sales/(purchase) of non-controlling interests1

  32                             1 116                               1 116       1 869       2 985  

Scope and other changes

        -       -       -       -       -       -       (87)       (87)       60       (26)  

As per 31 December 2020

        1 736       17 620       (4 911)       51 220       2 330       (30 841)       30 870       68 024       10 327       78 351  
          Attributable to equity holders of AB InBev        
  Million US dollar   Notes     Issued
Capital
    Share
premium
    Treasury
shares
    Reserves     Share-
based
payments
reserves
    Other
comprehensive
income
reserves
    Retained
earnings
    Total    

Non-

controlling
interest

    Total
Equity
 

As per 1 January 2021

        1 736       17 620       (4 911)       51 220       2 330       (30 841)       30 870       68 024       10 327       78 351  

Profit/(loss) of the period

        -       -       -       -       -       -       4 670       4 670       1 444       6 114  

Other comprehensive income/(loss)

                                                                                   

Exchange differences on translation of foreign operations (gains/(losses))

  22     -       -       -       -       -       (4 320)       -       (4 320)       (205)       (4 525)  

Cash flow hedges

  22     -       -       -       -       -       105       -       105       35       140  

Re-measurements of post-employment benefits

  22     -       -       -       -       -       479       -       479       25       504  

Total comprehensive income/(loss)

        -       -       -       -       -       (3 736)       4 670       934       1 299       2 233  

Dividends

        -       -       -       -       -       -       (1 139)       (1 139)       (1 112)       (2 251)  

Treasury shares

        -       -       917       -       -       -       (836)       81       -       81  

Share-based payments

  25     -       -       -       -       451       -       -       451       28       478  

Hyperinflation monetary adjustments

        -       -       -       -       -       -       231       231       143       374  

Scope and other changes

        -       -       -       -       -       -       86       86       (14)       73  

As per 31 December 2021

        1 736       17 620       (3 994)       51 220       2 780       (34 577)       33 882       68 669       10 671       79 340  

The accompanying notes are an integral part of these consolidated financial statements.

 

 

1 The 2020 sale of non-controlling interest relates to the issuance of a 49.9% minority stake in the company’s US-based metal container operations completed in December 2020 (refer to Note 22 Changes in equity and earnings per share for more details).

 

AB InBev – Financial Report 2021 | 30


Consolidated statement of cash flows

 

  For the year ended 31 December
  Million US dollar
   Notes      2021        2020  

OPERATING ACTIVITIES

                      

Profit/(loss) from continuing operations

          6 114        147  

Depreciation, amortization and impairment

   10      5 052        4 829  

Impairment losses on goodwill

   14      -      2 500  

Impairment losses on receivables, inventories and other assets

          135        218  

Additions/(reversals) in provisions and employee benefits

          196        278  

Net finance cost/(income)

   11      5 609        7 697  

Loss/(gain) on sale of property, plant and equipment and intangible assets

          (94)        (69)  

Loss/(gain) on sale of subsidiaries, associates and assets held for sale

          (44)        7  

Equity-settled share-based payment expense

   25      510        169  

Income tax expense

   12      2 350        1 932  

Other non-cash items included in profit

          (773)        (381)  

Share of result of associates and joint ventures

   16      (248)        (156)  

Cash flow from operating activities before changes in working capital and use of provisions

          18 806        17 171  

Decrease/(increase) in trade and other receivables

          164        516  

Decrease/(increase) in inventories

          (1 232)        (427)  

Increase/(decrease) in trade and other payables

          3 527        503  

Pension contributions and use of provisions

          (375)        (616)  

Cash generated from operations

          20 890        17 147  

Interest paid

          (3 987)        (4 340)  

Interest received

          200        255  

Dividends received

          106        51  

Income tax paid

          (2 410)        (2 306)  

Cash flow from operating activities on Australia discontinued operations

   21      -      84  

Cash flow from operating activities

          14 799        10 891  
                        

INVESTING ACTIVITIES

                      

Acquisition of property, plant and equipment and of intangible assets

   13/15      (5 640)        (3 781)  

Proceeds from sale of property, plant and equipment and of intangible assets

          142        94  

Acquisition of subsidiaries, net of cash acquired

   6      (451)        (510)  

Sale of other subsidiaries, net of cash disposed of

   6      7        -  

Net proceeds from sale/(acquisition) of other assets

          65        (292)  

Proceeds from Australia divestiture

   21      -      10 838  

Cash flow from investing activities on Australia discontinued operations

   21      -      (13)  

Cash flow from investing activities

          (5 878)        6 336  
                        

FINANCING ACTIVITIES

                      

Sale/(purchase) of non-controlling interests

   22      -      3 039  

Proceeds from borrowings

   23      454        14 822  

Payments on borrowings

   23      (8 965)        (23 116)  

Cash net finance (cost)/income other than interests

          (192)        (953)  

Payment of lease liabilities

          (531)        (461)  

Dividends paid

          (2 364)        (1 800)  

Cash flow from financing activities on Australia discontinued operations

   21      -      (6)  

Cash flow from financing activities

          (11 598)        (8 475)  
                        

Net increase/(decrease) in cash and cash equivalents

          (2 677)        8 752  

Cash and cash equivalents less bank overdrafts at beginning of year

          15 247        7 169  

Effect of exchange rate fluctuations

          (526)        (674)  

Cash and cash equivalents less bank overdrafts at end of period

   20      12 043        15 247  

The accompanying notes are an integral part of these consolidated financial statements.

 

AB InBev – Financial Report 2021 | 31


Notes to the consolidated financial statements

 

       Note  

Corporate information

     1  

Statement of compliance

     2  

Summary of significant accounting policies

     3  

Use of estimates and judgments

     4  

Segment reporting

     5  

Acquisitions and disposals of subsidiaries

     6  

Other operating income/(expenses)

     7  

Non-underlying items

     8  

Payroll and related benefits

     9  

Additional information on operating expenses by nature

     10  

Finance cost and income

     11  

Income taxes

     12  

Property, plant and equipment

     13  

Goodwill

     14  

Intangible assets

     15  

Investments in associates

     16  

Deferred tax assets and liabilities

     17  

Inventories

     18  

Trade and other receivables

     19  

Cash and cash equivalents and investment securities

     20  

Assets classified as held for sale, liabilities associated with assets held for sale and discontinued operations

     21  

Changes in equity and earnings per share

     22  

Interest-bearing loans and borrowings

     23  

Employee benefits

     24  

Share-based payments

     25  

Provisions

     26  

Trade and other payables

     27  

Risks arising from financial instruments

     28  

Collateral and contractual commitments for the acquisition of property, plant and equipment, loans to customers and other

     29  

Contingencies

     30  

Non-controlling interests

     31  

Related parties

     32  

Events after the balance sheet date

     33  

AB InBev companies

     34  

 

AB InBev – Financial Report 2021 | 32


1. Corporate information

Anheuser-Busch InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest natural ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona® and Stella Artois®; multi-country brands Beck’s®, Hoegaarden®, Leffe® and Michelob Ultra®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin® and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 169 000 employees based in nearly 50 countries worldwide. For 2021, AB InBev’s reported revenue was 54.3 billion US dollar (excluding joint ventures and associates).

The consolidated financial statements of the company for the year ended 31 December 2021 comprise the company and its subsidiaries (together referred to as “AB InBev” or the “company”) and the company’s interest in associates, joint ventures and operations.

The consolidated financial statements were authorized for issue by the Board of Directors on 23 February 2022.

2. Statement of compliance

The consolidated financial statements have been prepared in accordance with International Financial Reporting Standard as issued by the International Accounting Standard Board (“IASB”) and in conformity with International Financial Reporting Standards as adopted by the European Union up to 31 December 2021 (collectively “IFRS”). AB InBev did not early apply any new IFRS requirements that were not yet effective in 2021 and did not apply any European carve-outs from IFRS.

3. Summary of significant accounting policies

The accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements by the company and its subsidiaries.

(A) BASIS OF PREPARATION AND MEASUREMENT

Depending on the applicable IFRS requirements, the measurement basis used in preparing the financial statements is cost, net realizable value, fair value or recoverable amount. Whenever IFRS provides an option between cost and another measurement basis (e.g., systematic re-measurement), the cost approach is applied.

(B) FUNCTIONAL AND PRESENTATION CURRENCY

Unless otherwise specified, all financial information included in these financial statements has been stated in US dollar and has been rounded to the nearest million. As from 2009, following the combination with Anheuser-Bush, the company changed the presentation currency of the consolidated financial statements from the euro to the US dollar to provide greater alignment of the presentation currency with AB InBev’s most significant operating currency and underlying financial performance. The functional currency of the parent company is the euro.

(C) USE OF ESTIMATES AND JUDGMENTS

The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.

 

AB InBev – Financial Report 2021 | 33


(D) PRINCIPLES OF CONSOLIDATION

Subsidiaries are those entities controlled by AB InBev. AB InBev controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. In assessing control, potential voting rights are taken into account. Control is presumed to exist where AB InBev owns, directly or indirectly, more than one half of the voting rights (which does not always equate to economic ownership), unless it can be demonstrated that such ownership does not constitute control. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. Total comprehensive income of subsidiaries is attributed to the owners of the company and to the non-controlling interests even if this results in the non-controlling interests having a deficit balance.

Associates are undertakings in which AB InBev has significant influence over the financial and operating policies, but which it does not control. This is generally evidenced by ownership of between 20% and 50% of the voting rights. A joint venture is an arrangement in which AB InBev has joint control, whereby AB InBev has rights to the net assets of the arrangement, rather than rights to its assets and obligations for its liabilities. Associates and joint ventures are accounted for by the equity method of accounting, from the date that significant influence or joint control commences until the date that significant influence or joint control ceases. When AB InBev’s share of losses exceeds the carrying amount of the associate or joint venture, the carrying amount is reduced to nil and recognition of further losses is discontinued except to the extent that AB InBev has incurred legal or constructive obligations on behalf of the associate or joint venture.

Joint operations arise when AB InBev has rights to the assets and obligations to the liabilities of a joint arrangement. AB InBev accounts for its share of the assets, liabilities, revenues and expenses as from the moment joint operation commences until the date that joint operation ceases.

The financial statements of the company’s subsidiaries, joint ventures, joint operations and associates are prepared for the same reporting year as the parent company, using consistent accounting policies. In exceptional cases when the financial statements of a subsidiary, joint venture, joint operation or associate are prepared as of a different date from that of AB InBev, adjustments are made for the effects of significant transactions or events that occur between that date and the date of AB InBev’s financial statements. In such cases, the difference between the end of the reporting period of these subsidiaries, joint ventures, joint operations or associates from AB InBev’s reporting period is no more than three months. Results from the company’s associates Anadolu Efes and Castel are reported on a three-month lag. Therefore, estimates are made to reflect AB InBev’s share in the result of these associates for the last quarter. Such estimates are revisited when required.

Transactions with non-controlling interests are treated as transactions with equity owners of the company. For purchases from non-controlling interests, the difference between any consideration paid and the relevant share acquired of the carrying value of net assets of the subsidiary is recorded in equity. Gains or losses on disposals to non-controlling interests are also recorded in equity where there is no loss of control.

All intercompany transactions, balances and unrealized gains and losses on transactions between group companies have been eliminated. Unrealized gains arising from transactions with joint ventures, joint operations and associates are eliminated to the extent of AB InBev’s interest in the entity. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that there is no evidence of impairment.

A listing of the company’s most important subsidiaries, joint ventures, joint operations and associates is set out in Note 34 AB InBev companies.

(E) SUMMARY OF CHANGES IN ACCOUNTING POLICIES

A number of new standards, amendment to standards and new interpretations became mandatory for the first time for the financial year beginning on 1 January 2021 and have not been listed in these consolidated financial statements as they either do not apply or are immaterial to AB InBev’s consolidated financial statements.

(F) FOREIGN CURRENCIES

Foreign currency transactions

Foreign currency transactions are accounted for at exchange rates prevailing at the date of the transactions. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rates prevailing on the date of the balance sheet. Gains and losses resulting from the settlement of foreign currency transactions and from the translation of monetary assets and liabilities denominated in foreign currencies are recognized in the income statement. Non-monetary assets and liabilities denominated in foreign currencies are translated at the foreign exchange rate prevailing at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are translated to US dollar at foreign exchange rates prevailing at the dates the fair value was determined.

 

AB InBev – Financial Report 2021 | 34


Translation of the results and financial position of foreign operations

Assets and liabilities of foreign operations are translated to US dollar at foreign exchange rates prevailing at the balance sheet date. Income statements of foreign operations, excluding foreign entities in hyperinflationary economies, are translated to US dollar at exchange rates for the year approximating the foreign exchange rates prevailing at the dates of the transactions. The components of shareholders’ equity are translated at historical rates. Exchange differences arising from the translation of shareholders’ equity to US dollar at period-end exchange rates are taken to other comprehensive income (translation reserves).

Financial Reporting in hyperinflationary economies

In May 2018, the Argentinean peso underwent a severe devaluation, causing Argentina´s three-year cumulative inflation to exceed 100% and thus, triggering the requirement to transition to hyperinflation accounting as prescribed by IAS 29 Financial Reporting in Hyperinflationary Economies. IAS 29 requires that the results of the company’s Argentinian operations be reported as if these were highly inflationary as of 1 January 2018.

Under IAS 29, non-monetary assets and liabilities stated at historical cost, equity and income statements of subsidiaries operating in hyperinflationary economies are restated for changes in the general purchasing power of the local currency, applying a general price index. These re-measured accounts are used for conversion into US dollar at the period closing exchange rate. As a result, the balance sheet and net results of subsidiaries operating in hyperinflation economies are stated in terms of the measuring unit current at the end of the reporting period.

Consequently, the company applied hyperinflation accounting for its Argentinean subsidiaries for the first time in the year-to-date September 2018 unaudited condensed interim financial statements, with effect as of 1 January 2018. The IAS 29 rules are applied as follows:

 

   

Non-monetary assets and liabilities stated at historical cost (e.g. property plant and equipment, intangible assets, goodwill, etc.) and equity of Argentina were restated using an inflation index. The hyperinflation accounting impacts resulting from changes in the general purchasing power from 1 January 2018 are reported in the income statement in a dedicated account for hyperinflation monetary adjustments in the finance line (see also Note 11 Finance cost and income)

 

   

The income statement is adjusted at the end of each reporting period using the change in the general price index. It is converted at the closing exchange rate of each period (rather than the year-to-date average rate which is used for non-hyperinflationary economies), thereby restating the year-to-date income statement account for both inflation index and currency conversion.

The 2021 results, restated for purchasing power, were translated at the December 2021 closing rate of 102.749214 Argentinean pesos per US dollar (2020 results - at 84.143520 Argentinean pesos per US dollar).

Exchange rates

The most important exchange rates that have been used in preparing the financial statements are:

 

     Closing rate      Average rate  
 1 US dollar equals:    31 December 2021      31 December 2020      31 December 2021      31 December 2020  

 Argentinean peso

     102.749214        84.143520        -        -  

 Brazilian real

     5.580497        5.196694        5.368651        5.133082  

 Canadian dollar

     1.270792        1.273981        1.249693        1.346594  

 Colombian peso

     3 977.14        3 438.52        3 741.19        3 689.50  

 Chinese yuan

     6.352382        6.537798        6.456753        6.947936  

 Euro

     0.882924        0.814930        0.841767        0.878101  

 Mexican peso

     20.583378        19.948838        20.339905        21.182539  

 Pound sterling

     0.741903        0.732646        0.725564        0.780195  

 Peruvian nuevo sol

     3.976006        3.621009        3.877055        3.491580  

 South Korean won

     1 188.32        1 088.02        1 139.06        1 185.02  

 South African rand

     15.947907        14.686598        14.873785        16.213180  

(G) INTANGIBLE ASSETS

Research and development

Expenditure on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognized in the income statement as an expense as incurred.

Expenditure on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved products and processes, is capitalized if the product or process is technically and commercially feasible, future economic benefits are probable, and the company has sufficient resources to complete development. The

 

AB InBev – Financial Report 2021 | 35


expenditure capitalized includes the cost of materials, direct labor and an appropriate proportion of overheads. Other development expenditure is recognized in the income statement as an expense as incurred. Capitalized development expenditure is stated at cost less accumulated amortization (see below) and impairment losses (refer to accounting policy O).

Amortization related to research and development intangible assets is included within the cost of sales if production related and in sales and marketing if related to commercial activities.

Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets are capitalized as part of the cost of such assets.

Supply and distribution rights

A supply right is the right for AB InBev to supply a customer and the commitment by the customer to purchase from AB InBev. A distribution right is the right to sell specified products in a certain territory. Acquired distribution rights are measured initially at cost or fair value when obtained through a business combination. Amortization related to supply and distribution rights is included within sales and marketing expenses.

Brands

If part of the consideration paid in a business combination relates to trademarks, trade names, formulas, recipes or technological expertise these intangible assets are considered as a group of complementary assets that is referred to as a brand for which one fair value is determined. Expenditure on internally generated brands is expensed as incurred.

Software

Purchased software is measured at cost less accumulated amortization. Expenditure on internally developed software is capitalized when the expenditure qualifies as development activities; otherwise, it is recognized in the income statement when incurred. Amortization related to software is included in cost of sales, distribution expenses, sales and marketing expenses or administrative expenses based on the activity the software supports.

Other intangible assets

Other intangible assets, acquired by the company, are recognized at cost less accumulated amortization and impairment losses. Other intangible assets also include multi-year sponsorship rights acquired by the company. These are initially recognized at the present value of the future payments and subsequently measured at cost less accumulated amortization and impairment losses.

Subsequent expenditure

Subsequent expenditure on capitalized intangible assets is capitalized only when it increases the future economic benefits embodied in the specific asset to which it relates. All other expenditures are expensed as incurred.

Amortization

Intangible assets with a finite life are amortized using the straight-line method over their estimated useful lives. Licenses, brewing, supply and distribution rights are amortized over the period in which the rights exist. Brands are considered to have an indefinite life unless plans exist to discontinue the brand. Discontinuance of a brand can be either through sale or termination of marketing support. When AB InBev purchases distribution rights for its own products the life of these rights is considered indefinite, unless the company have a plan to discontinue the related brand or distribution. Software and capitalized development costs related to technology are amortized generally over 3 to 5 years.

Brands are deemed intangible assets with indefinite useful lives and, therefore, are not amortized but tested for impairment on an annual basis (refer to accounting policy O).

Gains and losses on sale

Net gains on sale of intangible assets are presented in the income statement as other operating income. Net losses on sale are included as other operating expenses. Net gains and losses are recognized in the income statement when the control has been transferred to the buyer, recovery of the consideration is probable, the associated costs can be estimated reliably, and there is no continuing managerial involvement with the intangible assets.

(H) BUSINESS COMBINATIONS

The company applies the acquisition method of accounting to account for acquisitions of businesses. The cost of an acquisition is measured as the aggregate of the fair values at the date of exchange of the assets given, liabilities incurred, and equity instruments issued. Identifiable assets, liabilities and contingent liabilities acquired or assumed are measured separately at their fair value as of the acquisition date. The excess of the cost of the acquisition over the company’s interest in the fair value of the identifiable net assets acquired is recorded as goodwill.

 

AB InBev – Financial Report 2021 | 36


The allocation of fair values to the identifiable assets acquired and liabilities assumed is based on various assumptions requiring management judgment.

Acquisition-related costs are expensed as incurred.

If the business combination is achieved in stages, the acquisition date carrying value of AB InBev’s previously held interest in the acquiree is re-measured to fair value at the acquisition date; any gains or losses arising from such re-measurement are recognized in profit or loss.

(I) GOODWILL

Goodwill is determined as the excess of the consideration paid over AB InBev’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the acquired subsidiary, jointly controlled entity or associate recognized at the date of acquisition. All business combinations are accounted for by applying the purchase method.

In conformity with IFRS 3 Business Combinations, goodwill is stated at cost and not amortized but tested for impairment on an annual basis and whenever there is an indicator that the cash generating unit to which goodwill has been allocated, may be impaired (refer to accounting policy O). Goodwill is expressed in the currency of the subsidiary or jointly controlled entity to which it relates and is translated to US dollar using the year-end exchange rate. In respect of associates and joint ventures, the carrying amount of goodwill is included in the carrying amount of the investment in the associate.

If AB InBev’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities recognized exceeds the cost of the business combination such excess is recognized immediately in the income statement as required by IFRS 3 Business Combinations. Expenditure on internally generated goodwill is expensed as incurred.

(J) PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment is measured at cost less accumulated depreciation and impairment losses (refer to accounting policy O). Cost includes the purchase price and any costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management (e.g., nonrefundable tax and transport cost). The cost of a self-constructed asset is determined using the same principles as for an acquired asset. The depreciation methods, residual value, as well as the useful lives are reassessed and adjusted if appropriate, annually.

Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets are capitalized as part of the cost of such assets.

Subsequent expenditure

The company recognizes in the carrying amount of an item of property, plant and equipment the cost of replacing part of such an item when that cost is incurred if it is probable that the future economic benefits embodied with the item will flow to the company and the cost of the item can be measured reliably. All other costs are expensed as incurred.

Depreciation

The depreciable amount is the cost of an asset less its residual value. Residual values, if not insignificant, are reassessed annually. Depreciation is calculated from the date the asset is available for use, using the straight-line method over the estimated useful lives of the assets.

The estimated useful lives are defined in terms of the asset’s expected utility to the company and can vary from one geographical area to another. On average the estimated useful lives are as follows:

 

 Industrial buildings – other real estate properties    20 - 50 years
 Production plant and equipment:     

Production equipment

   10 - 15 years

Storage, packaging and handling equipment

   5 - 7 years
 Returnable packaging:     

Kegs

   2 - 10 years

Crates

   2 - 10 years

Bottles

   2 - 5 years
 Point of sale furniture and equipment    5 years
 Vehicles    5 years
 Information processing equipment    3 - 10 years

Where parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items of property, plant and equipment.

Land is not depreciated as it is deemed to have an indefinite life.

 

AB InBev – Financial Report 2021 | 37


Gains and losses on sale

Net gains on sale of items of property, plant and equipment are presented in the income statement as other operating income. Net losses on sale are presented as other operating expenses. Net gains and losses are recognized in the income statement when the control has been transferred to the buyer, recovery of the consideration is probable, the associated costs can be estimated reliably, and there is no continuing managerial involvement with the property, plant and equipment.

(K) LEASES

The company as lessee

The company assesses whether a contract is or contains a lease at inception of a contract. The company recognizes a right-of-use asset and a corresponding lease liability with respect to all lease agreements in which it is the lessee, except for short-term leases (defined as leases with a lease term of 12 months or less) and leases of low value assets. For these leases, the company recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease, and payments for these leases are presented in cash flow from operating activities.

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by using the rate implicit in the lease. If this rate cannot be readily determined, the company uses its incremental borrowing rate specific to the country, term and currency of the contract. In addition, the company considers its recent debt issuances as well as publicly available data for instruments with similar characteristics when calculating the incremental borrowing rates.

Lease payments include fixed payments, less any lease incentives, variable lease payments that depend on an index or a rate known at the commencement date, and purchase options or extension option payments if the company is reasonably certain to exercise these options. Variable lease payments that do not depend on an index or rate are not included in the measurement of the lease liability and right-of-use asset and are recognized as an expense in the income statement in the period in which the event or condition that triggers those payments occurs.

A lease liability is remeasured upon a change in the lease term, changes in an index or rate used to determine the lease payments or reassessment of exercise of a renewal and/or purchase option. The corresponding adjustment is made to the related right-of-use asset.

The right-of-use assets comprise the initial measurement of the corresponding lease liability, lease payments made at or before the commencement day and any initial direct costs. They are subsequently measured at cost less accumulated depreciation and impairment losses. The right-of-use assets are depreciated starting at the commencement date over the shorter period of useful life of the underlying asset and lease term (refer to accounting policies J and O).

The lease liability is presented in the ‘Interest-bearing loans and borrowings’ line and the right-of-use assets are presented in the ‘Property, plant and equipment’ line in the consolidated statement of financial position. In addition, the principal portion of the lease payments is presented within financing activities and the interest component is presented within operating activities in the consolidated cash flow statement.

The company as lessor

Leases where the company transfers substantially all the risks and rewards of ownership to the lessee are classified as finance leases. Leases of assets under which all the risks and rewards of ownership are substantially retained by the company are classified as operating leases. Rental income is recognized in other operating income on a straight-line basis over the term of the lease.

(L) INVENTORIES

Inventories are valued at the lower of cost and net realizable value. Cost includes expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. The weighted average method is used in assigning the cost of inventories.

The cost of finished products and work in progress comprises raw materials, other production materials, direct labor, other direct cost and an allocation of fixed and variable overhead based on normal operating capacity. Net realizable value is the estimated selling price in the ordinary course of business, less the estimated completion and selling costs.

Inventories are written down on a case-by-case basis if the anticipated net realizable value declines below the carrying amount of the inventories. The calculation of the net realizable value takes into consideration specific characteristics of each inventory category, such as expiration date, remaining shelf life, slow-moving indicators, amongst others.

(M) TRADE AND OTHER RECEIVABLES

Trade receivables are amounts due from customers for goods sold or services performed in the ordinary course of business and generally due for settlement within 30 days. Trade receivables are recognized initially at the amount of the consideration

 

AB InBev – Financial Report 2021 | 38


that is unconditional unless they contain significant financing components, when they are recognized at the amount adjusted for the time value of money. The company holds trade and other receivables with the objective to collect the contractual cash flows and therefore measures them subsequently at amortized cost using the effective interest rate method.

Trade and other receivables are carried at amortized cost less impairment losses. To determine the appropriate amount to be impaired factors such as significant financial difficulties of the debtor, probability that the debtor will default, enter into bankruptcy or financial reorganization, or delinquency in payments are considered.

Other receivables are initially recognized at fair value and subsequently measured at amortized cost. Any impairment losses and foreign exchange results are directly recognized in profit or loss.

(N) CASH AND CASH EQUIVALENTS

Cash and cash equivalents include all cash balances and short-term highly liquid investments with a maturity of three months or less from the date of acquisition that are readily convertible into cash. They are stated at face value, which approximates their fair value. In the cash flow statement, cash and cash equivalents are presented net of bank overdrafts.

(O) IMPAIRMENT

The carrying amounts of property, plant and equipment, goodwill and intangible assets are reviewed at each balance sheet date to determine whether there is any indication of impairment. If there is an indicator of impairment, the asset’s recoverable amount is estimated. In addition, goodwill, intangible assets that are not yet available for use and intangibles with an indefinite useful life are tested for impairment annually at the cash-generating unit level (that is a country or group of countries managed as a group below a reporting region). An impairment loss is recognized whenever the carrying amount of an asset or the related cash-generating unit exceeds its recoverable amount. Impairment losses are recognized in the income statement.

Calculation of recoverable amount

The recoverable amount of non-financial assets is determined as the higher of their fair value less costs to sell and value in use. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs. The recoverable amount of the cash generating units to which the goodwill and the intangible assets with indefinite useful life belong is based on discounted future cash flows using a discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. These calculations are corroborated by valuation multiples, quoted share prices for publicly traded subsidiaries or other available fair value indicators.

Impairment losses recognized in respect of cash-generating units firstly reduce allocated goodwill and then the carrying amounts of the other assets in the unit on a pro rata basis.

Reversal of impairment losses

Non-financial assets other than goodwill that suffered an impairment are reviewed for possible reversal of the impairment at each reporting date. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

(P) FAIR VALUE MEASUREMENT

A number of AB InBev’s accounting policies and notes require fair value measurement for both financial and non-financial items.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When measuring fair value, AB InBev uses observable market data as far as possible. Fair values are categorized into different levels in a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

   

Level 1: inputs are unadjusted quoted prices in active markets for identical assets or liabilities.

 

   

Level 2: inputs are observable either directly (i.e., as prices) or indirectly (i.e., derived from prices).

 

   

Level 3: fair value measurements incorporate significant inputs that are based on unobservable market data.

If the inputs used to measure the fair value of an asset or liability fall into different levels of the fair value hierarchy, then the fair value measurement is categorized in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the entire measurement.

The company applies fair value measurement to the instruments listed below.

 

AB InBev – Financial Report 2021 | 39


Derivatives

The fair value of exchange traded derivatives (e.g., exchange traded foreign currency futures) is determined by reference to the official prices published by the respective exchanges (e.g., the New York Board of Trade). The fair value of over-the-counter derivatives is determined by commonly used valuation techniques.

Debt securities

This category includes both debt securities designated at FVOCI and FVPL. The fair value is measured using observable inputs such as interest rates and foreign exchange rates. When it pertains to instruments that are publicly traded, the fair value is determined by reference to observable quotes. In circumstances where debt securities are not publicly traded, the main valuation technique is the discounted cash flow. The company may apply other valuation techniques or combination of valuation techniques if the fair value results are more relevant.

Equity securities designated as at FVOCI

Investments in equity securities comprise quoted and unquoted securities. When liquid quoted prices are available, these are used to fair value investments in quoted securities. The unquoted securities are fair valued using primarily the discounted cash flow method.

Non-derivative financial liabilities

The fair value of non-derivative financial liabilities is generally determined using unobservable inputs and therefore fall into level 3. In these circumstances, the valuation technique used is discounted cash flow, whereby the projected cash flows are discounted using a risk adjusted rate.

(Q) SHARE CAPITAL

Repurchase of share capital

When AB InBev buys back its own shares, the amount of the consideration paid, including directly attributable costs, is recognized as a deduction from equity under treasury shares.

Dividends

Dividends paid are recognized in the consolidated financial statements on the date that the dividends are declared unless minimum statutory dividends are required by local legislation or the bylaws of the company’s subsidiaries. In such instances, statutory minimum dividends are recognized as a liability.

Share issuance costs

Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.

(R) PROVISIONS

Provisions are recognized when (i) the company has a present legal or constructive obligation as a result of past events, (ii) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and (iii) a reliable estimate of the amount of the obligation can be made. Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and, where appropriate, the risks specific to the liability.

Restructuring

A provision for restructuring is recognized when the company has approved a detailed and formal restructuring plan, and the restructuring has either commenced or has been announced publicly. Costs relating to the ongoing activities of the company are not provided for. The provision includes the benefit commitments in connection with early retirement and redundancy schemes.

Onerous contracts

A provision for onerous contracts is recognized when the expected benefits to be derived by the company from a contract are lower than the unavoidable cost of meeting its obligations under the contract. Such provision is measured at the present value of the lower of the expected cost of terminating the contract and the expected net cost of continuing with the contract.

Disputes and Litigations

A provision for disputes and litigation is recognized when it is more likely than not that the company will be required to make future payments as a result of past events, such items may include but are not limited to, several claims, suits and actions relating to antitrust laws, violations of distribution and license agreements, environmental matters, employment related disputes, claims from tax authorities related to indirect taxes, and alcohol industry litigation matters.

 

AB InBev – Financial Report 2021 | 40


(S) EMPLOYEE BENEFITS

Post-employment benefits

Post-employment benefits include pensions, post-employment life insurance and post-employment medical benefits. The company operates a number of defined benefit and defined contribution plans throughout the world, the assets of which are generally held in separate trustee-managed funds. The pension plans are generally funded by payments from employees and the company, and, for defined benefit plans taking account of the recommendations of independent actuaries. AB InBev maintains funded and unfunded pension plans.

a) Defined contribution plans

Contributions to defined contribution plans are recognized as an expense in the income statement when incurred. A defined contribution plan is a pension plan under which AB InBev pays fixed contributions into a fund. AB InBev has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

b) Defined benefit plans

A defined benefit plan is a pension plan that is not a defined contribution plan. Typically, defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation. For defined benefit plans, the pension expenses are assessed separately for each plan using the projected unit credit method. The projected unit credit method considers each period of service as giving rise to an additional unit of benefit entitlement. Under this method, the cost of providing pensions is charged to the income statement so as to spread the regular cost over the service lives of employees in accordance with the advice of qualified actuaries who carry out a full valuation of the plans at least every three years. The amounts charged to the income statement include current service cost, net interest cost (income), past service costs and the effect of any curtailments or settlements. Past service costs are recognized at the earlier of when the amendment / curtailment occurs or when the company recognizes related restructuring or termination costs. The pension obligations recognized in the balance sheet are measured at the present value of the estimated future cash outflows using interest rates based on high quality corporate bond yields, which have terms to maturity approximating the terms of the related liability, less the fair value of any plan assets. Re-measurements, comprising of actuarial gains and losses, the effect of the asset ceiling (excluding net interest) and the return on plan assets (excluding net interest) are recognized in full in the period in which they occur in the statement of comprehensive income. Re-measurements are not reclassified to profit or loss in subsequent periods.

Where the calculated amount of a defined benefit liability is negative (an asset), AB InBev recognizes such pension asset to the extent that economic benefits are available to AB InBev either from refunds or reductions in future contributions.

Other post-employment obligations

Some of AB InBev’s companies provide post-employment medical benefits to their retirees. The entitlement to these benefits is usually based on the employee remaining in service up to retirement age. The expected costs of these benefits are accrued over the period of employment, using an accounting methodology similar to that for defined benefit pension plans.

Termination benefits

Termination benefits are recognized as an expense at the earlier when the company is demonstrably committed, without realistic possibility of withdrawal, to a formal detailed plan to terminate employment before the normal retirement date and when the company recognizes costs for a restructuring. Termination benefits for voluntary redundancies are recognized if the company has made an offer encouraging voluntary redundancy and when the company can no longer withdraw the offer of termination, which is the earlier of either when the employee accepts the offer or when a legal, regulatory or contractual requirement or restriction on the company’s ability to withdraw the offer takes effect.

Bonuses

Bonuses received by company employees and management are based on pre-defined company and individual target achievement. The estimated amount of the bonus is recognized as an expense in the period the bonus is earned. To the extent that bonuses are settled in shares of the company, they are accounted for as share-based payments.

(T) SHARE-BASED PAYMENTS

Different share and share option programs allow company senior management and members of the board to acquire shares of the company and some of its affiliates. The fair value of the share options is estimated at grant date, using an option pricing model that is most appropriate for the respective option. Based on the expected number of options that will vest, the fair value of the options granted is expensed over the vesting period. When the options are exercised, equity is increased by the amount of the proceeds received.

 

AB InBev – Financial Report 2021 | 41


Equity-settled share-based payment transactions with parties other than employees are measured at the fair value of the goods or services received, except where that fair value cannot be estimated reliably, in which case they are measured at the fair value of the equity instruments granted, measured at the date the company obtains the goods or the counterparty renders the service.

(U) INTEREST-BEARING LOANS AND BORROWINGS

Interest-bearing loans and borrowings are recognized initially at fair value, less attributable transaction costs. Subsequent to initial recognition, interest-bearing loans and borrowings are stated at amortized cost with any difference between the initial amount and the maturity amount being recognized in the income statement (in accretion expense) over the expected life of the instrument on an effective interest rate basis.

(V) TRADE AND OTHER PAYABLES

Trade and other payables are recognized initially at fair value and subsequently measured at amortized cost using the effective interest method.

(W) INCOME TAX

Income tax on the profit for the year comprises current and deferred tax. Income tax is recognized in the income statement except to the extent that it relates to items recognized directly in equity, in which case the tax effect is also recognized directly in equity.

Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted, or substantively enacted, at the balance sheet date, and any adjustment to tax payable in respect of previous years.

In accordance with IAS 12 Income Taxes deferred taxes are provided using the so-called balance sheet liability method. This means that, for all taxable and deductible differences between the tax bases of assets and liabilities and their carrying amounts in the balance sheet a deferred tax liability or asset is recognized. Under this method a provision for deferred taxes is also made for differences between the fair values of assets and liabilities acquired in a business combination and their tax base. IAS 12 prescribes that no deferred taxes are recognized (i) on initial recognition of goodwill, (ii) at the initial recognition of assets or liabilities in a transaction that is not a business combination and affects neither accounting nor taxable profit and (iii) on differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future and to the extent that the company is able to control the timing of the reversal. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using currently or substantively enacted tax rates.

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously.

The company recognizes deferred tax assets, including assets arising from losses carried forward, to the extent that future probable taxable profit will be available against which the deferred tax asset can be utilized. A deferred tax asset is reduced to the extent that it is no longer probable that the related tax benefit will be realized.

The company presents income tax provisions in income tax liabilities. Assets and liabilities for uncertain tax treatments are presented as current tax assets/liabilities or deferred tax assets/liabilities.

(X) INCOME RECOGNITION

Goods sold

Revenue is measured based on the consideration to which the company expects to be entitled in a contract with a customer and excludes amounts collected on behalf of third parties. The company recognizes revenue when performance obligations are satisfied, meaning when the company transfers control of a product to a customer.

Specifically, revenue recognition follows the following five-step approach:

 

   

Identification of the contracts with a customer

 

   

Identification of the performance obligations in the contracts

 

   

Determination of the transaction price

 

   

Allocation of the transaction price to the performance obligations in the contracts

 

   

Revenue recognition when performance obligations are satisfied

 

AB InBev – Financial Report 2021 | 42


Revenue from the sale of goods is measured at the amount that reflects the best estimate of the consideration expected to receive in exchange for those goods. Contracts can include significant variable elements, such as discounts, rebates, refunds, credits, price concessions, incentives, performance bonuses and penalties. Such trade incentives are treated as variable consideration. If the consideration includes a variable amount, the company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to the customer. Variable consideration is only included in the transaction price if it is highly probable that the amount of revenue recognized would not be subject to significant future reversals when the uncertainty is resolved.

Royalty income

The company recognizes the sales-based or usage-based royalties in other operating income when the later of the following events occurs: (a) the customer’s subsequent sales or usage; and (b) the performance obligation to which some or all of the sales-based or usage-based royalty has been allocated has been satisfied (or partially satisfied).

Rental income

Rental income is recognized in other operating income on a straight-line basis over the term of the lease.

Government grants

A government grant is recognized in the balance sheet initially as deferred income when there is reasonable assurance that it will be received and that the company will comply with the conditions attached to it. Grants that compensate the company for expenses incurred are recognized as other operating income on a systematic basis in the same periods in which the expenses are incurred. Grants that compensate the company for the acquisition of an asset are presented by deducting them from the acquisition cost of the related asset.

Finance income

Finance income comprises interest received or receivable on funds invested, dividend income, foreign exchange gains, losses on currency hedging instruments offsetting currency gains, gains on hedging instruments that are not part of a hedge accounting relationship, gains on financial assets measured at FVPL as well as any gains from hedge ineffectiveness (refer to accounting policy Z).

Interest income is recognized as it accrues (taking into account the effective yield on the asset) unless collectability is in doubt.

Dividend income

Dividend income is recognized in the income statement on the date that the dividend is declared.

(Y) EXPENSES

Finance costs

Finance costs comprise interest payable on borrowings, calculated using the effective interest rate method, foreign exchange losses, gains on currency hedging instruments offsetting currency losses, results on interest rate hedging instruments, losses on hedging instruments that are not part of a hedge accounting relationship, losses on financial assets classified as trading, impairment losses on financial assets as well as any losses from hedge ineffectiveness (refer to accounting policy Z).

All interest costs incurred in connection with borrowings or financial transactions are expensed as incurred as part of finance costs. Any difference between the initial amount and the maturity amount of interest-bearing loans and borrowings, such as transaction costs and fair value adjustments, are recognized in the income statement (in accretion expense) over the expected life of the instrument on an effective interest rate basis (refer to accounting policy V). The interest expense component of lease payments is also recognized in the income statement (in accretion expense) using the effective interest rate method.

Research and development, advertising and promotional costs and systems development costs

Research, advertising and promotional costs are expensed in the year in which these costs are incurred. Development costs and systems development costs are expensed in the year in which these costs are incurred if they do not meet the criteria for capitalization (refer to accounting policy G).

Purchasing, receiving and warehousing costs

Purchasing and receiving costs are included in the cost of sales, as well as the costs of storing and moving raw materials and packaging materials. The costs of storing finished products at the brewery as well as costs incurred for subsequent storage in distribution centers are included within distribution expenses.

 

AB InBev – Financial Report 2021 | 43


(Z) FINANCIAL INSTRUMENTS AND HEDGE ACCOUNTING

AB InBev uses derivative financial instruments to mitigate the transactional impact of foreign currencies, interest rates, equity prices and commodity prices on the company’s performance. AB InBev’s financial risk management policy prohibits the use of derivative financial instruments for trading purposes and the company does therefore not hold or issue any such instruments for such purposes.

Classification and measurement

Except for certain trade receivables, the company initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs directly attributable to the acquisition or issue of the financial asset. Debt financial instruments are subsequently measured at amortized cost, FVOCI or FVPL. The classification is based on two criteria: the objective of the company’s business model for managing the assets; and whether the instruments’ contractual cash flows represent ‘solely payments of principal and interest’ on the principal amount outstanding (the ‘SPPI criterion’).

The classification and measurement of the company’s financial assets is as follows:

 

   

Debt instruments at amortized cost: comprise investments in debt securities where the contractual cash flows are solely payments of principal and interest and the company’s business model is to collect contractual cash flows. Interest income, foreign exchange gains and losses and any impairment charges for such instruments are recognized in profit or loss.

 

   

Debt instruments at FVOCI with gains or losses recycled to profit or loss on derecognition: comprise investments in debt securities where the contractual cash flows are solely payments of principal and interest and the company’s business model is achieved by both collecting contractual cash flows and selling financial assets. Interest income, foreign exchange gains and losses and any impairment charges on such instruments are recognized in profit or loss. All other fair value gains and losses are recognized in other comprehensive income. On disposal of these debt securities, any related balance within FVOCI reserve is reclassified to profit or loss.

 

   

Equity instruments designated at FVOCI, with no recycling of gains or losses to profit or loss on derecognition: these instruments are undertakings in which the company does not have significant influence or control and is generally evidenced by ownership of less than 20% of the voting rights. The company designates these investments on an instrument-by-instrument basis as equity securities at FVOCI because they represent investments held for long term strategic purposes. Investments in unquoted companies are subsequently measured at cost, when appropriate. These investments are non-monetary items and gains or losses presented in the other comprehensive income include any related foreign exchange component. Dividends received are recognized in the profit or loss. These investments are not subject to impairment testing and upon disposal, the cumulative gain or loss accumulated in other comprehensive income are not reclassified to profit or loss.

 

   

Financial assets and liabilities at FVPL: comprise derivative instruments and equity instruments which were not designated as FVOCI. This category also includes debt instruments which do not meet the cash flow or the business model tests.

Hedge accounting

The company designates certain derivatives as hedging instruments to hedge the variability in cash flows associated with highly probable forecast transactions arising from changes in foreign exchange rates, interest rates and commodity prices. To hedge changes in the fair value of recognized assets, liabilities and firm commitments, the company designates certain derivatives as part of fair value hedge. The company also designates certain derivatives and non-derivative financial liabilities as hedges of foreign exchange risk on a net investment in a foreign operation.

At the inception of the hedging relationships, the company documents the risk management objective and strategy for undertaking the hedge. Hedge effectiveness is measured at the inception of the hedge relationship and through periodic prospective effectiveness assessments to ensure that an economic relationship exists between hedged item and hedging instrument.

For the different type of hedges in place, the company generally enters into hedge relationships where the critical terms of the hedging instrument match exactly the terms of the hedged item. Therefore, the hedge ratio is typically 1:1. The company performs a qualitative assessment of effectiveness. In circumstances where the terms of the hedged item no longer exactly match the critical terms of the hedging instrument, the company uses a hypothetical derivative method to assess effectiveness. Possible sources of ineffectiveness are changes in the timing of the forecasted transaction, changes in the quantity of the hedged item or changes in the credit risk of either parties to the derivative contract.

 

AB InBev – Financial Report 2021 | 44


Cash flow hedge accounting

Cash flow hedge accounting is applied when a derivative hedges the variability in cash flows of a highly probable forecasted transaction, foreign currency risk of a firm commitment or a recognized asset or liability (such as variable interest rate instrument).

When the hedged forecasted transaction or firm commitment subsequently results in the recognition of a non-financial item, the amount accumulated in the hedging reserves is included directly in the initial carrying amount of the non-financial item when it is recognized.

For all other hedged transactions, the amount accumulated in the hedging reserves is reclassified to profit or loss in the same period during which the hedged item affects profit or loss (e.g., when the variable interest expense is recognized).

When a hedging instrument or hedge relationship is terminated but the hedged transaction is still expected to occur, the cumulative gain or loss (at that point) remains in equity and is reclassified to profit or loss when the hedged transaction occurs. If the hedged transaction is no longer expected to occur, the cumulative gain or loss recognized in other comprehensive income is reclassified to profit or loss immediately.

Any ineffectiveness is recognized immediately in profit or loss.

Fair value hedge accounting

When a derivative hedges the variability in fair value of a recognized asset or liability (such as a fixed rate instrument) or a firm commitment, any resulting gain or loss on the hedging instrument is recognized in the profit or loss. The carrying amount of the hedged item is also adjusted for fair value changes in respect of the risk being hedged, with any gain or loss being recognized in profit or loss. The fair value adjustment to the carrying amount of the hedged item is amortized to profit or loss from the date of discontinuation.

Net investment hedge accounting

When a non-derivative foreign currency liability hedges a net investment in a foreign operation, exchange differences arising on the translation of the liability to the functional currency are recognized directly in other comprehensive income (translation reserves).

When a derivative financial instrument hedges a net investment in a foreign operation, the portion of the gain or the loss on the hedging instrument that is determined to be effective is recognized directly in other comprehensive income (translation reserves) and is reclassified to profit or loss upon disposal of the foreign operation, while the ineffective portion is reported in profit or loss.

Offsetting

Financial assets and financial liabilities are offset, and the net amount presented in the statement of financial position when, and only when, the company has a currently legally enforceable right to set off the amounts and it intends either to settle them on a net basis or to realize the asset and settle the liability simultaneously.

(AA) SEGMENT REPORTING

Operating segments are components of the company’s business activities about which separate financial information is available that is evaluated regularly by senior management. The company has six operating segments.

AB InBev’s operating segment reporting format is geographical because the company’s risks and rates of return are affected predominantly by the fact that AB InBev operates in different geographical areas. The company’s management structure and internal reporting system to the Board of Directors is set up accordingly. The company’s five geographic regions are North America, Middle Americas, South America, EMEA and Asia Pacific.

The aggregation criteria applied are based on similarities in the economic indicators (e.g., margins) that have been assessed in determining that the aggregated operating segments share similar economic characteristics, as prescribed in IFRS 8. Furthermore, management assessed additional factors such as management’s views on the optimal number of reporting segments, AB InBev historical geographies, peer comparison (e.g., Asia Pacific and EMEA being a commonly reported regions amongst the company’s peers), as well as management’s view on the optimal balance between practical and more granular information.

The results of Global Export and Holding Companies, which includes the company’s global headquarters and the export businesses in countries in which AB InBev has no operations are reported separately. The company’s five geographic regions plus the Global Export and Holding Companies comprise the company’s six reportable segments for financial reporting purposes.

Segment capital expenditure is the total cost incurred during the period to acquire property, plant and equipment, and intangible assets other than goodwill.

 

AB InBev – Financial Report 2021 | 45


(BB) NON-UNDERLYING ITEMS

Non-underlying items are those that in management’s judgment need to be disclosed separately by virtue of their size or incidence. Such items are disclosed on the face of the consolidated income statement or separately disclosed in the notes to the financial statements. Transactions which may give rise to non-underlying items are principally restructuring activities, impairments, gains or losses on disposal of investments and the effect of the accelerated repayment of certain debt facilities.

(CC) DISCONTINUED OPERATIONS AND NON-CURRENT ASSETS HELD FOR SALE

A discontinued operation is a component of the company that either has been disposed of or is classified as held for sale and represents a separate major line of business or geographical area of operations and is part of a single coordinated plan to dispose of or is a subsidiary acquired exclusively with a view to resale.

AB InBev classifies a non-current asset (or disposal group) as held for sale if its carrying amount will be recovered principally through a sale transaction rather than through continuing use if all of the conditions of IFRS 5 are met. A disposal group is defined as a group of assets to be disposed of, by sale or otherwise, together as a group in a single transaction, and liabilities directly associated with those assets that will be transferred. Immediately before classification as held for sale, the company measures the carrying amount of the asset (or all the assets and liabilities in the disposal group) in accordance with applicable IFRS. Then, on initial classification as held for sale, non-current assets and disposal groups are recognized at the lower of carrying amount and fair value less costs to sell. Impairment losses on initial classification as held for sale are included in profit or loss. The same applies to gains and losses on subsequent re-measurement. Non-current assets classified as held for sale are no longer depreciated or amortized.

(DD) RECENTLY ISSUED IFRS

To the extent that new IFRS requirements are expected to be applicable in the future, they have not been applied in preparing these consolidated financial statements for the year ended 31 December 2021.

A number of amendments to standards are effective for annual periods beginning after 1 January 2021 and have not been discussed either because of their non-applicability or immateriality to AB InBev’s consolidated financial statements.

 

AB InBev – Financial Report 2021 | 46


4. Use of estimates and judgments

The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

These estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or, if the revision affects both current and future periods, in the period of the revision and future periods.

Although each of its significant accounting policies reflects judgments, assessments or estimates, AB InBev believes that the following accounting policies reflect the most critical judgments, estimates and assumptions that are important to its business operations and understanding results: business combinations, intangible assets, goodwill, impairment, provisions, share-based payments, employee benefits and accounting for current and deferred tax.

The fair values of acquired identifiable intangibles are based on an assessment of future cash flows. Impairment analyses of goodwill and indefinite-lived intangible assets are performed annually and whenever a triggering event has occurred, in order to determine whether the carrying value exceeds the recoverable amount. These calculations are based on estimates of future cash flows.

The company uses its judgment to select a variety of methods including the discounted cash flow method and option valuation models and makes assumptions about the fair value of financial instruments that are mainly based on market conditions existing at each balance sheet date.

Actuarial assumptions are established to anticipate future events and are used in calculating pension and other long-term employee benefit expenses and liabilities. These factors include assumptions with respect to interest rates, rates of increase in health care costs, rates of future compensation increases, turnover rates, and life expectancy.

The company is subject to income tax in numerous jurisdictions. Significant judgment is required to determine the worldwide provision for income tax. There are some transactions and calculations for which the ultimate tax determination is uncertain. Some subsidiaries within the group are involved in tax audits and local enquiries usually in relation to prior years. Investigations and negotiations with local tax authorities are ongoing in various jurisdictions at the balance sheet date and, by their nature, these can take considerable time to conclude. In assessing the amount of any income tax provisions to be recognized in the financial statements, estimates are made of the expected successful settlement of these matters. Estimates of interest and penalties on tax liabilities are also recorded. Where the final outcome of these matters is different from the amounts that were initially recorded, such differences will impact the current and deferred income tax assets and liabilities in the period that such determination is made.

Judgments made by management in the application of IFRS that have a significant effect on the financial statements and estimates with a significant risk of material adjustment in the following year are further discussed in the relevant notes hereafter.

In preparing these consolidated financial statements, the significant judgments made by management in applying the company’s accounting policies and the key sources of uncertainty relate mainly to accounting for the COVID-19 pandemic impact on the company’s results as discussed below.

COVID-19 PANDEMIC IMPACT

Management considered the impact of COVID-19 and the current economic environment on the basis of preparation of these consolidated financial statements. The company continues to adequately manage its liquidity and capital resources (refer to Note 20 Cash and cash equivalents and investment securities, Note 23 Interest-bearing loans and borrowings and Note 28 Risks arising from financial instruments). As such, management concluded the company is able to continue as a going concern.

COVID-19 costs

As required by IAS 1 Presentation of financial statements, the company has assessed the impact of the COVID-19 outbreak on its performance for the year ended 31 December 2021 and reported (105)m US dollar of costs in non-underlying items as a result of the pandemic. These expenses mainly comprise costs related to personal protection equipment for the company’s employees, charitable donations and other costs incurred as a direct consequence of the COVID-19 pandemic. Refer to Note 8 Non-underlying items.

 

AB InBev – Financial Report 2021 | 47


5. Segment reporting

Segment information is presented by geographical segments, consistent with the information available to and regularly evaluated by the chief operating decision maker. AB InBev operates its business through six business segments. Regional and operating company management is responsible for managing performance, underlying risks, and the effectiveness of operations. Internally, AB InBev’s management uses performance indicators such as normalized profit from operations (normalized EBIT) and normalized EBITDA as measures of segment performance and to make decisions regarding the allocation of resources. The organizational structure comprises five regions: North America, Middle Americas, South America, EMEA and Asia Pacific. In addition to these five geographic regions, the company uses a sixth segment, Global Export and Holding Companies, for all financial reporting purposes.

On 1 June 2020, AB InBev divested CUB, its Australian subsidiary, to Asahi (refer to Note 21 Assets classified as held for sale, liabilities associated with assets held for sale and discontinued operations). Since the results of the Australian operations represented a separate major line of business, these were accounted for as discontinued operations (“profit from discontinued operations”) up to 31 May 2020.

All figures in the tables below are stated in million US dollar, except volume (million hls) and Normalized EBITDA margin (in %).

 

    North America     Middle Americas     South America     EMEA     Asia Pacific     Global Export and
Holding companies
    AB InBev
Worldwide
 
     2021     2020     2021     2020     2021     2020     2021     2020     2021     2020     2021     2020     2021     2020  
                                                                                                                 

  Volume

    107       107       141       121       157       144       87       76       88       82       2       1       582       531  

  Revenue

    16 257       15 622       12 541       10 032       9 494       8 092       8 032       6 835       6 848       5 648       1 133       652       54 304       46 881  

  Normalized EBITDA

    6 131       6 172       6 126       5 014       3 125       3 179       2 598       1 895       2 321       1 737       (1 093     (677     19 209       17 321  

  Normalized EBITDA margin %

    37.7%       39.5%       48.8%       50.0%       32.9%       39.3%       32.4%       27.7%       33.9%       30.8%       -       -       35.4%       36.9%  

  Depreciation, amortization and impairment

    (782     (803     (1 138     (1 017     (760     (767     (1 014     (988     (712     (646     (364     (376     (4 771     (4 598

  Normalized profit from operations

    5 349       5 369       4 988       3 997       2 365       2 412       1 584       907     1 609       1 091       (1 457     (1 053     14 438       12 723  

  Non-underlying items (including non-underlying impairment)

    (239     (222     (100     (112     (60     (62     (112     (2 629     (40     (29     (63     (50     (614     (3 103

  

                                                                                                               

  Profit from operations

    5 110       5 147       4 888       3 885       2 305       2 350       1 472       (1 722     1 569       1 062       (1 520     (1 103     13 824       9 620  

  Net finance income/(cost)

                                                                                                    (5 609     (7 697

  Share of results of associates and joint ventures

                                                                                                    248       156  

  Income tax expense

                                                                                                    (2 350     (1 932

  Profit from continuing operations

                                                                                                    6 114       147  

  Profit from discontinued operations

                                                                                                    -     2 055  

  Profit/(loss)

                                                                                                    6 114       2 202  
                                                                                                                 

  Segment assets (non-current)

    63 722       63 765       67 516       72 331       12 917       12 348       34 098       35 578       13 453       13 845       1 973       2 024       193 678       199 891  

  Gross capex

    868       646       1 307       829       1 154       727       1 051       768       605       508       655       303       5 640       3 781  

  FTE

    19 691       20 281       51 969       48 751       42 209       40 630       22 215       22 357       26 095       26 510       7 160       5 166       169 339       163 695  

For the year ended 31 December 2021, net revenue from the beer business amounted to 49 333m US dollar (31 December 2020: 43 044m US dollar) while the net revenue from the non-beer business (soft drinks and other business) accounted for 4 971m US dollar (31 December 2020: 3 837m US dollar). Additionally, for the year ended 31 December 2021, net revenue from the company’s business in the United States amounted to 14 259m US dollar (31 December 2020: 13 815m US dollar) and net revenue from the company’s business in Brazil amounted to 6 500 m US dollar (31 December 2020: 5 868m US dollar).

On the same basis, net revenue from external customers attributable to AB InBev’s country of domicile (Belgium) represented 623m US dollar (31 December 2020: 501m US dollar) and non-current assets located in the country of domicile represented 2 457m US dollar (31 December 2020: 2 496m US dollar).

 

AB InBev – Financial Report 2021 | 48


6. Acquisitions and disposals of subsidiaries

The table below summarizes the impact of acquisitions and disposals on the statement of financial position and cash flows of AB InBev for the year ended 31 December 2021 and 31 December 2020:

 

 Million US dollar    2021
Acquisitions
     2020
Acquisitions
     2021
Disposals
     2020
Disposals
 
                                     

Non-current assets

                                   

Property, plant and equipment

     2        149        (5)         

Intangible assets

            162                

Investments in associates

            (7)                
                                     

Current assets

                                   

Inventories

            33        (7)         

Trade and other receivables

     1        9        (6)         

Cash and cash equivalents

     5        5        (5)         
                                     

Non-current liabilities

                                   

Interest-bearing loans and borrowings

            (74)                

Trade and other payables

            (34)                

Deferred tax liabilities

            (6)                
                                     

Current liabilities

                                   

Interest-bearing loans and borrowings

            (4)                

Trade and other payables

     (5)        (59)        10         
                                     

Net identifiable assets and liabilities

     3        174        (13)         
                                     

Non-controlling interest

                           
                                     

Goodwill on acquisitions and goodwill disposed of

            185                

Loss/(gain) on disposal

                   1         

Consideration to be (paid)/received

            (14)                

Net cash paid/(received) on prior years acquisitions/(disposals)

     453        170                

Consideration paid/(received)

     456        515        (12)         
                                     

Cash (acquired)/disposed of

     (5)        (5)        5         
                                     

Net cash outflow / (inflow)

     451        510        (7)         

On 1 June 2020, AB InBev completed the divestiture of CUB to Asahi – see Note 21 Assets classified as held for sale, liabilities associated with assets held for sale and discontinued operations.

On 30 September 2020, AB InBev completed the acquisition of the remaining 68.8% shares of Craft Brew Alliance for the net consideration of 0.2 billion US dollar and hence obtained 100% control over the acquiree.

The company undertook a series of additional acquisitions and disposals during 2021 and 2020, with no significant impact in the company’s consolidated financial statements.

 

AB InBev – Financial Report 2021 | 49


7. Other operating income/(expenses)

 

Million US dollar

     2021                  2020  
                   

Brazilian tax credits

     226        481  

Government grants

     322        227  

Net gain on disposal of property, plant and equipment, intangible assets and assets held for sale

     65        56  

License income

     25        22  

Net (additions to)/reversals of provisions

     (1)        (14)  

Net rental and other operating income

     168        72  

Other operating income/(expenses)

     805        845  

In the second quarter of 2021, Ambev, a subsidiary of AB InBev, recognized 226m US dollar income in Other operating income related to tax credits following a favorable decision from the Brazilian Supreme Court. Additionally, Ambev recognized 118m US dollar of interest income in Finance income (refer to Note 11 Finance cost and income) for the year ended 31 December 2021.

In the fourth quarter of 2020, Ambev concluded the calculation of its tax credits on a judicial decision related to the exclusion of the Value-Added Tax (ICMS) from the taxable basis of the social contribution on gross revenues (PIS and COFINS). The decision refers to the period between November 2009 and April 2015. As a result of this judicial decision and other tax credit adjustments, Ambev recognized 481m US dollar income in Other operating income and 315m US dollar of interest income in Finance income (refer to Note 11 Finance cost and income) for the year ended 31 December 2020.

The income from government grants primarily relate to fiscal incentives given by certain Brazilian states and Chinese provinces, based on the company’s operations and developments in those regions.

In 2021, the company expensed 298m US dollar in research, compared to 296m US dollar in 2020. The spend focused on product innovations, market research, as well as process optimization and product development.

8. Non-underlying items

IAS 1 Presentation of financial statements requires that material items of income and expense be disclosed separately. Non-underlying items are items that in management’s judgment need to be disclosed by virtue of their size or incidence so that a user can obtain a proper understanding of the company´s financial information. The company considers these items to be significant and accordingly, management has excluded them from their segment measure of performance in Note 5 Segment Reporting.

The non-underlying items included in the income statement are as follows:

 

Million US dollar

     2021                    2020  
                   

COVID-19 costs

     (105)        (182)  

Restructuring

     (172)        (157)  

Business and asset disposal (including impairment losses)

     (247)        (239)  

Acquisition costs business combinations

     (17)        (25)  

Zenzele Kabili costs

     (72)         

Impairment of goodwill

            (2 500)  

Impact on profit from operations

     (614)        (3 103)  
                   

Gain on divestiture of Australia (discontinued operations)

            1 919  

Non-underlying net finance income/(cost)

     (806)        (1 738)  

Non-underlying taxes

     346        155  

Non-underlying non-controlling interest

     20        228  

Net impact on profit attributable to equity holders of AB InBev

     (1 054)        (2 538)  

COVID-19 costs amount to (105)m US dollar for the year ended 31 December 2021 (31 December 2020: (182)m US dollar). These expenses mainly comprise costs related to personal protection equipment for the company’s employees, charitable donations and other costs incurred as a direct consequence of the COVID-19 pandemic.

The non-underlying restructuring charges for the year ended 31 December 2021 total (172)m US dollar (31 December 2020: (157)m US dollar). These charges primarily relate to organizational alignments. These changes aim to eliminate overlapping organizations or duplicated processes, taking into account the matching of employee profiles with new organizational requirements. These one-time expenses provide the company with a lower cost base and bring a stronger focus to AB InBev’s core activities, quicker decision-making and improvements to efficiency, service and quality.

 

AB InBev – Financial Report 2021 | 50


Business and asset disposals (including impairment losses) amount to (247)m US dollar for the year ended 31 December 2021, mainly comprising (258)m US dollar of non-cash impairment charge associated with Bedford Systems, a joint venture with Keurig Dr. Pepper, following the announcement of the cessation of the business in December 2021, that was partially offset with gains incurred in relation to disposals completed in the first half of 2021. Business and asset disposals (including impairment losses) amounted to (239)m US dollar for the year ended 31 December 2020, mainly comprising impairment of tangible assets classified as held for sale as of 31 December 2020, intangible assets sold in 2020 and other intangibles.

The acquisition costs of business combinations amount to (17)m US dollar for the year ended 31 December 2021, mainly comprising costs incurred in relation to the company’s joint venture partnerships. The acquisition costs of business combinations amount to (25)m US dollar for the year ended 31 December 2020 and mainly relate to the acquisition of Craft Brew Alliance.

In May 2021, the company set up a new broad-based black economic empowerment (“B-BBEE”) scheme (the “Zenzele Kabili scheme”) and reported (72)m US dollar in non-underlying items mainly representing the IFRS 2 cost related to the grant of shares to qualifying SAB retailers and employees participating to the Zenzele Kabili scheme. For more details, refer to Note 22 Changes in equity and earnings per share.

In the second quarter of 2020, the company recognized (2 500)m US dollar of goodwill impairment for its South Africa and Rest of Africa cash-generating units – see Note 14 Goodwill for further details.

On 1 June 2020, the company completed the previously announced sale of CUB to Asahi resulting in a net non-underlying gain of 1 919m US dollar reported in discontinued operations. For more details, refer to Note 21 Assets classified as held for sale, liabilities associated with assets held for sale and discontinued operations.

The company incurred a non-underlying net finance cost of (806)m US dollar for the year ended 31 December 2021 (31 December 2020: net finance cost of (1 738)m US dollar) – see Note 11 Finance cost and income.

All the amounts referenced above are before income taxes. The non-underlying income taxes amounted to 346m US dollar (decrease of income taxes) for the year ended 31 December 2021 (31 December 2020: decrease of income taxes by 155m US dollar).

Non-controlling interest on the non-underlying items amounts to 20m US dollar for the year ended 31 December 2021 (31 December 2020: 228m US dollar).

9. Payroll and related benefits

 

Million US dollar

     2021                    2020  
                   

Wages and salaries

     (4 734)        (4 124)  

Social security contributions

     (670)        (582)  

Other personnel cost

     (706)        (637)  

Pension expense for defined benefit plans

     (176)        (218)  

Share-based payment expense

     (510)        (169)  

Contributions to defined contribution plans

     (147)        (91)  

Payroll and related benefits

     (6 944)        (5 821)  

The number of full-time equivalents can be split as follows:

 

       2021                    2020  
                   

AB InBev NV/SA (parent company)

     214        204  

Other subsidiaries

     169 125        163 491  

Total number of FTE

     169 339        163 695  

 

AB InBev – Financial Report 2021 | 51


10. Additional information on operating expenses by nature

Depreciation, amortization and impairment charges are included in the following line items of the 2021 consolidated income statement:

 

 Million US dollar         Depreciation and
impairment of
property, plant
and equipment
    Amortization and
impairment of
intangible assets
    Depreciation and
impairment of
right-of-use asset
    Impairment of
goodwill, tangible
and intangible
assets
 
                                      

Cost of sales

         2 782       91       39       -  

Distribution expenses

         136       10       176       -  

Sales and marketing expenses

         319       223       249       -  

Administrative expenses

         306       327       110       -  

Other operating expenses

         3       -       -       -  

Non-underlying items

         -       -       -       281  

Depreciation, amortization and impairment

         3 546       651       574       281  

Depreciation, amortization and impairment charges are included in the following line items of the 2020 consolidated income statement:

 

 Million US dollar         Depreciation and
impairment of
property, plant
and equipment
    Amortization and
impairment of
intangible assets
    Depreciation and
impairment of
right-of-use asset
    Impairment of
goodwill, tangible
and intangible
assets
 
                                      

Cost of sales

         2 599       91       42       -  

Distribution expenses

         141       3       108       -  

Sales and marketing expenses

         339       291       224       -  

Administrative expenses

         310       323       125       -  

Other operating expenses

         3       -       -       -  

Non-underlying items

         -       -       -       2 733  

Depreciation, amortization and impairment

         3 392       708       499       2 733  

The depreciation, amortization and impairment of property, plant and equipment included a full-cost reallocation of (11)m US dollar in 2021 from the aggregate depreciation, amortization and impairment expense to cost of goods sold (2020: (5)m US dollar).

 

AB InBev – Financial Report 2021 | 52


11. Finance cost and income

The finance cost and income included in the income statement are as follows:

 

Million US dollar

     2021                    2020  
                   

Interest expense

     (3 684)        (4 016)  

Capitalization of borrowing costs

     10        12  

Net interest on net defined benefit liabilities

     (73)        (82)  

Accretion expense

     (593)        (564)  

Net losses on hedging instruments that are not part of a hedge accounting relationship

     (562)        (502)  

Net foreign exchange results (net of the effect of foreign exchange derivative instruments)

     (101)        -  

Tax on financial transactions

     (73)        (103)  

Net mark-to-market results on derivatives related to the hedging of share-based payment programs

     (23)        (1 211)  

Other financial costs, including bank fees

     (135)        (135)  

Finance cost excluding non-underlying items

     (5 234)        (6 601)  
                   

Non-underlying finance cost

     (806)        (1 818)  

Finance cost

     (6 040)        (8 419)  
                   

Interest income

     113        150  

Interest income on Brazilian tax credits

     118        315  

Hyperinflation monetary adjustments

     152        76  

Net foreign exchange results (net of the effect of foreign exchange derivative instruments)

     -        43  

Other financial income

     48        58  

Finance income excluding non-underlying items

     431        642  
                   

Non-underlying finance income

     -        80  

Finance income

     431        722  
                   

Net finance income/(cost) excluding non-underlying items

     (4 803)        (5 959)  

Net finance income/(cost)

     (5 609)        (7 697)  

Net finance costs, excluding non-underlying items, were 4 803m US dollar in 2021 compared to 5 959m US dollar in 2020. The decrease was predominantly due to a mark-to-market loss of 23m US dollar in 2021, compared to a loss of 1 211m US dollar in 2020, resulting in a change of 1 188m US dollar.

Borrowing costs capitalized relate to the capitalization of interest expenses directly attributable to the acquisition and construction of qualifying assets mainly in Belgium. Interest is capitalized at a borrowing rate of approximately 4%.

In 2021, accretion expense includes interest on lease liabilities of 123m US dollar (2020: 116m US dollar), unwind of discounts of 349m US dollar (2020: 306m US dollar), bond fees of 67m US dollar (2020: 102m US dollar) and interest on provisions of 54m US dollar (2020: 41m US dollar).

Interest expenses are presented net of the effect of interest rate derivative instruments hedging AB InBev’s interest rate risk – see also Note 28 Risks arising from financial instruments.

In the second quarter of 2021, Ambev, a subsidiary of AB InBev, recognized 226m US dollar income in Other operating income (refer to Note 7 Other operating income/(expenses)) related to tax credits following a favorable decision from the Brazilian Supreme Court. Additionally, Ambev recognized 118m US dollar of interest income in Finance income for the year ended 31 December 2021.

In the fourth quarter of 2020, Ambev concluded the calculation of its tax credits on a judicial decision related to the exclusion of the Value-Added Tax (ICMS) from the taxable basis of the social contribution on gross revenues (PIS and COFINS). The decision refers to the period between November 2009 and April 2015. As a result of this judicial decision and other tax credit adjustments, Ambev recognized 481m US dollar income in Other operating income (refer to Note 7 Other operating income/(expenses)) and 315m US dollar of interest income in Finance income for the year ended 31 December 2020.

 

AB InBev – Financial Report 2021 | 53


Non-underlying finance income/(cost) for 2021 and 2020 include:

 

   

25m US dollar loss resulting from mark-to-market adjustments on derivative instruments entered into to hedge the shares issued in relation to the combination with Grupo Modelo and the restricted shares issued in connection with the combination with SAB (2020: 1 008m US dollar loss);

 

   

741m US dollar loss resulting from the early termination of certain bonds (2020: 795m US dollar loss);

 

   

22m US dollar loss from impairment of receivables against Delta Corporation Ltd (Delta), a Zimbabwean associate, as a result of hyperinflation (2020: 15m US dollar loss on the company’s investment in Delta);

 

   

19m US dollar loss related to remeasurement of deferred considerations on prior year acquisitions (2020: 80m US dollar gain).

No interest income was recognized on impaired financial assets.

The interest income stems from the following financial assets:

 

Million US dollar

     2021                    2020  
                   

Cash and cash equivalents

     85        103  

Investment debt securities held for trading

     16        1  

Other loans and receivables

     11        46  

Total

     112        150  

The interest income on other loans and receivables includes the interest accrued on cash deposited as guarantees for certain legal proceedings pending their resolution.

For further information on instruments hedging AB InBev’s foreign exchange risk see Note 28 Risks arising from financial instruments.

 

AB InBev – Financial Report 2021 | 54


12. Income taxes

Income taxes recognized in the income statement can be detailed as follows:

 

 Million US dollar    2021      2020  
                   

 Current year

     (2 857)        (2 082)  

 (Underprovided)/overprovided in prior years

     159        119  

 Current tax expense

     (2 698)        (1 963)  
                   

 Origination and reversal of temporary differences

     319        (30)  

 (Utilization)/recognition of deferred tax assets on tax losses

     24        13  

 Recognition of previously unrecognized tax losses

     5        48  

 Deferred tax (expense)/income

     348        31  
                   

 Total income tax expense

     (2 350)        (1 932)  

The reconciliation of the effective tax rate with the aggregated weighted nominal tax rate can be summarized as follows:

 

 Million US dollar    2021      2020  
                   

 Profit/(loss) before tax

     8 463        2 080  

 Deduct share of results of associates and joint ventures

     248        156  

 Profit/(loss) before tax and before share of results of associates and joint ventures

     8 215        1 924  
                   

 Adjustments to the tax basis

                 

 Government incentives

     (543)        (428)  

 Non-deductible/(non-taxable) mark-to-market on derivatives

     48        2 219  

 Non-deductible impairment of goodwill

     -        2 500  

 Other expenses not deductible for tax purposes

     1 979        1 512  

 Other non-taxable income

     (476)        (250)  
       9 223        7 477  
                   

 Aggregate weighted nominal tax rate

     26.7%        27.7%  
                   

 Tax at aggregated nominal tax rate

     (2 463)        (2 069)  
                   

 Adjustments on tax expense

                 

 Utilization of tax losses not previously recognized

     24        13  

 Recognition of deferred taxes on previous years’ tax losses

     5        48  

 Write-down of deferred tax assets on losses and current year losses for which

 no deferred tax asset is recognized

     (314)        (386)  

 (Underprovided)/overprovided in prior years

     159        119  

 Deductions from interest on equity

     469        431  

 Deductions from goodwill

     14        16  

 Other tax deductions

     212        218  

 Change in tax rate

     (147)        61  

 Withholding taxes

     (485)        (423)  

 Other tax adjustments

     175        39  
       (2 350)        (1 932)  
                   

 Effective tax rate

     28.6%                100.4%  

The total income tax expense for 2021 amounts to 2 350m US dollar compared to 1 932m US dollar for 2020. The effective tax rate is 28.6% for 2021 compared to 100.4% for 2020.

The 2020 effective tax rate was negatively impacted by non-deductible losses from derivatives related to the hedging of share-based payment programs and the hedging of the shares issued in a transaction related to the combination with Grupo Modelo and SAB, and the non-deductible, non-cash goodwill impairment loss.

The company benefits from tax exempted income and tax credits which are expected to continue in the future. The company does not have significant benefits coming from low tax rates in any particular jurisdiction.

The normalized effective tax rate for 2021 is 28.0% (2020: 30.9%). The normalized effective tax rate excluding mark-to-market gains or losses on derivatives related to the hedging of share-based payment programs for 2021 is 27.9% (2020: 26.2%).

 

AB InBev – Financial Report 2021 | 55


Normalized effective tax rate is the effective tax rate adjusted for non-underlying items. Normalized effective tax rate is not an accounting measure under IFRS accounting and should not be considered as an alternative to the effective tax rate. Normalized effective tax rate method does not have a standard calculation method and AB InBev’s definition of normalized tax rate may not be comparable to other companies.

Income taxes were directly recognized in other comprehensive income as follows:

 

 Million US dollar    2021      2020  
                   

 Re-measurements of post-employment benefits

     (123)        58  

 Exchange differences, cash flow and net investment hedges

     (45)        304  

 Income tax (losses)/gains

     (167)                361  

13. Property, plant and equipment

Property, plant and equipment comprises owned and leased assets, as follows:

 

 Million US dollar   31 December 2021         31 December 2020
                 

 Property, plant and equipment owned

  24 459        24 191

 Property, plant and equipment leased (right-of-use assets)

  2 219        2 228

 Total property, plant and equipment

  26 678        26 419

 

     31 December 2021      31 December
2020
 
 Million US dollar    Land and
buildings
     Plant and
equipment,
fixtures and
fittings
     Under
construction
     Total      Total  
                                              

 Acquisition cost

                                            

 Balance at end of previous year

     12 237        34 976        1 780        48 993        48 757  

 Effect of movements in foreign exchange

     (383)        (1 162)        (70)        (1 616)        (1 644)  

 Acquisitions

     44        1 296        3 399        4 739        3 188  

 Acquisitions through business combinations

     (0)        2        0        2        111  

 Disposals through sale and derecognition

     (104)        (1 197)        (1)        (1 301)        (1 274)  

 Disposals through the sale of subsidiaries

     (18)        (33)        -        (51)        -  

 Transfer (to)/from other asset categories and

 other movements¹

     598        2 025        (2 646)        (23)        (145)  

 Balance at end of the period

     12 374        35 906        2 462        50 742        48 993  

 

                                            

 Depreciation and impairment losses

                                            

 Balance at end of previous year

     (3 950)        (20 852)        -        (24 802)        (23 242)  

 Effect of movements in foreign exchange

     123        690        -        813        625  

 Depreciation

     (376)        (3 008)        -        (3 384)        (3 250)  

 Disposals through sale and derecognition

     64        1 104        -        1 168        1 130  

 Disposals through the sale of subsidiaries

     17        29        -        46        -  

 Impairment losses

     (19)        (161)        (2)        (182)        (145)  

 Transfer to/(from) other asset categories and

 other movements1

     (151)        206        2        57        80  

 Balance at end of the period

     (4 292)        (21 992)        -        (26 284)        (24 802)  
                                              

 Carrying amount

                                            

 at 31 December 2020

     8 287        14 124        1 780        24 191        24 191  

 at 31 December 2021

     8 082        13 915        2 462                24 459        -  

As at 31 December 2021, the carrying amount of property, plant and equipment subject to restrictions on title amounted to 1m US dollar (31 December 2020: 2m US dollar).

 

 

1 The transfer (to)/from other asset categories and other movements relates mainly to transfers from assets under construction to their respective asset categories, to contributions of assets to pension plans, to the separate presentation in the balance sheet of property, plant and equipment held for sale in accordance with IFRS 5 Non-current assets held for sale and discontinued operations and to the restatement of non-monetary assets under hyperinflation accounting in line with IAS 29 Financial reporting in hyperinflationary economies.

 

AB InBev – Financial Report 2021 | 56


Contractual commitments to purchase property, plant and equipment amounted to 449m US dollar as at 31 December 2021 compared to 528m US dollar as at 31 December 2020.

AB InBev’s net capital expenditures in the statement of cash flow amounted to 5 498m US dollar in 2021 compared to 3 687m US dollar for the same period last year. Out of the total 2021 capital expenditures approximately 44% was used to improve the company’s production facilities while 41% was used for logistics and commercial investments and 15% for improving administrative capabilities and for the purchase of hardware and software.

Property, plant and equipment leased by the company (right-of-use assets) is detailed as follows:

 

     2021  
  Million US dollar    Land and
buildings
    

Machinery,

equipment and

other

     Total  

            

                          

  Net carrying amount at 31 December

     1 696        523        2 219  

  Depreciation for the year ended 31 December

     (373)        (201)        (574)  
     2020  
  Million US dollar    Land and
buildings
    

Machinery,

equipment and

other

     Total  

            

                          

  Net carrying amount at 31 December

     1 726        502        2 228  

  Depreciation for the year ended 31 December

     (343)        (156)        (499)  

Additions to right-of-use assets in 2021 were 674m US dollar (2020: 381m US dollar).

Following the sale of Dutch and Belgian pub real estate to Cofinimmo in October 2007, AB InBev entered into lease agreements with a term of 27 years. Furthermore, the company leases a number of warehouses, trucks, factory facilities and other commercial buildings, which typically run for a period of five to ten years. Lease payments are increased annually to reflect market rentals, if applicable. None of the leases include contingent rentals.

The company leases out pub real estate for an average outstanding period of 6 to 8 years and part of its own property under operating leases. In 2021, 112m US dollar was recognized as income in the income statement in respect of subleasing of right-of-use assets (2020: 107m US dollar). As at 31 December 2021, the undiscounted lease payments of the non-cancelable lease payments are expected to be received as follows: 116m US dollar in the next 12 months, 295m US dollar in the years 2 through 5 and 104m US dollar after 5 years.

The expense related to short-term and low-value leases and variable lease payments that are not included in the measurement of the lease liabilities is not significant.

14. Goodwill

 

  Million US dollar                                      31 December 2021   31 December 2020
                  

  Acquisition cost

                

  Balance at end of previous year

           123 702   128 119

  Effect of movements in foreign exchange

           (5 456)   (4 723)

  Acquisitions through business combinations

           -   185

  Transfers (to)/from intangible assets

           18   -

  Hyperinflation monetary adjustments

           196   120

  Balance at end of the period

           118 461   123 702
                  

  Impairment losses

                

  Balance at end of previous year

           (2 731)   (5)

  Effect of movements in foreign exchange

           66   (226)

  Impairment losses

           -   (2 500)

  Balance at end of the period

           (2 665)   (2 731)
                  

  Carrying amount

                

  at 31 December 2020

           120 971   120 971
  at 31 December 2021              115 796     

 

AB InBev – Financial Report 2021 | 57


The carrying amount of goodwill was allocated to the different cash-generating units as follows:

 

  Million US dollar    31 December 2021     31 December 2020

            

        

  United States

   33 607   33 552

  Rest of North America

   2 114   2 105

  Mexico

   12 062   12 446

  Colombia

   15 344   17 748

  Rest of Middle Americas

   22 769   24 036

  Brazil

   3 280   3 521

  Rest of South America

   1 173   1 061

  Europe

   2 244   2 444

  South Africa

   10 231   11 110

  Rest of Africa

   5 287   4 990

  China

   3 387   3 291

  Rest of Asia Pacific

   3 717   4 059

  Global Export and Holding Companies

   582   608
  Total carrying amount of goodwill    115 796   120 971

Goodwill, which accounted for approximately 53% of AB InBev total assets as at 31 December 2021, is tested for impairment at the cash-generating unit level (that is one level below the operating segments). The cash-generating unit level is the lowest level at which goodwill is monitored for internal management purposes. Except in cases where the initial allocation of goodwill has not been concluded by the end of the initial reporting period following the business combination, goodwill is allocated as from the acquisition date to each of AB InBev’s cash-generating units that are expected to benefit from the synergies of the combination whenever a business combination occurs.

2021 impairment testing

AB InBev completed its annual impairment test for goodwill and concluded that, based on the assumptions described below, no impairment charge was warranted.

The company cannot predict whether an event that triggers impairment will occur, when it will occur or how it will affect the value of the asset reported. Goodwill impairment testing relies on a number of critical judgments, estimates and assumptions. AB InBev believes that all of its estimates are reasonable: they are consistent with the company’s internal reporting and reflect management’s best estimates. However, inherent uncertainties exist that management may not be able to control. If the company’s current assumptions and estimates, including projected revenues growth rates, competitive and consumer trends, weighted average cost of capital, terminal growth rates, and other market factors, are not met, or if valuation factors outside of the company’s control change unfavorably, the estimated fair value of goodwill could be adversely affected, leading to a potential impairment in the future.

During its valuation, the company ran sensitivity analysis for key assumptions including the weighted average cost of capital and the terminal growth rate, in particular for the valuations of Colombia, South Africa and Rest of Africa cash-generating units that show the highest invested capital to EBITDA multiple. In the sensitivity analysis performed by management during the annual impairment testing in 2021, an adverse change of 1% in WACC or terminal growth rate would not cause a cash-generating unit’s carrying amount to exceed its recoverable amount. While a change in the estimates used could have a material impact on the calculation of the fair values and trigger an impairment charge, the company, based on the sensitivity analysis performed is not aware of any reasonably possible change in a key assumption used that would cause a cash-generating unit’s carrying amount to exceed its recoverable amount.

Impairment testing methodology

The company performed its annual goodwill impairment test at cash-generating unit level, which is the lowest level at which goodwill is monitored for internal management purposes.

AB InBev’s impairment testing methodology is in accordance with IAS 36 Impairment of Assets, in which fair-value-less-cost-to-sell and value in use approaches are taken into consideration. This consists in applying a discounted cash flow approach based on acquisition valuation models for the cash-generating units showing an invested capital to EBITDA multiple above 9x and valuation multiples for the other cash-generating units.

The key judgments, estimates and assumptions used in the discounted cash flow calculations were generally as follows:

 

   

In the first three years of the model, cash flows are based on AB InBev’s 1-year plan as approved by key management and management assumptions for the following 2 years. The three-year plan model is prepared per cash-generating unit and is based on external sources in respect of macro-economic assumptions, industry, inflation and foreign exchange rates, past experience and identified initiatives in terms of market share, revenue, variable and fixed cost, capital expenditure and working capital assumptions;

 

AB InBev – Financial Report 2021 | 58


   

For the subsequent seven years of the model, data from the strategic plan is extrapolated generally using simplified assumptions such as macro-economic and industry assumptions, variable cost per hectoliter and fixed cost linked to inflation, as obtained from external sources;

 

   

Cash flows after the first ten-year period are extrapolated generally using expected annual long-term GDP growth rates, based on external sources, in order to calculate the terminal value, considering sensitivities on this metric;

 

   

Projections are discounted at the unit’s weighted average cost of capital (WACC), considering sensitivities on this metric;

 

   

Cost to sell is assumed to reach 2% of the entity value based on historical precedents.

For the main cash generating units, the terminal growth rate applied generally ranged between 2% and 5%.

The WACC applied in US dollar nominal terms were as follows:

 

 Cash-generating unit    31 December 2021     31 December 2020
          

 Colombia

   6%   6%

 Rest of Middle Americas

   10%   9%

 South Africa

   8%   7%

 Rest of Africa

   10%   10%

 Rest of Asia Pacific

   6%   6%

Goodwill impairment testing relies on a number of critical judgments, estimates and assumptions. AB InBev believes that all of its estimates are reasonable: they are consistent with the company’s internal reporting and reflect management’s current best estimates. However, inherent uncertainties exist, including the rate of recovery of the countries following the COVID-19 pandemic, and other factors that management may not be able to control. If the company’s current assumptions and estimates, including projected revenues growth rates, competitive and consumer trends, weighted average cost of capital, terminal growth rates, and other market factors, are not met, or if valuation factors outside of the company’s control change unfavorably, the estimated fair value of goodwill could be adversely affected, leading to a potential further impairment in the future.

Although AB InBev believes that its judgments, assumptions and estimates are appropriate, actual results may differ from these estimates under different assumptions or market or macro-economic conditions.

2020 impairment testing

In the second quarter of 2020, the company recognized a 2.5 billion US dollar non-cash goodwill impairment charge. The COVID-19 pandemic resulted in a sharp contraction of sales during the second quarter of 2020 in many countries in which the company operates. The decline in performance resulting from the COVID-19 pandemic was viewed as a triggering event for impairment testing in accordance with IAS 36 Impairment of Assets. The 2020 interim impairment test considered three scenarios for recovery of sales for the tested cash-generating units: a base case (which the company deemed to be the most likely case at the time of the interim impairment test), a best case and a worst case. Based on the results of the interim impairment test, the company concluded that no goodwill impairment was warranted under the base and best case scenarios. Nevertheless, under the worst case scenario ran with higher discounts rates to factor the heightened business risk, the company concluded that the estimated recoverable amounts were below their carrying value for the South Africa and Rest of Africa cash-generating units. As a consequence, management determined that it was prudent, in view of the uncertainties, to record an impairment charge of 2.5 billion US dollar applying a 30% probability of occurrence of the worst-case scenario.

The company did not recognize any additional impairment of goodwill based on the results of its annual impairment testing conducted in the fourth quarter of 2020.

 

AB InBev – Financial Report 2021 | 59


15. Intangible assets

 

     31 December 2021      31 December
2020
 
 Million US dollar    Brands      Commercial
intangibles
     Software      Other      Total      Total  
                                                       

 Acquisition cost

                                                     

 Balance at end of previous year

     39 427        3 031        2 972        455        45 885        46 108  

 Effect of movements in foreign exchange

     (1 017)        (81)        (185)        (6)        (1 289)        (789)  

 Acquisitions through business combinations

     -        -        -        -        -        162  

 Acquisitions and expenditures

     21      23        457        259        760        557  

 Disposals through sale and derecognition

     (14)        (22)        (47)        (15)        (98)        (142)  

 Disposals through the sale of subsidiaries

     -        -        -        (3)        (3)        -  

 Transfer (to)/from other asset categories and other movements1

     (8)        (119)        240      (353)        (240)        (11)  

 Balance at end of period

     38 409        2 832        3 437        337        45 015        45 885  
                                                       

 Amortization and impairment losses

                                                     

 Balance at end of previous year

     (41)        (2 072)        (2 181)        (64)        (4 358)        (3 656)  

 Effect of movements in foreign exchange

     -        62        128        2        192        (16)  

 Amortization

     -        (218)        (377)        (49)        (644)        (715)  

 Impairment

     (23)        -        (1)        (153)        (176)        (165)  

 Disposals through sale and derecognition

     2        19        46        6        73        62  

 Disposals through the sale of subsidiaries

     -        -        -        3        3        -  

 Transfer to/(from) other asset categories and other movements1

     (27)        127        4        222        326        132  

 Balance at end of period

     (89)        (2 082)        (2 381)        (33)        (4 585)        (4 358)  
                                                       

 Carrying value

                                                     

 at 31 December 2020

     39 386        959        791        391        41 527        41 527  

 at 31 December 2021

     38 320        750        1 056        304        40 430           

During 2021, the company recognized (176)m US dollar impairment on intangibles associated with Bedford Systems, a 70%-owned subsidiary of the company and joint venture with Keurig Dr. Pepper, following the announcement of the cessation of the business in December 2021 (31 December 2020: (165)m US dollar) - refer to Note 8 Non-underlying items.

AB InBev is the owner of some of the world’s most valuable brands in the beer industry. As a result, brands and certain distribution rights are expected to generate positive cash flows for as long as the company owns the brands and distribution rights. Given AB InBev’s more than 600-year history, brands and certain distribution rights have been assigned indefinite lives.

Acquisitions and expenditures of commercial intangibles mainly represent supply and distribution rights, exclusive multi-year sponsorship rights and other commercial intangibles.

Intangible assets with indefinite useful lives are comprised primarily of brands and certain distribution rights that AB InBev purchased for its own products and are tested for impairment during the fourth quarter of the year or whenever a triggering event has occurred. Based on the impairment testing results, no impairment loss was allocated to intangible assets with indefinite useful lives – refer to Note 14 Goodwill.

As at 31 December 2021, the carrying amount of the intangible assets amounted to 40 430m US dollar (31 December 2020: 41 527m US dollar) of which 38 320m US dollar was assigned an indefinite useful life (31 December 2020: 39 395m US dollar) and 2 110m US dollar a finite life (31 December 2020: 2 132m US dollar).

 

 

1 The transfer (to)/from other asset categories and other movements mainly relates to transfers from assets under construction to their respective asset categories, to contributions of assets to pension plans, to the separate presentation in the balance sheet of intangible assets held for sale in accordance with IFRS 5 Non-current assets held for sale and discontinued operations and to the restatement of non-monetary assets under hyperinflation accounting in line with IAS 29 Financial reporting in hyperinflationary economies.

 

 

AB InBev – Financial Report 2021 | 60


Million US dollar

Cash-generating unit

     2021        2020  
                   

United States

     22 129        22 172  

Rest of North America

     42        42  

Mexico

     2 977        3 067  

Colombia

     2 870        3 320  

Rest of Middle Americas

     3 432        3 655  

Brazil

     -        1  

Rest of South America

     724        681  

Europe

     452        461  

South Africa

     3 029        3 289  

Rest of Africa

     1 112        1 068  

China

     440        427  

Rest of Asia Pacific

     1 113        1 212  

Total carrying amount of intangible assets with indefinite useful lives

     38 320                39 395  

16. Investments in associates

A reconciliation of the summarized financial information to the carrying amount of the company’s interests in material associates is as follows:

 

     2021      2020  
 Million US dollar    AB InBev
Efes
     Castel      Efes      AB InBev
Efes
     Castel      Efes  
                                                       

Balance at 1 January

     1 135        3 566        391        1 132        3 239        451  

Effect of movements in foreign exchange

     -        (246)        (159)        -        270        (92)  

Dividends received

     -        (36)        (67)        -        (19)        -  

Share of results of associates

     7        116        35        3        76        32  

Balance at 31 December

             1 143                3 400        201                1 135                3 566        391  

Summarized financial information of the company’s material associates is as follows:

 

     2021      2020  
 Million US dollar    AB InBev
Efes
     Castel      Efes      AB InBev
Efes
     Castel      Efes  
                                                       

Current assets

     385        3 016        1 500        351        4 048        2 156  

Non-current assets

     624        3 923        3 157        603        3 775        4 642  

Current liabilities

     (693)        (1 774)        (1 259)        (591)        (1 531)        (1 639)  

Non-current liabilities

     (42)        (499)        (1 218)        (75)        (671)        (1 852)  

Non-controlling interests

     -        (543)        (1 128)        -        (687)        (1 627)  

Net assets1

     274        4 124            1 053        288        4 934                1 679  
                                                       

Revenue

     1 393        5 017        3 781        1 276        4 879        3 847  

Profit (loss)

     1        741        275      (20)        700        224  

Other comprehensive income (loss)

     -        (295)        241        -        (134)        392  

Total comprehensive income (loss)

     1        447        516        (20)        566        617  

In 2021, associates that are not individually material contributed 90m US dollar to the results of investment in associates (2020: 45m US dollar).

Following the entry of Zimbabwe in a hyperinflation economy in 2019, the company recorded an impairment of 15m US dollar in 2020 on its investment in Delta Corporation Ltd. The impairment was recorded as a non-underlying net finance cost. Refer to Note 11 Finance cost and income.

Additional information related to the significant associates is presented in Note 34 AB InBev Companies.

 

 

 

1 The net assets are converted at the respective closing rates of December.

 

AB InBev – Financial Report 2021 | 61


17. Deferred tax assets and liabilities

The amount of deferred tax assets and liabilities by type of temporary difference can be detailed as follows:

 

             2021          
 Million US dollar    Assets      Liabilities      Net  
                            

Property, plant and equipment

     91        (2 113)        (2 023)  

Intangible assets

     60        (9 796)        (9 736)  

Inventories

     88        (66)        22  

Trade and other receivables

     48        -        48  

Interest-bearing loans and borrowings

     905        (628)        277  

Employee benefits

     577        (8)        569  

Provisions

     511        (19)        492  

Derivatives

     11        (118)        (107)  

Other items

     407        (1 198)        (792)  

Loss carry forwards

     1 015        -        1 015  

Gross deferred tax assets/(liabilities)

     3 713        (13 947)        (10 235)  
                            

Netting by taxable entity

     (1 743)        1 743        -  
                            

Net deferred tax assets/(liabilities)

     1 969        (12 204)        (10 235)  
             2020          
 Million US dollar    Assets      Liabilities      Net  
                            

Property, plant and equipment

     398        (2 487)        (2 089)  

Intangible assets

     106        (10 007)        (9 901)  

Inventories

     86        (65)        22  

Trade and other receivables

     62        -        62  

Interest-bearing loans and borrowings

     858        (603)        255  

Employee benefits

     648        (8)        640  

Provisions

     525        (30)        495

Derivatives

     13        (46)        (33)  

Other items

     312        (1 152)        (840)  

Loss carry forwards

     782        -        782  

Gross deferred tax assets/(liabilities)

     3 790        (14 398)        (10 607)  
                            

Netting by taxable entity

     (1 771)        1 771        -  
                            

Net deferred tax assets/(liabilities)

     2 019        (12 627)        (10 607)  

The change in net deferred taxes recorded in the consolidated statement of financial position can be detailed as follows:

 

Million US dollar

  

2021

  

2020

           

Balance at 1 January

  

(10 607)

  

(11 105)

Recognized in profit or loss

  

348

  

32

Recognized in other comprehensive income

  

(166)

  

361

Acquisitions through business combinations

  

-

  

(6)

Reclassified as held for sale

  

-

  

(1)

Other movements and effect of changes in foreign exchange rates

  

190

  

112

Balance at 31 December

  

(10 235)

  

    (10 607)

Most of the temporary differences are related to the fair value adjustment on intangible assets with indefinite useful lives and property, plant and equipment acquired through business combinations. The realization of the temporary differences on intangible assets acquired through business combinations is unlikely to revert within 12 months as they would be realized upon impairment or disposal of these intangibles which is currently not expected. The net deferred tax liabilities attributable to the US business and mainly related to purchase price accounting amount to 6.5 billion US dollar as of 31 December 2021.

As of 31 December 2021, the total amount of unrecognized tax attributes amounts to 27.9 billion US dollar compared to 27.0 billion US dollar as of 31 December 20201. These unrecognized tax attributes include tax losses carry forward, capital losses, foreign and withholding tax credits, excess dividend received deduction, excess interest carry forward, amongst

 

 

1 restated to include all tax attributes

 

AB InBev – Financial Report 2021 | 62


others. 24.9 billion US dollar of these tax attributes do not have an expiration date, 0.2 billion US dollar, 0.3 billion US dollar and 0.2 billion US dollar expire within respectively 1, 2 and 3 years, while 2.3 billion US dollar have an expiration date of more than 3 years. Deferred tax assets have not been recognized on these items because it is not probable that future taxable profits will be available against which these tax losses and deductible temporary differences can be utilized and the company has no tax planning strategy currently in place to utilize these tax losses and deductible temporary differences.

18. Inventories

 

 Million US dollar    31 December 2021      31 December 2020  
                  

Prepayments

     115        92  

Raw materials and consumables

     3 072        2 499  

Work in progress

     451        439  

Finished goods

     1 537        1 256  

Goods purchased for resale

     224        197  

Inventories

     5 399        4 482  
                   

Inventories other than work in progress

                 

Inventories stated at net realizable value

     368        214  

The cost of inventories recognized as an expense in 2021 amounts to 23 097m US dollar, included in cost of sales (2020: 19 634m US dollar). Impairment losses on inventories recognized in 2021 amount to 91m US dollar (2020: 117m US dollar).

19. Trade and other receivables

 

 Million US dollar    31 December 2021      31 December 2020  
                  

Cash deposits for guarantees

     168        184  

Loans to customers

     17        25  

Tax receivable, other than income tax

     116        99  

Brazilian tax credits and interest receivables

     960        997  

Trade and other receivables

     319        357  

Non-current trade and other receivables

     1 580        1 661  
                   

Trade receivables and accrued income

     3 465        3 284  

Interest receivables

     18        4  

Tax receivable, other than income tax

     593        552  

Loans to customers

     99        117  

Prepaid expenses

     350        354  

Other receivables

     521        522  

Current trade and other receivables

     5 046        4 833  

Ambev’s tax credits and interest receivables are expected to be collected over a period exceeding 12 months after the reporting date. As of 31 December 2021, the total amount of such credits and interest receivables represented 960m US dollar (31 December 2020: 997m US dollar). Refer to Note 7 Other operating income/(expenses) and Note 11 Finance cost and income for more details.

 

AB InBev – Financial Report 2021 | 63


The carrying amount of trade and other receivables is a good approximation of their fair value as the impact of discounting is not significant. The ageing of the current trade receivables and accrued income, interest receivable, other receivables and current and non-current loans to customers can be detailed as follows for 2021 and 2020 respectively:

 

     

Net carrying

amount as

of 31

December
2021

    

Of which:

neither

impaired

nor past due

on the
reporting
date

    

Of which not impaired as of the reporting

date and past due

 
      
   Less than
30 days
     Between 30
and 59 days
     Between 60
and 89 days
     More than 90
days
 
                                                       

 Trade receivables and accrued income

     3 465        3 223        164        62        11        5  

 Loans to customers

     117        83        2        2        31        -  

 Interest receivable

     18        18        -        -        -        -  

 Other receivables

     521        513        2        1        2        3  
       4 120      3 836      167      65      44      8
     

Net carrying
amount as

of 31

December
2020

     Of which:
neither
impaired
nor past due
on the
reporting
date
    

Of which not impaired as of the reporting

date and past due

 
      
   Less than
30 days
     Between 30
and 59 days
     Between 60
and 89 days
     More than 90
days
 
                                                       

 Trade receivables and accrued income

     3 285        3 074        155        37        10        8  

 Loans to customers

     142        86        3        2        50        -  

 Interest receivable

     4        4        -        -        -        -  

 Other receivables

     522        416        2        16        5        83  
       3 953        3 580        161        55        66        91  

The above analysis of the age of financial assets that are past due as at the reporting date but not impaired also includes non-current loans to customers. Past due amounts were not impaired when collection is still considered likely, for instance because the amounts can be recovered from the tax authorities, AB InBev has sufficient collateral, or the customer entered into a payment plan. Impairment losses on trade and other receivables recognized in 2021 amount to 36m US dollar (2020: 99m US dollar). The impairment loss recognized in 2020 included AB InBev’s estimate of overdue receivables the company would not be able to collect from defaulting customers as a result of the COVID-19 pandemic.

AB InBev’s exposure to credit, currency and interest rate risks is disclosed in Note 28 Risks arising from financial instruments.

 

AB InBev – Financial Report 2021 | 64


20. Cash and cash equivalents and investment securities

 

 Million US dollar    31 December 2021   

31 December 2020

           
 Short-term bank deposits    6 542   

3 319

 Treasury Bills    1 050   

6 800

 Cash and bank accounts    4 505   

5 132

 Cash and cash equivalents

   12 097   

15 252

           

 Bank overdrafts

   (53)   

(5)

     12 043   

15 247

The company’s investment in Treasury Bills is to facilitate liquidity and for capital preservation.

The cash outstanding as at 31 December 2021 includes restricted cash for an amount of 78m US dollar (31 December 2020: 84m US dollar). This restricted cash relates to an outstanding consideration payable to former Anheuser-Busch shareholders that have not yet claimed the proceeds from the 2008 combination (1m US dollar) and amounts deposited on a blocked account in respect to the state aid investigation into the Belgian excess profit ruling system (77m US dollar).

Investment securities

 

 Million US dollar    31 December 2021   

31 December 2020

           
 Investment in unquoted companies    139   

115

 Investment on debt securities    22   

22

 Non-current investments

   161   

137

           
 Investment on debt securities    374   

396

 Current investments

   374   

396

As at 31 December 2021, current debt securities of 374m US dollar mainly represented investments in government bonds (31 December 2020: 396m US dollar). The company’s investments in such short-term debt securities are primarily to facilitate liquidity and for capital preservation.

21. Assets classified as held for sale, liabilities associated with assets held for sale and discontinued operations

ASSETS CLASSIFIED AS HELD FOR SALE

 

 Million US dollar    31 December 2021   

31 December 2020

           

 Balance at the end of previous year

   74   

10 013

 Reclassified to assets held for sale in the period    11   

210

 Impairment losses    (20)   

-

 Disposals    (33)   

(9 665)

 Effect of movements in foreign exchange    (2)   

(484)

 Balance at the end of year

   30   

74

LIABILITIES ASSOCIATED WITH ASSETS HELD FOR SALE

 

 Million US dollar    31 December 2021   

31 December 2020

           

 Balance at end of previous year

   -   

1 145

 Reclassified to liabilities associated with assets held for sale    5   

(46)

 Disposals    (5)   

(1 044)

 Effect of movements in foreign exchange    -   

(55)

 Balance at end of the period

   -   

-

 

AB InBev – Financial Report 2021 | 65


AUSTRALIA DISCONTINUED OPERATIONS

On 1 June 2020, AB InBev divested CUB, its Australian subsidiary, to Asahi for 16.0 billion AUD on a cash free, debt free basis. Upon the closing of the transaction, the company received 10.8 billion US dollar proceeds net of disposal costs, derecognized (8.5) billion US dollar of net assets in relation to its former Australian operations, recycled (0.4) billion US dollar of the cumulative foreign exchange differences on its former Australian operations and cashflow hedges from equity to profit or loss, resulting in a net gain on disposal of 1.9 billion US dollar recognized in discontinued operations. The results of the Australian operations were accounted for as discontinued operations and presented in a separate line in the consolidated income statement (“profit from discontinued operations”) up to 31 May 2020.

Assets and liabilities relating to the Australian operations disposed of on 1 June 2020 are detailed in the table below:

 

 Million US dollar    1 June 2020  
          

Assets

        

Property, plant and equipment

     581  

Goodwill and intangible assets

     8 584  

Other assets

     371  

Assets classified as held for sale

     9 537  
          

Liabilities

        

Trade and other payables

     (581)  

Deferred tax liabilities

     (363)  

Other liabilities

     (101)  

Liabilities associated with assets held for sale

     (1 044)  
          

Net assets disposed of

     8 493  

Gain on divestiture of Australia (non-underlying discontinued operations)

     1 919  

Recycling of cash flow hedges and cumulative translation adjustments

     426  

Consideration received

     10 838  

The following table summarizes the results of the Australian operations included in the consolidated income statement and presented as discontinued operations:1

 

For the period ended

Million US dollar

     1 June 2020  
          

Revenue

     477  

Profit from operations

     178  

Profit from discontinued operations (including gain on divestiture)

     2 055  

Weighted average number of ordinary and restricted shares1

     1 998  

Basic EPS from discontinued operations

     1.03  

Weighted average number of ordinary and restricted shares (diluted)1

     2 037  

Diluted EPS from discontinued operations

     1.01  

Cash flows attributable to the operating, investing and financing activities of the Australian operations are summarized as follows:

 

For the period ended

Million US dollar

     1 June 2020  
          

Cash flow from operating activities

     84  

Cash flow from investing activities (proceeds from Australia divestiture)

     10 838  

Cash flow from investing activities (other)

     (13)  

Cash flow from financing activities

     (6)  

Net increase in cash and cash equivalents

     10 903  

 

 

                                         

1 The calculation of basic EPS and diluted EPS from discontinued operations for 2020 is based on the profit from discontinued operations (including gain on divestiture) and a weighted average number of ordinary and restricted shares outstanding (including deferred share instruments and stock lending) as of 31 December 2020 and a weighted average number of ordinary and restricted shares (diluted) outstanding (including deferred share instruments and stock lending) as of 31 December 2020, respectively.

 

AB InBev – Financial Report 2021 | 66


22. Changes in equity and earnings per share

STATEMENT OF CAPITAL

The tables below summarize the changes in issued capital and treasury shares during 2021:

 

     Issued capital  
 Issued capital    Million shares             Million US dollar  
                   

At the end of the previous year

     2 019        1 736  

Changes during the period

     -        -  
       2 019        1 736  

Of which:

                 

Ordinary shares

     1 737           

Restricted shares

     282           

 

     Treasury shares      Result on the use of
treasury shares
 
 Treasury shares    Million shares      Million US dollar      Million US dollar  
                            

At the end of the previous year

     47.0        (4 911)        (3 530)  

Changes during the period

     (8.8)        917        (836)  
       38.2        (3 994)        (4 366)  

As at 31 December 2021, the share capital of AB InBev amounts to 1 238 608 344.12 euro (1 736 million US dollar). It is represented by 2 019 241 973 shares without nominal value, of which 38 217 386 are held in treasury by AB InBev and its subsidiaries. All shares are ordinary shares, except for 282 107 042 restricted shares (31 December 2020: 325 999 817). As at 31 December 2021, the total of authorized, unissued capital amounts to 37m euro.

The treasury shares held by the company are reported in equity in Treasury shares. In 2021, 5.1 million AB InBev Treasury shares were used for the settlement of the prior and new Zenzele B-BBEE schemes in South Africa in May 2021 (see below).

The holders of ordinary and restricted shares are entitled to receive dividends as declared from time to time and are entitled to one vote per share at meetings of the company. In respect of the company’s shares that are held by AB InBev and its subsidiaries, the economic and voting rights are suspended.

The restricted shares are unlisted, not admitted to trading on any stock exchange, and are subject to, among other things, restrictions on transfer until converted into new ordinary shares. As from 11 October 2021 (fifth anniversary of completion of the SAB combination), the restricted shares are convertible at the election of the holder into new ordinary shares on a one-for-one basis and they rank equally with the ordinary shares with respect to dividends and voting rights. By 31 December 2021, from the 326 million restricted shares issued at the time of the SAB combination, 44 million restricted shares were converted into new ordinary shares.

The shareholders’ structure is based on the notifications made to the company pursuant to the Belgian Law of 2 May 2007, which governs the disclosure of significant shareholdings in listed companies. It is included in the Corporate Governance section of AB InBev’s annual report.

ZENZELE SCHEMES IN SOUTH AFRICA

Following the combination with SAB in 2016, AB InBev decided to maintain the SAB Zenzele share-scheme (Zenzele Scheme), the broad-based black economic empowerment (B-BBEE) scheme, which provided opportunities for black South Africans, including employees (through the SAB Zenzele Employee Trust), SAB retailers (through SAB Zenzele Holdings Limited) and the SAB Foundation, to participate as shareholders of AB InBev’s indirect subsidiary, South African Breweries Pty Ltd (SAB). The Zenzele Scheme, originally implemented by SAB in 2010 as a 10-year scheme, was amended at the time of the combination with SAB and matured on 31 March 2020.

Obligations to the SAB Foundation and the employees as beneficiaries of the SAB Zenzele Employee Share Trust were settled in full on 15 April 2020. The obligations to SAB retailers, who participate in the Zenzele Scheme through SAB Zenzele Holdings, were partially settled (77.4%) on 15 April 2020. As a direct consequence of the COVID-19 outbreak, the remaining settlement (22,6%) was postponed and was performed on 28 May 2021, when AB InBev and SAB implemented the new scheme as described below. Some SAB retailers received the balance of their entitlement and others reinvested a portion of their Zenzele payout into the new scheme.

In total, 10.8 million AB InBev Treasury shares with a total value of 491m US dollar were used in 2020 to settle the obligations to the participants of the Zenzele Scheme. The total value delivered to the participants of the Zenzele Scheme amounted to 8.6 billion ZAR.

 

AB InBev – Financial Report 2021 | 67


As part of the combination with SAB in 2016, AB InBev made a commitment to the South African Government and Competition Authorities to create a new B-BBEE scheme upon maturity of the Zenzele Scheme. In order to create the new B-BBEE scheme, the following steps were undertaken:

 

   

The new scheme was implemented through the listing of a special purpose company, which is called SAB Zenzele Kabili Holdings Limited (Zenzele Kabili) on the segment of the Johannesburg Stock Exchange’s Main Board on which an issuer may list its B-BBEE shares;

 

   

Zenzele Kabili holds AB InBev shares;

 

   

Existing Zenzele participants (SAB retailers) reinvested a portion of their Zenzele payout into Zenzele Kabili and the SAB Foundation invested AB InBev shares into Zenzele Kabili;

 

   

A new Employee Share Plan, funded by AB InBev, subscribed for shares in Zenzele Kabili.

The settlement of the balance of the SAB retailers entitlement required 1.1 billion ZAR (0.1 billion US dollar1), out of which 0.7 billion ZAR (0.1 billion US dollar) were re-invested in the new B-BBEE scheme by the SAB retailers. The set-up of the new B-BBEE scheme required 4.7 billion ZAR (0.3 billion US dollar), out of which 4.4 billion ZAR in AB InBev Treasury shares and 0.3 billion ZAR in AB InBev shares that were bought from the SAB retailers by the SAB Foundation.

5.1 million AB InBev Treasury shares were used for the settlement of part of the prior and the new B-BBEE schemes (based on the AB InBev share price and the ZAR Euro exchange rate as at 24 May 20212). The new Zenzele scheme arrangement met the criteria under IFRS 2 to be classified as equity settled. The IFRS 2 charge for the period is reported in non-underlying items (Refer to Note 8 Non-underlying items).

CHANGES IN OWNERSHIP INTERESTS

In accordance with IFRS 10 Consolidated Financial Statements, the acquisition or disposal of additional shares in a subsidiary is accounted for as an equity transaction with owners.

On 31 December 2020, AB InBev completed the issuance of a 49.9% minority stake in its US-based metal container operations to Apollo Global Management, Inc. for net proceeds of 3.0 billion USD. This transaction allowed the company to create additional shareholder value by optimizing its business at an attractive price and generate proceeds to repay debt, in line with its deleveraging commitments. AB InBev retained operational control of its US-based metal container operations. The transaction was reported in the equity statement resulting in recognition of 1.9 billion US dollar in Non-controlling interest and 1.1 billion US dollar in Reserves.

During 2021, there were no significant purchases or disposals of non-controlling interests in subsidiaries.

ACQUISITIONS AND DISPOSALS OF OWN SHARES (REPORT ACCORDING TO ARTICLE 7:220 OF THE BELGIAN COMPANIES CODE OF COMPANIES AND ASSOCIATIONS) AND BORROWINGS OF OWN SHARES– PURCHASE OF OWN SHARES

During 2021, the company has not acquired any treasury shares in accordance with article 7:215 of the Belgian Code of Companies and Associations (former article 620 of the Belgian Companies Code) and has proceeded with the following disposals of its own shares.

Treasury shares

The company has used 5 148 866 treasury shares to settle the participants’ obligations related to part of the Zenzele and the entire Zenzele Kabili Scheme (see above for more details). The company has also used 3 626 315 treasury shares mainly for settling employee share-based payments. As a consequence, the treasury shares used during 2021 represented 6 568 491 US dollar (5 352 860 euro) of the subscribed capital. As at 31 December 2021, the group owned 38 217 386 own shares of which 37 579 393 were held directly by AB InBev. The par value of the share is 0.61 euro. The treasury shares that the company still owned at the end of 2021 represented 28 606 881 US dollar (23 312 605 euro) of the subscribed capital.

Borrowed shares

In order to fulfill AB InBev’s commitments under various outstanding share-based compensation plans, during the course of 2021, the company had stock lending arrangements in place for up to 30 million shares, which were fully used to fulfill share-based compensation plan commitments. The company shall pay any dividend equivalent after tax in respect of such borrowed shares. This payment will be reported through equity as dividend.

 

                                                         

1 Converted at the closing rate as at 24 May 2021.

2 Considering the closing share price of 62.26 euro per share as at 24 May 2021 and ZAR per Euro exchange rate of 17.0064 as at 24 May 2021.

 

AB InBev – Financial Report 2021 | 68


DIVIDENDS

On 23 February 2022, a dividend of 0.50 euro per share or 1 006m euro was proposed by the Board of Directors and will be subject to approval at the shareholders’ meeting on 27 April 2022.

On 28 April 2021, a dividend of 0.50 euro per share or 1 003m euro was approved at the shareholders’ meeting. The dividend was paid out as of 6 May 2021.

On 3 June 2020, a dividend of 0.50 euro per share or 1 002m euro was approved at the shareholders’ meeting. The dividend was paid out as of 11 June 2020.

TRANSLATION RESERVES

The translation reserves comprise all foreign currency exchange differences arising from the translation of the financial statements of foreign operations. The translation reserves also comprise the portion of the gain or loss on the foreign currency liabilities and on the derivative financial instruments determined to be effective net investment.

HEDGING RESERVES

The hedging reserves comprise the effective portion of the cumulative net change in the fair value of cash flow hedges to the extent that the hedged risk has not yet impacted profit or loss. On 1 June 2020, upon the Australia divestiture, the company recycled 370m US dollar of cash flow hedges in relation to its former Australia operations from equity to profit or loss.

TRANSFERS FROM SUBSIDIARIES

The amount of dividends payable to AB InBev by its operating subsidiaries is subject to, among other restrictions, general limitations imposed by the corporate laws, capital transfer restrictions and exchange control restrictions of the respective jurisdictions where those subsidiaries are organized and operate. Capital transfer restrictions are also common in certain emerging market countries and may affect AB InBev’s flexibility in implementing a capital structure it believes to be efficient. As at 31 December 2021, the restrictions above mentioned were not deemed significant on the company’s ability to access or use the assets or settle the liabilities of its operating subsidiaries.

Dividends paid to AB InBev by certain of its subsidiaries are also subject to withholding taxes. Withholding taxes, if applicable, generally do not exceed 15%.

 

AB InBev – Financial Report 2021 | 69


OTHER COMPREHENSIVE INCOME RESERVES

The changes in the other comprehensive income reserves are as follows:

 

 Million US dollar    Translation
Reserves
     Hedging
reserves
     Post-
employment
benefits
     Total OCI
Reserves
 
                                     

As per 1 January 2021

     (29 234)        376        (1 983)        (30 841)  

Other comprehensive income/(loss)

                                   

Exchange differences on translation of foreign operations

(gains/(losses))

     (4 320)                  (4 320)  

Cash flow hedges

          105             105  

Re-measurements of post-employment benefits

               479        479  

Other comprehensive income/(loss)

     (4 320)        105        479        (3 736)  

As per 31 December 2021

     (33 554)        481        (1 504)        (34 577)  

The increase in translation reserves is primarily related to the combined effect of the weakening of the closing rates of the Colombian pesos, the Peruvian Sol, the South African rand and the Mexican pesos, partially offset by the weakening of the closing rate of the Euro, which resulted in a foreign exchange translation adjustment of 4 320m US dollar as of 31 December 2021 (decrease of equity).

 

 Million US dollar    Translation
Reserves
     Hedging
reserves
     Post-
employment
benefits
     Total OCI
Reserves
 
                                     

As per 1 January 2020

     (19 936)        397        (1 740)        (21 279)  

Other comprehensive income/(loss)

                                   

Exchange differences on translation of foreign operations

(gains/(losses))

     (9 943)                  (9 943)  

Cash flow hedges

          198             198  

Cash flow hedges and cumulative translation adjustments

reclassified from equity to profit or loss in relation to Australia

divestiture

     645        (219)             426  

Re-measurements of post-employment benefits

               (243)        (243)  

Other comprehensive income/(loss)

     (9 298)        (21)        (243)        (9 562)  

As per 31 December 2020

     (29 234)        376        (1 983)        (30 841)  

 

AB InBev – Financial Report 2021 | 70


EARNINGS PER SHARE

The calculation of basic earnings per share for 2021 is based on the profit attributable to equity holders of AB InBev of 4 670m US dollar (2020: 1 405m US dollar) and a weighted average number of ordinary and restricted shares outstanding (including deferred share instruments and stock lending) per end of the period, calculated as follows:

 

 Million shares    2021      2020  
                   

Issued ordinary and restricted shares at 1 January, net of treasury shares

     1 972        1 959  

Effect of stock lending

     30        30  

Effect of delivery of treasury shares

     4        9  
 Weighted average number of ordinary and restricted shares at 31 December    2 007      1 998  

 

The calculation of diluted earnings per share for 2021 is based on the profit attributable to equity holders of AB InBev of 4 670m US dollar (2020: 1 405m US dollar) and a weighted average number of ordinary and restricted shares (diluted) outstanding (including deferred share instruments and stock lending) at the end of the period, calculated as follows:

 

 Million shares    2021      2020  
                   

Weighted average number of ordinary and restricted shares at 31 December

     2 007        1 998  

Effect of share options, warrants and restricted stock units

     38        39  
 Weighted average number of ordinary and restricted shares (diluted) at 31 December    2 045      2 037  

 

The calculation of earnings per share before non-underlying items and discontinued operations is based on the profit from continuing operations attributable to equity holders of AB InBev. A reconciliation of the profit before non-underlying items and discontinued operations, attributable to equity holders of AB InBev to the profit attributable to equity holders of AB InBev is calculated as follows:

 

 Million US dollar    2021      2020  
                   

Profit before non-underlying items and discontinued operations, attributable to

equity holders of AB InBev

     5 723        3 807  

Non-underlying items, before taxes (refer to Note 8)

     (614)        (3 103)  

Non-underlying finance cost, before taxes (refer to Note 11)

     (806)        (1 738)  

Non-underlying taxes (refer to Note 8)

     346        155  

Non-underlying non-controlling interest (refer to Note 8)

     20        228  

Profit from discontinued operations (refer to Note 21)

          2 055  
 Profit attributable to equity holders of AB InBev    4 670      1 405  

 

The calculation of the Underlying EPS is based on the profit before non-underlying items, discontinued operations, mark-to-market gains/losses and hyperinflation impacts attributable to equity holders of AB InBev. A reconciliation of the profit before non-underlying items, discontinued operations, mark-to-market gains/losses and hyperinflation impacts, attributable to equity holders of AB InBev to the profit before non-underlying items and discontinued operations, attributable to equity holders of AB InBev, is calculated as follows:

 

  Million US dollar    2021      2020  
                   

Profit before non-underlying items, discontinued operations, mark-to-market gains/losses and

hyperinflation impacts, attributable to equity holders of AB InBev

     5 774        5 022  

Mark-to-market losses on certain derivatives related to the hedging of share-based payment programs

(refer to Note 11)

     (23)        (1 211)  

Hyperinflation impacts

     (28)        (4)  

 Profit before non-underlying items and discontinued operations, attributable to

 equity holders of AB InBev

   5 723      3 807  

 

AB InBev – Financial Report 2021 | 71


The table below sets out the EPS calculation:

 

  Million US dollar    2021      2020  

            

                 

  Profit attributable to equity holders of AB InBev

     4 670        1 405  

  Weighted average number of ordinary and restricted shares

     2 007        1 998  

  Basic EPS from continuing and discontinued operations

     2.33        0.70  

            

                 

  Profit/(loss) from continuing operations attributable to equity holders of AB InBev

     4 670        (650)  

  Weighted average number of ordinary and restricted shares

     2 007        1 998  

  Basic EPS from continuing operations

     2.33        (0.33)  

            

                 

  Profit from continuing operations before non-underlying items and discontinued operations,

  attributable to equity holders of AB InBev

     5 723        3 807  

  Weighted average number of ordinary and restricted shares

     2 007        1 998  

  Basic EPS from continuing operations before non-underlying items

     2.85        1.91  

            .

                 

  Profit before non-underlying items, discontinued operations, mark-to-market gains/losses and

  hyperinflation impacts, attributable to equity holders of AB InBev

     5 774        5 022  

  Weighted average number of ordinary and restricted shares

     2 007        1 998  

  Underlying EPS

     2.88        2.51  

            

                 

  Profit attributable to equity holders of AB InBev

     4 670        1 405  

  Weighted average number of ordinary and restricted shares (diluted)

     2 045        2 037  

  Diluted EPS from continuing and discontinued operations

     2.28        0.69  

            

                 

  Profit/(loss) from continuing operations attributable to equity holders of AB InBev

     4 670        (650)  

  Weighted average number of ordinary and restricted shares (diluted)

     2 045        1 998  

  Diluted EPS from continuing operations

     2.28        (0.33)  

            

                 

  Profit from continuing operations before non-underlying items and discontinued operations,

  attributable to equity holders of AB InBev

     5 723        3 807  

  Weighted average number of ordinary and restricted shares (diluted)

     2 045        2 037  

  Diluted EPS from continuing operations before non-underlying items

     2.80        1.87  

The average market value of the company’s shares for purposes of calculating the dilutive effect of share options and restricted stock units was based on quoted market prices for the period that the options and restricted stock units were outstanding. For the calculation of Diluted EPS from continuing operations before non-underlying items, 68m share options were anti-dilutive and not included in the calculation of the dilutive effect as at 31 December 2021 (31 December 2020: 76m share options). In accordance with the guidance provided by IAS 33 Earnings per Share, for the 2020 calculation of Diluted EPS from continuing operations, the potential dilutive effect of share options, warrants and restricted stock units was disregarded considering the negative results in the period.

 

AB InBev – Financial Report 2021 | 72


23. Interest-bearing loans and borrowings

This note provides information about the company’s interest-bearing loans and borrowings. For more information about the company’s exposure to interest rate and foreign exposure currency risk – refer to Note 28 Risks arising from financial instruments.

 

 Non-current liabilities

 Million US dollar

   31 December 2021      31 December 2020  
                   

Secured bank loans

     75        46  

Unsecured bond issues

     85 433        93 523  

Unsecured other loans

     31        73  

Lease liabilities

     1 830        1 837  

Non-current interest-bearing loans and borrowings

     87 369        95 478  

 Current liabilities

 Million US dollar

   31 December 2021      31 December 2020  
                   

Secured bank loans

     553        656  

Commercial papers

     -        1 522  

Unsecured bank loans

     106        294  

Unsecured bond issues

     293        202  

Unsecured other loans

     9        10  

Lease liabilities

     447        397  

Current interest-bearing loans and borrowings

     1 408        3 081  

The current and non-current interest-bearing loans and borrowings amount to 88.8 billion US dollar as at 31 December 2021, compared to 98.6 billion US dollar as at 31 December 2020.

On 18 February 2021, the company entered into a new 10.1 billion US dollar Sustainable-Linked Loan Revolving Credit Facility (“SLL RCF”) with an initial five-year term, replacing the previous 9.0 billion US dollar of committed long-term credit facilities.    

As at 31 December 2021, the company had no outstanding balance on commercial papers compared to 1.5 billion US dollar as at 31 December 2020. The commercial papers included programs in US dollar and euro with a total authorized issuance up to 5.0 billion US dollar and 3.0 billion euro, respectively.

In 2021, Anheuser-Busch InBev NV/SA (“ABISA”) announced that it and its wholly-owned subsidiary Anheuser-Busch InBev Worldwide Inc. (“ABIWW”, and together with ABISA, the “Issuers”) exercised their respective options to redeem the outstanding principal amounts for an aggregate principal amount of 6.2 billion US dollar of the following series of notes:

 

 Date of

 redemption

  Issuer
(abbreviated)
  

Title of series of notes

issued exchanged

   Currency   

Original principal
amount
outstanding

(in million)

    

Principal amount        

redeemed        

(in million)        

 
                                 

27 January 2021

  ABIWW    3.750% Notes due 2024    AUD      650        650      

28 January 2021

  ABISA    1.500% Notes due 2025    EUR      2 147        2 147      

29 June 2021

  ABIWW    4.150% Notes due 2025    USD      2 500        2 500      

23 July 2021

  ABIFI    4.600% Notes due 2045    USD      565        565      

Net debt is defined as non-current and current interest-bearing loans and borrowings and bank overdrafts minus debt securities and cash and cash equivalents. Net debt is a financial performance indicator that is used by AB InBev’s management to highlight changes in the company’s overall liquidity position.

AB InBev’s net debt decreased to 76.2 billion US dollar as at 31 December 2021, from 82.7 billion US dollar as at 31 December 2020. Aside from operating results that are net of capital expenditures, the net debt is impacted mainly by the payment of interests and taxes (6.2 billion US dollar), dividend payments to shareholders of AB InBev and Ambev (2.4 billion US dollar) and foreign exchange impact on net debt (1.6 billion US dollar decrease of net debt).

 

AB InBev – Financial Report 2021 | 73


The following table provides a reconciliation of AB InBev’s net debt as at the dates indicated:

 

 Million US dollar    31 December 2021   

31 December 2020

           

 Non-current interest-bearing loans and borrowings

   87 369   

95 478

 Current interest-bearing loans and borrowings

   1 408   

3 081

 Interest-bearing loans and borrowings

   88 777   

98 559

           

 Bank overdrafts

   53   

5

 Cash and cash equivalents

   (12 097)   

(15 252)

 Interest bearing loans granted and other deposits

 (included within Trade and other receivables)

   (175)   

(173)

 Debt securities (included within Investment securities)

   (396)   

(418)

 Net debt

   76 162   

82 722

Reconciliation of liabilities arising from financing activities

The table below details changes in the company’s liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be classified in the company’s consolidated cash flow statement from financing activities.

 

 Million US dollar    Long-term debt,
net of current portion
  

Short-term debt and
current portion of

long-term debt

 
               

 Balance at 1 January 2021

   95 478      3 081  

 Proceeds from borrowings

   148      306  

 Payments on borrowings

   (6 735)      (2 230)  

 Capitalization / (payment) of lease liabilities

   697      (547)  

 Amortized cost

   64      -  

 Unrealized foreign exchange effects

   (2 149)      (88)  

 Current portion of long-term debt

   (875)      875  

 Loss on bond redemption and other movements

   741      10  

 Balance at 31 December 2021

   87 369      1 408  
 Million US dollar    Long-term debt,
net of current portion
   Short-term debt and
current portion of
long-term debt
 
               

 Balance at 1 January 2020

   97 564      5 410  

 Proceeds from borrowings

   11 226      3 596  

 Payments on borrowings

   (13 596)      (9 520)  

 Capitalization / (payment) of lease liabilities

   394      (484)  

 Amortized cost

   71      17  

 Unrealized foreign exchange effects

   2 521      241  

 Current portion of long-term debt

   (3 744)      3 744  

 Loss on bond redemption and other movements

   1 042      77  

 Balance at 31 December 2020

   95 478      3 081  

 

AB InBev – Financial Report 2021 | 74


24. Employee benefits

AB InBev sponsors various post-employment benefit plans worldwide, which include both defined contribution plans, defined benefit plans, and other post-employment benefits. In accordance with IAS 19 Employee Benefits post-employment benefit plans are classified as either defined contribution plans or defined benefit plans.

DEFINED CONTRIBUTION PLANS

For defined contribution plans, AB InBev pays contributions to publicly or privately administered pension funds or insurance contracts. Once the contributions have been paid, the group has no further payment obligation. The regular contributions constitute an expense for the year in which they are due. For 2021, contributions paid into defined contribution plans for the company amounted to 147m US dollar compared to 91m US dollar for 2020.

DEFINED BENEFIT PLANS

During 2021, the company contributed to 82 defined benefit plans, of which 61 are retirement or leaving service plans, 17 are medical cost plans and 4 other long-term employee benefit plans. Most plans provide retirement and leaving service benefits related to pay and years of service. In many of the countries the plans are partially funded. When plans are funded, the assets are held in legally separate funds set up in accordance with applicable legal requirements and common practice in each country. The medical cost plans in Brazil, Canada, Colombia, Barbados, South Africa and US provide medical benefits to employees and their families after retirement. Many of the defined benefit plans are closed to new entrants.

The present value of funded obligations includes a 96m US dollar liability related to two medical plans in Brazil, for which the benefits are provided through the Fundação Antonio Helena Zerrenner (“FAHZ”). The FAHZ is a legally distinct entity which provides medical, dental, educational and social assistance to current and retired employees of Ambev. As at 31 December 2021, the actuarial liabilities related to the benefits provided by the FAHZ are fully offset by an equivalent amount of assets existing in the fund. The net liability recognized in the balance sheet is nil.

The employee benefit net liability amounts to 2 256m US dollar as at 31 December 2021 compared to 2 964m US dollar as at 31 December 2020. In 2021, the fair value of the plan assets decreased by 268m US dollar and the defined benefit obligations decreased by 1 018m US dollar. The decrease in the employee benefit net liability is mainly driven by increases in the discount rates and favorable asset returns.

The company’s net liability for post-employment and long-term employee benefit plans comprises the following as at 31 December 2021 and 2020:

 

  Million US dollar    2021      2020    

  Present value of funded obligations

     (6 791)                        (7 703)    

  Fair value of plan assets

     5 381        5 649    

  Present value of net obligations for funded plans

     (1 410)        (2 054)    

  Present value of unfunded obligations

     (687)        (793)    

  Present value of net obligations

     (2 097)        (2 847)    
                   

  Unrecognized asset

     (32)        (31)    

  Net liability

     (2 129)        (2 878)    
                   

  Other long term employee benefits

     (127)        (86)    

  Total employee benefits

     (2 256)        (2 964)    
                   

  Employee benefits amounts in the balance sheet:

                 

  Liabilities

     (2 261)        (2 970)    

  Assets

     5        6    

  Net liability

     (2 256)        (2 964)    

 

AB InBev – Financial Report 2021 | 75


The changes in the present value of the defined benefit obligations are as follows:

 

  Million US dollar    2021      2020    

  Defined benefit obligation at 1 January

     (8 496)                     (8 143)    

  Current service costs

     (80)        (72)    

  Interest cost

     (212)        (250)    

  Past service gain/(cost)

     (5)        16    

  Settlements

     176        153    

  Benefits paid

     553        519    

  Contribution by plan participants

     (3)        (2)    

  Actuarial gains/(losses) – demographic assumptions

     (41)        20    

  Actuarial gains/(losses) – financial assumptions

     460        (690)    

  Experience adjustments

     16        (12)    

  Exchange differences

     154        (35)    

  Defined benefit obligation at 31 December

     (7 478)        (8 496)    

As at the last valuation date, the present value of the defined benefit obligation was comprised of approximately 1.6 billion US dollar relating to active employees, 1.7 billion US dollar relating to deferred members and 4.2 billion US dollar relating to members in retirement.

The changes in the fair value of plan assets are as follows:

 

  Million US dollar    2021      2020    

  Fair value of plan assets at 1 January

     5 649                        5 442    

  Interest income

     137        168    

  Administration costs

     (19)        (19)    

  Return on plan assets exceeding interest income

     197        332    

  Contributions by AB InBev

     241        394    

  Contributions by plan participants

     3        2    

  Benefits paid net of administration costs

     (553)        (519)    

  Assets distributed on settlements

     (172)        (146)    

  Exchange differences

     (102)        (9)    

  Transfers and other movements

     -        4    

  Fair value of plan assets at 31 December

     5 381        5 649    

Actual return on plans assets amounted to a gain of 334m US dollar in 2021 compared to a gain of 500m US dollar in 2020.

The changes in the unrecognized asset are as follows:

 

  Million US dollar    2021      2020    

  Irrecoverable surplus impact at 1 January

     (31)                           (74)    

  Interest expense

     (2)        (4)    

  Changes excluding amounts included in interest expense

     1      47  

  Irrecoverable surplus impact at 31 December

     (32)        (31)    

The expense recognized in the income statement with regard to defined benefit plans can be detailed as follows:

 

  Million US dollar    2021      2020    

  Current service costs

     (80)                           (72)    

  Administration costs

     (19)        (19)    

  Past service cost due to plan amendments, curtailments or settlements

     (2)        16  

  (Losses)/gains due to experience and demographic assumption changes

     1      6  

  Profit from operations

     (100)        (69)    

  Net finance cost

     (76)        (87)    

  Total employee benefit expense

     (176)        (156)    

The employee benefit expense is included in the following line items of the income statement:

 

  Million US dollar    2021      2020    

  Cost of sales

     (30)                           (28)    

  Distribution expenses

     (11)        (9)    

  Sales and marketing expenses

     (24)        (18)    

  Administrative expenses

     (34)        (20)    

  Other operating (expense)/income

     (1)        (1)    

  Non-underlying items

     -        7  

  Net finance cost

     (76)        (87)    
       (176)        (156)    

 

AB InBev – Financial Report 2021 | 76


Weighted average assumptions used in computing the benefit obligations of the company’s significant plans at the balance sheet date are as follows:

 

     2021  
  Million US dollar    United
States
     Canada      Mexico      Brazil      United
Kingdom
     AB InBev    
                                                       

  Discount rate

     2.8%                    2.9%        8.0%        8.7%                1.9%        3.2%    

  Price inflation

     2.5%        2.0%        3.5%        3.3%        3.6%        2.7%    

  Future salary increases

     -        1.0%                4.5%-4.0%            6.9%-5.0%        -        3.7%    

  Future pension increases

     -        2.0%        3.5%        3.3%        3.2%        2.7%    

  Medical cost trend rate

     5.3%-4.5%        4.5%        -        6.9%        -                5.9%-5.7%    

  Life expectation for a 65-year old male

     86        87        85        85        87        85    

  Life expectation for a 65-year old female

     88        90        88        87        89        88    
     2020  
  Million US dollar    United
States
     Canada      Mexico      Brazil      United
Kingdom
     AB InBev    

  Discount rate

     2.5%        2.4%        6.3%        6.9%        1.4%        2.6%    

  Price inflation

     2.5%        2.0%        3.5%        3.3%        3.1%        2.6%    

  Future salary increases

     -        1.0%        4.3%        6.9%-5.0%        -        3.7%    

  Future pension increases

     -        2.0%        3.5%        3.3%        2.9%        2.6%    

  Medical cost trend rate

     5.5%-4.5%        4.5%        -        6.9%        -        6.0%-5.7%    

  Life expectation for a 65-year old male

     86        87        82        85        87        85    

  Life expectation for a 65-year old female

     87        90        85        88        89        88    

Through its defined benefit pension plans and post-employment medical plans, the company is exposed to a number of risks, the most significant are detailed below:

INVESTMENT STRATEGY

In case of funded plans, the company ensures that the investment positions are managed within an asset-liability matching (ALM) framework that has been developed to achieve long-term investments that are in line with the obligations under the pension schemes. Within this framework, the company’s ALM objective is to match assets to the pension obligations by investing in long-term fixed interest securities with maturities that match the benefit payments as they fall due and in the appropriate currency. The company actively monitors how the duration and the expected yield of the investments are matching the expected cash outflows arising from the pension obligation.

ASSET VOLATILITY

In general, the company’s funded plans are invested in a combination of equities and bonds, generating high but volatile returns from equities and at the same time stable and liability-matching returns from bonds. As the plans mature, the company usually reduces the level of investment risk by investing more in assets that better match the liabilities. Since 2015, the company started the implementation of a pension de-risking strategy to reduce the risk profile of certain plans by reducing gradually the current exposure to equities and shifting those assets to fixed income securities.

CHANGES IN BOND YIELDS

A decrease in corporate bond yields will increase plan liabilities, although this will be partially offset by an increase in the value of the plans’ bond holdings.

INFLATION RISK

Some of the company’s pension obligations, mainly in the UK, are linked to inflation, and higher inflation will lead to higher liabilities. The majority of the plan’s assets are either unaffected by or loosely correlated with inflation, meaning that an increase in inflation could potentially increase the company’s net benefit obligation.

LIFE EXPECTANCY

The majority of the plans’ obligations are to provide benefits for the life of the member, so increases in life expectancy will result in an increase in the plans’ liabilities.

The weighted average duration of the defined benefit obligation in 2021 is 13.7 years (2020: 13.9 years).

 

AB InBev – Financial Report 2021 | 77


The sensitivity of the defined benefit obligation to changes in the weighted principal assumptions is:

 

     2021  
  Million US dollar    Change in
assumption
     Increase in
assumption
     Decrease in  
assumption  
 
                            

  Discount rate

     0.5%                                 (482)        533    

  Price inflation

     0.5%        175                                 (183)    

  Future salary increases

     0.5%        26        (25)    

  Medical cost trend rate

     1%        30        (26)    

  Longevity

     One year        256        (255)    

The above are purely hypothetical changes in individual assumptions holding all other assumptions constant: economic conditions and changes therein will often affect multiple assumptions at the same time and the effects of changes in key assumptions are not linear.

Sensitivities are reasonably possible changes in assumptions, and they are calculated using the same approach as was used to determine the defined benefit obligation. Therefore, the above information is not necessarily a reasonable representation of future results.

The fair value of plan assets at 31 December consists of the following:

 

     2021      2020  
  Million US dollar    Quoted      Unquoted                  Total      Quoted      Unquoted                  Total    
                                                       

  Government bonds

     34%        -        34%        33%        -        33%    

  Corporate bonds

     34%        -        34%        34%        -        34%    

  Equity instruments

     24%        -        24%        25%        -        25%    

  Property

     -        4%        4%        -        3%        3%    

  Insurance contracts and others

     2%        2%        4%        3%        2%        5%    
       94%        6%        100%        95%        5%        100%    

AB InBev expects to contribute approximately 192m US dollar for its funded defined benefit plans and 68m US dollar in benefit payments to its unfunded defined benefit plans and post-retirement medical plans in 2022.

25. Share-based payments

Different share and share option programs allow company senior management and members of the board of directors to receive or acquire shares of AB InBev, Ambev or Budweiser APAC. AB InBev has three primary share-based compensation plans, the share-based compensation plan (“Share-Based Compensation Plan”), the long-term restricted stock unit plan for directors (“Restricted Stock Units Plan for Directors), and the long-term incentive plan for executives (“LTI Plan Executives”). For all option plans, the fair value of share-based payment compensation is estimated at grant date, using a binomial Hull model, modified to reflect the IFRS 2 Share-based Payment requirement that assumptions about forfeiture before the end of the vesting period cannot impact the fair value of the option. All the company share-based payment plans are equity-settled. Amounts have been converted to US dollar at the average rate of the period, unless otherwise indicated.

Share-based payment transactions resulted in a total expense of 510m US dollar for 2021, of which 72m US dollar were reported in non-underlying items representing the IFRS 2 cost related to the Zenzele Kabili scheme. For more details, refer to Note 22 Changes in equity and earnings per share. Share-based payment transactions resulted in a total expense of 169m US dollar for 2020. During 2020, as a result of the COVID-19 pandemic, the company reversed accrued cost for performance-related LTIs for which the conditions would not be met.

AB INBEV SHARE-BASED COMPENSATION PROGRAMS

Share-Based Compensation Plan for Executives

Under this plan, members of the Executive Committee and other senior employees receive their bonus in cash but have the choice to invest some or all of the value of their bonus in AB InBev shares, referred to as bonus shares. Half of the bonus shares will be subject to a lock-up period of three years and the other half to a lock-up period of 5 years. This voluntary investment of the bonus in AB InBev shares leads to a 20% discount to the market price of the shares. The company also matches such voluntary investment by granting three matching shares for each bonus share voluntarily invested in, up to a limited total percentage of each participant’s bonus. The percentage of the variable compensation that is entitled to get matching shares varies depending on the position of the executive. The matching is based on the gross amount of the variable compensation invested. The discount shares and matching shares are granted in the form of restricted stock units, half of which have a three-year vesting period and the other half has a five-year vesting period. Additionally, the holders of the restricted stock units may be entitled to receive from AB InBev additional restricted stock units equal to the dividends declared since the restricted stock units were granted.

 

AB InBev – Financial Report 2021 | 78


During 2021, AB InBev issued 0.2m matching restricted stock units in relation to bonuses granted to company employees and management (2020: 0.2m matching restricted stock units). These matching restricted stock units represent a fair value of approximately 9m US dollar (2020: 9m US dollar).

Restricted Stock Units Plan for Directors

Since the annual shareholder meeting of 24 April 2019, the share-based portion of the remuneration of the directors of the company has been granted in the form of restricted stock units and will no longer be granted in the form of stock options as was previously the case. Such restricted stock units vest after 5 years and, upon vesting, entitle their holders to one AB InBev share per restricted stock unit.

During 2021, 0.1m restricted stock units with an estimated fair value of 4mUS dollar were granted to directors (2020: 0.1m with an estimated fair value of approximately 4m US dollar).

Annual and Exceptional LTI Plans for Executives

As from 1 July 2009, senior employees are eligible for an annual long-term incentive to be paid out in LTI stock options (or, in the future, similar share-based instruments), depending on management’s assessment of the employee’s performance and future potential.

During 2021, no LTI stock options were granted to Executives (2020: 38.1m LTI stock options were granted with an estimated fair value of 287m US dollar, out of which, 3.6m stock options were granted to members of the Executive Committee).

As from 1 December 2020, under a sub-plan of the company’s new base long-term Restricted Stock Units program, senior employees are eligible for an annual long-term incentive paid out in Restricted Stock Units, depending on management’s assessment of the employee’s performance and future potential. Half of the Restricted Stock Units cliff vest over a three-year period and the other half cliff vest over a five-year period. During 2021, AB InBev issued 2.8m Restricted Stock Units with an estimated fair value of 155m US dollar under this plan (2020: 1.7m with an estimated fair value of 116m US dollar under this plan). Out of these Restricted Stock Units, 0.2m restricted stock units were granted to members of the Executive Committee (2020: 0.1m restricted stocks units).

Recurring LTI Restricted Stock Units Plans for Executives

AB InBev has specific recurring long-term Restricted Stock Units incentive programs in place, including

 

   

A program allowing for the offer of restricted stock units to certain members of senior management in certain specific circumstances, e.g., as a special retention incentive or to compensate for assignments of expatriates in countries with difficult living conditions. The restricted stock units vest after five years and in the event that an employee’s service is terminated before the vesting date, special forfeiture rules apply. During 2021, no discretionary restricted stock units were granted. (2020: 7m discretionary restricted stock units with an estimated fair value of 307m US dollar of which 0.8m restricted stock units were granted to members of the Executive Committee).

 

   

A program allowing for certain employees to purchase company shares at a discount and that is aimed at providing a long-term retention incentive for (i) high-potential employees of the company, who are at a mid-manager level (“People bet share purchase program”) or (ii) newly hired employees. The voluntary investment in company shares leads to the grant of an amount of matching restricted stock units or stock options which vest after 5 years. In the event that an employee’s service is terminated before the vesting date, special forfeiture rules apply. In 2021, employees received approximately 0.1m restricted stock units under this program representing a fair value of 7m US dollar (2020: 0.1m restricted stock units representing a fair value of 6m US dollar).

 

   

A series of sub-plans under the Company’s new base long-term Restricted Stock Units program (created in 2020) allowing for the offer of Restricted Stock Units to certain members of the company’s senior management in certain specific circumstances, e.g., as a special retention incentive or to compensate for assignments of expatriates in certain limited countries. Under this program, Restricted Stock Units can be granted under sub-plans with specific terms and conditions and for specific purposes. The Restricted Stock Units in principle vest after five years without a performance test and in the event of termination of service before the vesting date, forfeiture rules apply. The Board may set shorter or longer vesting periods for specific sub-plans or introduce performance tests similar to those described under the program above. In 2021, 0.8m restricted stock units with an estimated fair value of 45m US dollar were granted under this program (2020: 1.7m restricted stock units with an estimated fair value of 120m US dollar). No restricted stock units were granted to members of the Executive Committee (2020: nil).

 

AB InBev – Financial Report 2021 | 79


Performance related incentive plan for ZX Ventures

In 2016, the company implemented a new performance related incentive plan which substitutes the long-term incentive stock option plan for executives of ZX Ventures. ZX Ventures is our global growth and innovation group whose mandate is to invest in, incubate and develop new products and businesses that address emerging consumer needs.

During 2021, 1m performance units were granted to senior management of ZX Ventures (2020: 1.2m performance units). The value of the performance units will depend on the return of ZX Ventures. These units vest after 5 years provided that a performance test is met. Specific forfeiture rules apply in the event that the executive leaves the company.

Other programs

In order to maintain the consistency of benefits granted to executives and to encourage the international mobility of executives, an option exchange program can be executed whereby unvested options are exchanged for restricted shares that remain locked-up until 5 years after the end of the initial vesting period. The shares that result from the exercise of the options must in principle remain locked-up until 31 December 2023. In 2021, no options were exchanged for ordinary blocked shares (2020: nil).

The Board has also approved the early release of vesting conditions of unvested stock options or restricted stock units that are vesting within 6 months of the executives’ relocation. The shares that result from the early exercise of the options or the early vesting of the restricted stock units must remain blocked until the end of the initial vesting period. In 2021, no restricted stock units were accelerated under this program for members of the senior management (2020: 0.1m restricted stock units).

The weighted average fair value of the options and assumptions used in applying the AB InBev option pricing model for the 2020 grants of awards described above are as follows. No stock options were granted in 2021.

 

  Amounts in US dollar unless otherwise indicated    2021      2020    

  Fair value of options granted

                    -        7.54    

  Share price

     -                        46.35    

  Exercise price

     -        46.35    

  Expected volatility

     -        25%    

  Expected dividends

     -        3.00%    

  Risk-free interest rate

     -        -0.32%    

Expected volatility is based on historical volatility calculated over a 10-year period. The binomial Hull model assumes that all employees would immediately exercise their options if the AB InBev share price is 2.5 times above the exercise price. As a result, no single expected option life applies.

The total number of outstanding AB InBev options developed as follows:

 

  Million options    2021      2020    

  Options outstanding at 1 January

     113.3        88.7    

  Options issued during the year

     -                           38.1    

  Options exercised during the year

     (1.3)        (3.9)    

  Options forfeited during the year

     (9.2)        (9.0)    

  Options outstanding at the end of December

     102.7        113.3    

The range of exercise prices of the outstanding options is between 10.32 euro (11.69 US dollar)1 and 121.95 euro (138.12 US dollar) while the weighted average remaining contractual life is 6.50 years.

Out of the 102.7m outstanding options, 24.3m are vested at 31 December 2021.

The weighted average exercise price of the AB InBev options is as follows:

 

  Amounts in US dollar    2021      2020    

  Options outstanding at 1 January

     71.22                          79.66    

  Granted during the year

     -        53.41    

  Exercised during the year

     46.30        29.92    

  Forfeited during the year

     89.56        117.82    

  Outstanding at the end of December

     64.77        71.22    

  Exercisable at the end of December

     98.27        99.54    

For share options exercised during 2021, the weighted average share price at the date of exercise was 53.47 euro (60.56 US dollar)¹.

 

1 

Amounts have been converted to US dollar at the closing rate of the respective period.

 

AB InBev – Financial Report 2021 | 80


The total number of outstanding AB InBev restricted stock units developed as follows:

 

  Million restricted stock units    2021      2020    

  Restricted stock units outstanding at 1 January

     19.1                          9.9    

  Restricted stock units issued during the year

     3.9        10.9    

  Restricted stock units vested during the year

     (1.1)        (0.7)    

  Restricted stock units forfeited during the year

     (1.1)        (0.9)    

  Restricted stock units outstanding at the end of December

     20.9        19.1    

AMBEV SHARE-BASED COMPENSATION PROGRAMS

Since 2005, Ambev has had in place a plan which is substantially similar to the Share-based compensation plan under which bonuses granted to company employees and management are partially settled in shares. Under the Share-based compensation plan, Ambev issued 0.1m deferred stock units with an estimated fair value of less than 1m US dollar in 2021 (2020: 0.2m deferred stock units with an estimated fair value of 1m US dollar).

Since 2018, Ambev has had in place a plan which is substantially similar to the Share-based compensation plan under which bonuses granted to company employees and management are partially settled in shares. Under the 2018 Share-based compensation plan, Ambev issued 20.6m restricted stock units in 2021 with an estimated fair value of 61m US dollar (2020: 21.1m restricted stock units with an estimated fair value of 61m US dollar).

As of 2010, senior employees are eligible for an annual long-term incentive to be paid out in Ambev LTI stock options (or, in the future, similar share-based instruments), depending on management’s assessment of the employee’s performance and future potential. In 2021, Ambev did not grant any LTI stock options (2020: 22 thousand LTI stock options with an estimated fair value of less than 1m US dollar).

The weighted average fair value of the options and assumptions used in applying the option pricing model for the 2020 grants of awards described above are as follows. No stock options were granted in 2021.

 

  Amounts in US dollar unless otherwise indicated1    2021      2020    

  Fair value of options granted

     -        0.78    

  Share price

     -        3.47    

  Exercise price

     -        3.47    

  Expected volatility

     -        22%    

  Expected dividends

     0.00% - 5.00%        0.00% - 5.00%    

  Risk-free interest rate

     -        6.80%    

The total number of outstanding Ambev options developed as follows:

 

  Million options    2021      2020    

  Options outstanding at 1 January

     127.3                         141.8    

  Options issued during the year

     -        -    

  Options exercised during the year

     (5.2)        (5.7)    

  Options forfeited during the year

     (8.3)        (8.8)    

  Options outstanding at the end of December

     113.8        127.3    

The range of exercise prices of the outstanding options is between 15.95 Brazilian real (2.86 US dollar) and 45.97 Brazilian real (8.24US dollar) while the weighted average remaining contractual life is 6.7 years.

Of the 113.8m outstanding options 59.3m options are vested at 31 December 2021.

The weighted average exercise price of the Ambev options is as follows:

 

  Amounts in US dollar1    2021      2020    

  Options outstanding at 1 January

     3.81                            4.60    

  Granted during the year

     -        3.47    

  Exercised during the year

     2.36        1.60    

  Forfeited during the year

     4.53        4.42    

  Outstanding at the end of December

     3.57        3.81    

  Exercisable at the end of December

     3.79        4.56    

For share options exercised during 2021, the weighted average share price at the date of exercise was 17.87 Brazilian real (3.2 US dollar).

 

1 Amounts have been converted to US dollar at the closing rate of the respective period.

 

AB InBev – Financial Report 2021 | 81


The total number of outstanding Ambev deferred and restricted stock units developed as follows:

 

  Million restricted stock units    2021      2020    

  Restricted stock units outstanding at 1 January

     49.6                        31.7    

  Restricted stock units issued during the year

     20.7        21.3    

  Restricted stock units vested during the year

     (5.0)        (1.9)    

  Restricted stock units forfeited during the year

     (1.5)        (1.5)    

  Restricted stock units outstanding at the end of December

     63.8        49.6    

Additionally, as a means of creating a long-term incentive (wealth incentive) for certain senior employees and members of management considered as having “high potential”, share appreciation rights in the form of phantom stocks have been granted to those employees, pursuant to which the beneficiary shall receive two separate lots – Lot A and Lot B – subject to lockup periods of five and ten years, respectively. In 2020 and 2021, Ambev did not issue any share appreciation rights.

During 2021, a limited number of Ambev shareholders who are part of the senior management of AB InBev were given the opportunity to exchange Ambev shares against a total of 3 thousand AB InBev shares (2020: 0.1m AB InBev shares) at a discount of 16.66% provided that they stay in service for another five years. The fair value of this transaction amounts to less than 1m US dollar (2020: 1m US dollar) and is expensed over the five years’ service period. The fair values of the Ambev and AB InBev shares were determined based on the market price.

BUDWEISER APAC SHARE-BASED COMPENSATION PROGRAM

LTI Stock Option Plans for Executives

In December 2019, Budweiser APAC set up a long-term incentive plan in which certain employees are eligible for an annual grant to be paid out in Budweiser APAC stock options (or, in the future, similar share-based instruments), depending on management’s assessment of the employee’s performance and future potential. In 2021, no stock options were granted (2020: 69.7m LTI stock options with an estimated fair value of 52m US dollar).

Discretionary Restricted Stock Units Plan

In December 2019, Budweiser APAC set up a discretionary restricted stock units plan which allows for the offer of restricted stock units to certain employees in certain specific circumstances, at the discretion of the Board, e.g., as a special retention incentive. The restricted stock units vest after three to five years and in the event that an employee’s service is terminated before the vesting date, special forfeiture rules apply. In 2021, no restricted stock units were granted under this program (2020: 29.7m restricted stock units with an estimated fair value of 84m US dollar).

Share-Based Compensation Plan

In March 2020, Budweiser APAC set up a program allowing for certain employees to invest some or all of their variable compensation in Budweiser APAC shares (Voluntary Shares). As an additional reward, employees who invest in Voluntary Shares also receive a company shares match of three matching shares for each Voluntary Share invested up to a limited total percentage of each employee’s variable compensation. In 2021, Budweiser APAC issued 0.1m matching restricted stock units in relation to bonuses granted to Budweiser APAC employees with an estimated fair value of less than 1m US dollar (2020: 0.2m matching restricted stock units with a fair value of approximately 1m US dollar).

New Restricted Stock Units Plan

In November 2020, Budweiser APAC set up a new restricted stock units plan which allows for the offer of restricted stock units to certain eligible employees in certain specific circumstances, at the discretion of the Board, e.g., as a long-term incentive. The vesting period of the restricted stock units is in principle five years without a performance test and in the event of termination of service before the vesting date, forfeiture rules apply. The Board may set shorter or longer periods for specific grants or introduce performance tests similar to other programs in the company. During 2021, 10m restricted stock units with an estimated fair value of 26m US dollar were granted under this program to a selected number of employees (2020: 6.8m restricted stock units with an estimated fair value of 23m US dollar).

People Bet Plan

In March 2020, Budweiser APAC set up a program allowing for certain employees to purchase Budweiser APAC shares at a discount which is aimed at providing a long-term retention incentive for high-potential employees of the company, who are at a mid-manager level (“People bet share purchase program”). The voluntary investment in company shares leads to the grant of an amount of matching restricted stock units which vest after 5 years. In the event that an employee’s service is terminated before the vesting date, special forfeiture rules apply. During 2021, no restricted stock units were granted under this program (2020: 0.6m restricted stock units with an estimated fair value of 2m US dollar were granted to a selected number of employees).

 

AB InBev – Financial Report 2021 | 82


26. Provisions

 

  Million US dollar    Restructuring              Disputes              Other              Total    

  Balance at 1 January 2021

     104        489        170        763    

  Effect of movements in foreign exchange

     (2)        (20)        (4)        (25)    

  Provisions made

     63        132        9        203    

  Provisions used

     (73)        (129)        (11)        (213)    

  Provisions reversed

     (13)        (35)        (1)        (48)    

  Other movements

     1        (18)        (58)        (75)    

  Balance at 31 December 2021

     80        420        106        605    

The restructuring provisions are primarily explained by the organizational alignments - see also Note 8 Non-underlying items. Provisions for disputes mainly relate to various disputed taxes other than income taxes and to claims from former employees.

The provisions are expected to be settled within the following time windows:

 

  Million US dollar    Total          < 1 year          1-2 years              2-5 years      > 5 years    

  Restructuring

     80        36        11        14        19    
                                              

  Indirect taxes

     90        10        27        2        51    

  Labor

     114        14        55        36        10    

  Commercial

     55        16        27        9        3    

  Environmental

     5        5        -        -        -    

  Excise duties

     16        -        11        5        -    

  Other disputes

     140        39        70        13        18    

  Disputes

     420        82        190        65        83    
                                              

  Other provisions

     106        49        35        21        0    

  Total provisions

     605        168        235        100        102    

AB InBev is subject to the greenhouse gas emission allowance trading scheme in force in the European Union and a similar scheme in South Korea. Acquired emission allowances are recognized at cost as intangible assets. To the extent that it is expected that the number of allowances needed to settle the CO2 emissions exceeds the number of emission allowances owned, a provision is recognized. Such provision is measured at the estimated amount of the expenditure required to settle the obligation.

27. Trade and other payables

 

  Million US dollar    31 December 2021     31 December 2020    
                  

  Indirect taxes payable

     194       252    

  Trade payables

     51       98    

  Deferred consideration on acquisitions

     662       1 082    

  Other payables

     100       90    

  Non-current trade and other payables

     1 008       1 522    
                  

  Trade payables and accrued expenses

     17 810       15 898    

  Payroll and social security payables

     1 716       800    

  Indirect taxes payable

     2 457       2 629    

  Interest payable

     1 501       1 625    

  Consigned packaging

     1 050       1 010    

  Dividends payable

     355       427    

  Deferred income

     51       27    

  Deferred consideration on acquisitions

     191       301    

  Other payables

     302       249    

  Current trade and other payables

     25 434       22 965    

As at 31 December 2021, deferred consideration on acquisitions is mainly comprised of 0.6 billion US dollar for the put option included in the 2012 shareholders’ agreement between Ambev and ELJ, which may result in Ambev acquiring additional shares in Cervecería Nacional Dominicana S.A. (“CND”) (31 December 2020: 0.7 billion US dollar). The terms of the shareholders’ agreement were amended as described in Note 28 Risk arising from financial instruments.

 

AB InBev – Financial Report 2021 | 83


28. Risks arising from financial instruments

FINANCIAL ASSETS AND FINANCIAL LIABILITIES

Set out below is an overview of financial assets1 and liabilities held by the company as at the dates indicated:

 

     31 December 2021      31 December 2020  
Million US dollar    At
amortized
cost
     At fair
value
through
profit or
loss
     At fair
value
through
OCI
     Total      At
amortized
cost
     At fair
value
through
profit or
loss
     At fair
value
through
OCI
     Total  
                                                                         

Trade and other receivables

     4 607        -        -        4 607        4 493        -        -        4 493  

Unquoted debt (debt instruments)

     22        -        -        22        22        -        -        22  

Quoted debt (debt instruments)

     -        374        -        374        -        396        -        396  

Unquoted companies (equity instruments)

     -        -        139        139        -        -        115        115  

Derivatives not designated in hedge accounting relationships:

                                                                       

Equity swaps

     -        -        -        -        -        27        -        27  

Interest rate swaps

     -        20        -        20        -        45        -        45  

Cross currency interest rate swaps

     -        52        -        52        -        7        -        7  

Derivatives designated in hedge accounting relationships:

                                                                       

Foreign exchange forward contracts

     -        -        238        238        -        -        480        480  

Foreign currency futures

     -        -        -        -        -        -        36        36  

Interest rate swaps

     -        -        17        17        -        -        35        35  

Cross currency interest rate swaps

     -        -        60        60        -        -        100        100  

Commodities

     -        -        282        282        -        -        235        235  
                                                                         

Financial assets

     4 629        446        736        5 811        4 515        475        1 001        5 991  

Non-current

     526        73        115        714      588        79        174        841  

Current

     4 103        373        621        5 097        3 927        396        827        5 150  
                                                                         

Trade and other payables

     22 074        -        -        22 074        20 807        -        -        20 807  

Interest-bearing loans and borrowings:

                                                                       

Secured bank loans

     628        -        -        628        702        -        -        702  

Unsecured bank loans

     106        -        -        106        294        -        -        294  

Unsecured bond issues

     85 726        -        -        85 726        93 725        -        -        93 725  

Unsecured other loans

     40        -        -        40        83        -        -        83  

Commercial paper

     -        -        -        -        1 522        -        -        1 522  

Bank overdrafts

     53        -        -        53        5        -        -        5  

Lease liabilities

     2 277        -        -        2 277        2 234        -        -        2 234  

Derivatives not designated in hedge accounting relationships:

                                                                       

Equity swaps

     -        5 412        -        5 412        -        5 353        -        5 353  

Cross currency interest rate swaps

     -        172        -        172        -        446        -        446  

Foreign exchange forward contracts

     -        26        -        26        -        321        -        321  

Derivatives designated in hedge accounting relationships:

                                                                       

Foreign exchange forward contracts

     -        -        103        103        -        -        370        370  

Foreign currency futures

     -        -        37        37        -        -        5        5  

Cross currency interest rate swaps

     -        -        98        98        -        -        264        264  

Commodities

     -        -        35        35        -        -        26        26  

Equity swaps

     -        -        -        -        -        -        21        21  

Interest rate swaps

     -        -        3        3        -        -        -        -  
                                                                         

Financial liabilities

     110 904        5 610        276        116 790        119 372        6 120        686        126 178  

Non-current

     88 182        100        -        88 282        96 748        1 758        -        98 506  

Current

     22 722        5 510        276        28 508        22 624        4 362        686        27 672  

 

1 Cash and short-term deposits are not included in this overview.

 

84


DERIVATIVES

AB InBev’s activities expose it to a variety of financial risks: market risk (including currency risk, fair value interest rate risk, cash flow interest risk, commodity risk and equity risk), credit risk and liquidity risk. The company analyses each of these risks individually as well as on a combined basis and defines strategies to manage the economic impact on the company’s performance in line with its financial risk management policy.

AB InBev primarily uses the following derivative instruments: foreign currency rate agreements, exchange traded foreign currency futures, interest rate swaps and forwards, cross currency interest rate swaps (“CCIRS”), commodity swaps, exchange traded commodity futures and equity swaps.

The table below provides an overview of the notional amounts of derivatives outstanding as at the dates indicated by maturity bucket.

 

     31 December 2021      31 December 2020  

Million US dollar

   < 1
year
     1-2
years
     2-3
years
     3-5
years
     > 5
years
     < 1
year
     1-2
years
     2-3
years
     3-5
years
     > 5
years
 
                                                                                           

Foreign currency

                                                                                         

Forward exchange contracts

     12 599        29        -        -        -        18 505        290        -        -        -  

Foreign currency futures

     1 617        -        -        -        -        2 218        -        -        -        -  
                                                                                           

Interest rate

                                                                                         

Interest rate swaps

     1 500        1 000        -        -        -        -        1 500        1 000        -        -  

Cross currency interest rate swaps

     4 614        1 400        1 173        1 573        1 453        513        5 658        1 400        1 866        789  

Other interest rate derivatives

     -        -        -        -        -        -        -        -        -        -  
                                                                                           

Commodities

                                                                                         

Aluminum swaps

     1 241        -        -        -        -        1 184        -        -        -        -  

Other commodity derivatives

     1 034        -        -        -        -        644                 -        -        -  
                                                                                           

Equity

                                                                                         

Equity derivatives

     11 469        -        -        -        -        10 234        2 326        -        -        -  

FOREIGN CURRENCY RISK

AB InBev is subject to foreign currency risk when contracts are denominated in a currency other than the functional currency of the entity. This includes borrowings, investments, (forecasted) sales, (forecasted) purchases, royalties, dividends, licenses, management fees and interest expense/income. To manage foreign currency risk the company uses mainly foreign currency rate agreements, exchange traded foreign currency futures and cross currency interest rate swaps.

 

AB InBev - Financial Report 2021 | 85


FOREIGN EXCHANGE RISK ON OPERATING ACTIVITIES

AB InBev’s policy is to hedge operating transactions which are reasonably expected to occur (e.g. cost of goods sold and selling, general & administrative expenses) within the forecast period determined in the financial risk management policy. Operating transactions that are considered certain to occur are hedged without any time limits. Non-operating transactions (such as acquisitions and disposals of subsidiaries) are hedged as soon as they are highly probable.

The table below shows the company’s main net foreign currency positions for firm commitments and forecasted transactions for the most important currency pairs. The open positions are the result of the application of AB InBev’s risk management policy. Positive amounts indicate that the company is long (net future cash inflows) in the first currency of the currency pair while negative amounts indicate that the company is short (net future cash outflows) in the first currency of the currency pair. The second currency of the currency pairs listed is the functional currency of the related subsidiary.

 

     31 December 2021      31 December 2020  

Million US dollar

   Total
exposure
     Total
hedges
     Open
position
     Total
exposure
     Total
hedges
     Open
position
 
                                                       

Euro/Canadian dollar

     (6)        6        -        (9)        9        -  

Euro/Mexican peso

     (112)        111        (1)        (106)        102        (4)  

Euro/Pound sterling

     (124)        112        (12)        (203)        130        (73)  

Euro/South African rand

     (79)        75        (4)        (95)        65        (30)  

Euro/South Korean won

     (39)        36        (3)        (40)        38        (2)  

Euro/US dollar

     (123)        100        (23)        (354)        284        (70)  

Mexican peso/Euro

     (254)        231        (23)        (249)        146        (103)  

Pound sterling/Euro

     (14)        22        8        (35)        36        1  

US dollar/Argentinian peso

     (661)        674        13        (602)        543        (59)  

US dollar/Bolivian boliviano

     (80)        75        (5)        (64)        56        (8)  

US dollar/Brazilian real

     (1 846)        1 618        (228)        (1 573)        1 577        4  

US dollar/Canadian dollar

     (304)        253        (51)        (302)        194        (108)  

US dollar/Chilean peso

     (171)        162        (9)        (151)        129        (22)  

US dollar/Chinese yuan

     (123)        116        (7)        (171)        201        30  

US dollar/Colombian peso

     (476)        434        (42)        (359)        352        (7)  

US dollar/Euro

     (103)        96        (7)        (98)        96        (2)  

US dollar/Mexican peso

     (1 236)        1 168        (68)        (1 032)        995        (37)  

US dollar/Paraguayan guarani

     (153)        139        (14)        (132)        125        (7)  

US dollar/Peruvian nuevo sol

     (292)        278        (14)        (225)        168        (57)  

US dollar/South African rand

     (196)        148        (48)        (130)        116        (14)  

US dollar/South Korean won

     (114)        79        (35)        (71)        70        (1)  

US dollar/Uruguayan peso

     (42)        42        -        (40)        39        (1)  

Others

     (323)        207        (116)        (260)        131        (129)  

Further analysis on the impact of open currency exposures is performed in the currency sensitivity analysis below.

Hedges of firm commitments and highly probable forecasted transactions denominated in foreign currency are designated as cash flow hedges.

Foreign exchange risk on foreign currency denominated debt

It is AB InBev’s policy to have the debt in the subsidiaries as much as possible linked to the functional currency of the subsidiary. To the extent this is not the case, foreign exchange risk is managed using derivatives unless the cost to hedge outweighs the benefits. Interest rate decisions and currency mix of debt and cash are decided on a global basis and take into consideration the holistic risk management approach.

A description of the foreign currency risk hedging of debt instruments issued in a currency other than the functional currency of the subsidiary is further detailed in the Interest Rate Risk section below.

 

AB InBev – Financial Report 2021 | 86


Currency sensitivity analysis

Currency transactional risk

Most of AB InBev’s non-derivative financial instruments are either denominated in the functional currency of the subsidiary or are converted into the functional currency through the use of derivatives. Where illiquidity in the local market prevents hedging at a reasonable cost, the company can have open positions. The transactional foreign currency risk mainly arises from open positions in Brazilian real, Mexican Peso, Canadian dollar and South African rand against the US dollar and the euro. AB InBev estimated the reasonably possible change of exchange rate, on the basis of the average volatility on the open currency pairs, as follows:

 

       2021  
        Closing rate
31 December 2021
       Possible
closing rate1
       Volatility
of rates in %
 

Euro/Mexican peso

       23.31          21.04 - 25.59          9.75%  

Euro/Pound sterling

       0.84          0.80 - 0.88          5.15%  

Euro/South Korean won

       1 345.90          1 273.31 - 1 418.48          5.39%  

Euro/US dollar

       1.13          1.07 - 1.20          5.58%  

Pound sterling/US dollar

       1.35          1.26 - 1.43          6.36%  

US dollar/Argentinian peso

       102.75          99.72 - 105.78          2.95%  

US dollar/Brazilian real

       5.58          4.68 - 6.48          16.07%  

US dollar/Canadian dollar

       1.27          1.19 - 1.35          6.54%  

US dollar/Chinese yuan

       6.35          6.06 - 6.64          4.55%  

US dollar/Colombian peso

       3 977.14          3 568.65 - 4 385.62          10.27%  

US dollar/Euro

       0.88          0.83 - 0.93          5.58%  

US dollar/Mexican peso

       20.58          18.38 - 22.79          10.71%  

US dollar/Nigerian naira

       424.89          379.56 - 470.22          10.67%  

US dollar/Peruvian nuevo sol

       3.98          3.60 - 4.35          9.53%  

US dollar/South African rand

       15.95          13.74 - 18.15          13.82%  

US dollar/South Korean won

       1 188.32          1 092.29 - 1 284.36          8.08%  

US dollar/Tanzanian shilling

       2 305.28          2 236.69 - 2 373.88          2.98%  

US dollar/Zambian kwacha

       16.67          13.41 - 19.93          19.58%  
       2020  
        Closing rate
31 December 2020
       Possible closing
rate2
       Volatility of
rates in %
 

Euro/Mexican peso

       24.48          19.38 - 29.58          20.83%  

Euro/Pound sterling

       0.90          0.82 - 0.98          9.09%  

Euro/South Korean won

       1 335.11          1 218.41 - 1 451.81          8.74%  

Euro/US dollar

       1.23          1.13 - 1.32          7.75%  

Pound sterling/US dollar

       1.36          1.22 - 1.51          10.79%  

US dollar/Argentinian peso

       84.14          74.55 - 93.73          11.40%  

US dollar/Brazilian real

       5.20          4.13 - 6.26          20.51%  

US dollar/Canadian dollar

       1.27          1.17 - 1.38          8.25%  

US dollar/Chinese yuan

       6.54          6.25 - 6.82          4.34%  

US dollar/Colombian peso

       3 438.52          2 908.55 - 3 968.50          15.41%  

US dollar/Euro

       0.81          0.75 - 0.88          7.75%  

US dollar/Mexican peso

       19.95          16.19 - 23.71          18.83%  

US dollar/Nigerian naira

       397.72          345.23 - 450.21          13.20%  

US dollar/Peruvian nuevo sol

       3.62          3.37 - 3.87          6.95%  

US dollar/South African rand

       14.69          12.19 - 17.18          16.99%  

US dollar/South Korean won

       1 088.02          1 000.21 - 1 175.84          8.07%  

US dollar/Tanzanian shilling

       2 321.74          2 205.30 - 2 438.18          5.02%  

US dollar/Zambian kwacha

       21.16          18.44 - 23.89          12.89%  

In case the open positions in Brazilian real, Mexican Peso, Canadian dollar and South African rand as of 31 December 2021 remain unchanged, considering the volatility mentioned above and all other variables held constant, these currencies could lead to an increase/decrease on the consolidated profit before tax from continuing operations of approximately 54m US dollar over the next 12 months (31 December 2020: 30m US dollar considering the open positions in Mexican peso, Canadian dollar, Argentinean peso and Pound sterling).

 

1 Sensitivity analysis is assessed based on the yearly volatility using daily observable market data during 250 days at 31 December 2021.

2 Sensitivity analysis is assessed based on the yearly volatility using daily observable market data during 250 days at 31 December 2020.

 

AB InBev – Financial Report 2021 | 87


Additionally, the AB InBev sensitivity analysis1 to the foreign exchange rates on its total derivatives positions as of 31 December 2021, shows a positive/negative pre-tax impact on equity reserves of 604m US dollar (31 December 2020: 850m US dollar).

Foreign exchange risk on net investments in foreign operations

AB InBev mitigates exposures of its investments in foreign operations using both derivative and non-derivative financial instruments as hedging instruments.

As of 31 December 2021, designated derivative and non-derivative financial instruments in net investment hedges amount to 11 921m US dollar equivalent (31 December 2020: 9 691m US dollar) in Holding companies and approximately 589m US dollar equivalent at Ambev level (31 December 2020: 671m US dollar). These instruments hedge foreign operations with Canadian dollar, Chinese yuan, Dominican peso, euro, Mexican peso, pound sterling, South African rand, South Korean won, Nigerian Naira and US dollar functional currencies.

Net foreign exchange results

Foreign exchange results recognized on unhedged and hedged exposures are as follows:

 

Million US dollar

   2021      2020  

Economic hedges

     717        (181

Other results — not hedged

     (801      195  
       (84      14

INTEREST RATE RISK

The company applies a dynamic interest rate hedging approach whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of AB InBev’s policy is to achieve an optimal balance between the cost of funding and the volatility of financial results, while taking into account market conditions as well as AB InBev’s overall business strategy.

Fair value hedges

US dollar fixed rate bond hedges (interest rate risk on borrowings in US dollar)

The company manages and reduces the impact of changes in the US dollar interest rates on the fair value of certain fixed rate bonds with an aggregate principal amount of 1.0 billion US dollar through fixed/floating interest rate swaps. These derivative instruments have been designated in fair value hedge accounting relationships.

Cash flow hedges

Pound sterling bond hedges (foreign currency risk and interest rate risk on borrowings in pound sterling)

In September 2013, the company issued a pound sterling bond for 500m pound sterling at a rate of 4.00% per year and maturing in September 2025. The impact of changes in the pound sterling exchange rate and interest rate on this bond is managed and reduced through pound sterling fixed/euro fixed cross currency interest rate swaps. These derivative instruments have been designated in a cash flow hedge accounting.

US dollar bank loan hedges (foreign currency risk on borrowings against the Nigerian naira)

The company has a floating rate loan denominated in US dollar for a total of 268m in Nigeria. This loan is held by an entity with functional currency in Nigerian Naira. In order to hedge against fluctuations in foreign exchange rates, the company entered into foreign exchange futures which have been designated in cash flow hedge relationship.

Economic Hedges

Marketable debt security hedges (interest rate risk on Brazilian real)

During 2021 and 2020, Ambev invested in highly liquid Brazilian real denominated government debt securities.

 

AB InBev – Financial Report 2021 | 88


Interest rate sensitivity analysis

The table below reflects the effective interest rates of interest-bearing financial liabilities at balance sheet date as well as the currency in which the debt is denominated.

 

31 December 2021

Interest-bearing financial liabilities

Million US dollar

     Before hedging        After hedging  
     Effective
interest rate
       Amount        Effective
interest rate
       Amount  
                                             

Floating rate

                                           

Australian dollar

       1.03        218          -          -  

Canadian dollar

       -          -          1.21%          2 043  

Euro

       -          1 113          -          1 113  

Pound sterling

       -          -          1.05%          1 002  

South Korean won

       -          -          1.67%          502  

US dollar

       1.67        463          -          -  

Other

       7.22        516          5.99%          1 504  
                    2 310                     6 164  

Fixed rate

                                           

Australian dollar

       4.12        324          -          -  

Brazilian real

       7.21        420          7.21%          420  

Canadian dollar

       4.11        626          4.29%          3 158  

Euro

       2.27        21 654          2.11%          27 553  

Pound sterling

       4.35        3 611          4.43%          2 937  

South Korean won

       3.85        32          0.87%          1 695  

US dollar

       4.93        59 399          5.41%          46 288  

Other

       11.42        454          8.80%          615  
                    86 520                     82 666  

31 December 2020

Interest-bearing financial liabilities

Million US dollar

     Before hedging        After hedging  
     Effective
interest rate
       Amount        Effective
interest rate
       Amount  
                                             

Floating rate

                   

Australian dollar

       0.99        231          -          -  

Brazilian real

       3.90        164          3.90%          164  

Canadian dollar

       -          -          1.23%          1 895  

Euro

       0.15        2 690          0.15%          2 690  

Pound sterling

       -          -          1.10%          937  

US dollar

       1.05        617          1.13%          201  

Other

       7.30        260          7.90%          573  
                    3 962                     6 461  

Fixed rate

                   

Australian dollar

       3.91        846          -          -  

Brazilian real

       8.58        578          8.58%          578  

Canadian dollar

       4.12        613          4.29%          2 646  

Euro

       2.12        26 092          2.15%          35 515  

Pound sterling

       4.30        3 655          4.36%          2 973  

South Korean won

       -          -          1.30%          1 997  

US dollar

       4.91        62 340          5.30%          47 892  

Other

       11.96        479          11.72%          502  
                    94 602                     92 103  

As at 31 December 2021, the total carrying amount of the floating and fixed rate interest-bearing financial liabilities before hedging as listed above includes bank overdrafts of 53m US dollar (31 December 2020: 5m US dollar).

 

AB InBev – Financial Report 2021 | 89


As disclosed in the above table, 6 164m US dollar or 6.9% of the company’s interest-bearing financial liabilities bears interest at a variable rate. The company estimated that the reasonably possible change of the market interest rates applicable to its floating rate debt after hedging is as follows:

 

       2021  
        Interest rate
31 December 20211
       Possible
interest rate2
       Volatility
of rates in %
 
              

Brazilian real

       8.88%          7.85% —9.91%          11.58%  

Euro

       -          -          10.64%  

US dollar

       0.21%          0.11% — 0.31%          48.10%  
       2020  
        Interest rate
31 December 20201
       Possible
interest rate2
       Volatility
of rates in %
 

Brazilian real

       2.09%          1.74% — 2.44%          16.77%  

Euro

       -          -          16.83%  

US dollar

       0.24%          0.10% — 0.38%         
58.30%
 

When AB InBev applies the reasonably possible increase/decrease in the market interest rates mentioned above on its floating rate debt at 31 December 2021, with all other variables held constant, 2021 interest expense would have been 8m US dollar higher/lower (31 December 2020: 3m US dollar). This effect would be more than offset by 44m US dollar higher/lower interest income on AB InBev’s interest-bearing financial assets (31 December 2020: 58m US dollar).

Interest expense

Interest expense recognized on unhedged and hedged financial liabilities are as follows:

 

Million US dollar

     2021        2020  

Financial liabilities measured at amortized cost – not hedged

       (3 836)          (4 154)  

Fair value hedges

       (6)          (1)  

Cash flow hedges

       17          19  

Net investment hedges — hedging instruments (interest component)

       -          2  

Economic hedges

       141          118  
         (3 684)          (4 016)  

COMMODITY PRICE RISK

The commodity markets have experienced and are expected to continue to experience price fluctuations. AB InBev therefore uses both fixed price purchasing contracts and commodity derivatives to manage the exposure to the price volatility. The most significant commodity exposures as at 31 December 2021 and 31 December 2020 are included in the table below (expressed in outstanding notional amounts):

 

Million US dollar

   31 December 2021      31 December 2020  
                   

Aluminum swaps

     1 241        1 184  

Exchange traded sugar futures

     85        74  

Natural gas and energy derivatives

     350        202  

Corn swaps

     292        160  

Exchange traded wheat futures

     129        83  

Rice swaps

     85        76  

Plastic derivatives

     93        50  
       2 274        1 828  

Commodity price sensitivity analysis

The impact of changes in the commodity prices would not have had a material impact on AB InBev’s profit in 2021 as most of the company’s exposure is hedged using derivative contracts and designated in hedge accounting in accordance with IFRS 9 rules.

 

1 Applicable 3-month InterBank Offered Rates as of 30 December 2021 and as of 31 December 2020.

2 Sensitivity analysis is assessed based on the yearly volatility using daily observable market data during 250 days at 30 December 2021 and at December 2020. For the Brazilian real floating rate debt, the estimated market interest rate is composed of the InterBank Deposit Certificate (‘CDI’) and the Long-Term Interest Rate (‘TJLP’). With regard to other market interest rates, the company’s analysis is based on the 3-month InterBank Offered Rates applicable for the currencies concerned (e.g. EURIBOR 3M, LIBOR 3M). The sensitive analysis does not include any spread applicable to the company’s funding.

 

AB InBev – Financial Report 2021 | 90


The tables below show the estimated impact that changes in the price of the commodities, for which AB InBev held material derivative exposures as at 31 December 2021 and 31 December 2020, would have on the equity reserves.

 

     2021  
            Pre-tax impact on equity  

Million US dollar

  

Volatility of

prices in %1

     Prices increase      Prices decrease  
                            

Aluminum

     23.09%        287        (287)  

Sugar

     26.39%        22        (22)  

Energy

     25.88%        91        (91)  

Corn

     23.26%        68        (68)  

Wheat

     29.24%        38        (38)  

Rice

     15.96%        14        (14)  

Plastic

     28.68%        27        (27)  
     2020  
            Pre-tax impact on equity  

Million US dollar

  

Volatility of

prices in %2

     Prices increase      Prices decrease  

Aluminum

     14.96%        177        (177)  

Sugar

     31.48%        23        (23)  

Energy

     47.08%        95        (95)  

Corn

     32.84%        52        (52)  

Wheat

     25.30%        21        (21)  

Rice

     46.17%        35        (35)  

Plastic

     26.74%        13        (13)  

EQUITY PRICE RISK

AB InBev enters into equity swap derivatives to hedge the price risk on its shares in connection with its share-based payments programs, as disclosed in Note 26 Share-based Payments. AB InBev also hedges its exposure arising from shares issued in connection with the Modelo and SAB combination (see also Note 11 Finance cost and income). These derivatives do not qualify for hedge accounting and the changes in fair value are recorded in the profit or loss.

As at 31 December 2021, an exposure for an equivalent of 100.5m of AB InBev shares was hedged, resulting in a total loss of (48)m US dollar recognized in the profit or loss account for the period, of which (23)m US dollar related to the company’s share-based payment programs, (13)m US dollar and (12)m US dollar related to the Modelo and SAB transactions respectively. As at 31 December 2021 liabilities for equity swap derivatives amounted to 5.4 billion US dollar (31 December 2020: 5.4 billion US dollar).

Equity price sensitivity analysis

The sensitivity analysis on the equity swap derivatives, calculated based on a 26.51% (2020: 53.87%) reasonably possible volatility of the AB InBev share price, with all the other variables held constant, would show 1 604m US dollar positive/negative impact on the 2021 profit before tax (31 December 2020: 3 787m US dollar).

CREDIT RISK

Credit risk encompasses all forms of counterparty exposure, i.e. where counterparties may default on their obligations to AB InBev in relation to lending, hedging, settlement and other financial activities. The company has a credit policy in place and the exposure to counterparty credit risk is monitored.

AB InBev mitigates its exposure through a variety of mechanisms. It has established minimum counterparty credit ratings and enters into transactions only with financial institutions of investment grade rating. The company monitors counterparty credit exposures closely and reviews any external downgrade in credit rating immediately. To mitigate pre-settlement risk, counterparty minimum credit standards become more stringent with increases in the duration of the derivatives. To minimize the concentration of counterparty credit risk, the company enters into derivative transactions with different financial institutions.

The company also has master netting agreements with all of the financial institutions that are counterparties to over the counter (OTC) derivatives. These agreements allow for the net settlement of assets and liabilities arising from different transactions with the same counterparty. Based on these factors, AB InBev considers the impact of the risk of counterparty default as at 31 December 2021 to be limited.

 

1 Sensitivity analysis is assessed based on the yearly volatility using daily observable market data during 250 days at 31 December 2021.

2 Sensitivity analysis is assessed based on the yearly volatility using daily observable market data during 250 days at 31 December 2020.

 

AB InBev – Financial Report 2021 | 91


The impairment loss recognized in 2020 included AB InBev’s estimate of overdue receivables the company would not be able to collect from defaulting customers as a result of the COVID-19 pandemic.

Exposure to credit risk

The carrying amount of financial assets represents the maximum credit exposure of the company. The carrying amount is presented net of the impairment losses recognized. The maximum exposure to credit risk at the reporting date was:

 

     31 December 2021      31 December 2020  

Million US dollar

   Gross      Impairment      Net carrying
amount
     Gross      Impairment      Net carrying
amount
 
                                                       

Investment in unquoted companies

     145        (6)        139        121        (6)        115  

Investment in debt securities

     396        -        396        418        -        418  

Trade receivables

     3 796        (331)        3 465        3 593        (308)        3 285  

Cash deposits for guarantees

     168        -        168        184        -        184  

Loans to customers

     117        -        117        142        -        142  

Other receivables

     1 272        (65)        1 207        1 299        (62)        1 237  

Derivatives

     669        -        669        965        -        965  

Cash and cash equivalents

     12 097        -        12 097        15 252        -        15 252  
       18 660        (402)        18 258        21 974        (376)        21 598  

There was no significant concentration of credit risks with any single counterparty as of 31 December 2021 and no single customer represented more than 10% of the total revenue of the group in 2021.

Impairment losses

The allowance for impairment recognized during the period per classes of financial assets was as follows:

 

     2021  

Million US dollar

   Trade
receivables
     FVOCI      Other
receivables
     Total  
                                     

Balance at 1 January

     (308)        (6)        (62)        (376)  

Impairment losses

     (34)        -        (3)        (37)  

Derecognition

     29        -        1        30  

Currency translation and other

     (18)        -        (1)        (19)  

Balance at 31 December

     (331)        (6)        (65)        (402)  
     2020  

Million US dollar

   Trade
receivables
     FVOCI      Other
receivables
     Total  
                                     

Balance at 1 January

     (173)        (6)        (103)        (283)  

Impairment losses

     (93)        -        (6)        (99)  

Derecognition

     7        -        42        49  

Currency translation and other

     (50)        -        4        (46)  

Balance at 31 December

     (308)        (6)        (62)        (376)  

LIQUIDITY RISK

Historically, AB InBev’s primary sources of cash flow have been cash flows from operating activities, the issuance of debt, bank borrowings and equity securities. AB InBev’s material cash requirements have included the following:

 

   

Debt servicing;

 

   

Capital expenditures;

 

   

Investments in companies;

 

   

Increases in ownership of AB InBev’s subsidiaries or companies in which it holds equity investments;

 

   

Share buyback programs; and

 

   

Payments of dividends and interest on shareholders’ equity.

The company believes that cash flows from operating activities, available cash and cash equivalents as well as short term investments, along with related derivatives and access to borrowing facilities, will be sufficient to fund capital expenditures, financial instrument liabilities and dividend payments going forward. It is the intention of the company to continue to reduce its financial indebtedness through a combination of strong operating cash flow generation and continued refinancing.

 

AB InBev – Financial Report 2021 | 92


The following are the nominal contractual maturities of non-derivative financial liabilities including interest payments and derivative liabilities:

 

     31 December 2021  

Million US dollar

   Carrying
amount1
    

Contractual
cash

flows

     Less
than 1
year
     1-2 years      2-3 years      3-5 years      More
than 5
years
 
                                                                

Non-derivative financial liabilities

                                                              

Secured bank loans

     (628)        (636)        (551)        (53)        (5)        (9)        (18)  

Unsecured bank loans

     (106)        (106)        (106)        -        -        -        -  

Unsecured bond issues

     (85 726)        (152 064)        (3 479)        (3 596)        (6 192)        (13 800)        (124 997)  

Unsecured other loans

     (40)        (84)        (11)        (48)        (5)        (4)        (16)  

Lease liabilities

     (2 277)        (2 429)        (497)        (470)        (337)        (450)        (675)  

Bank overdraft

     (53)        (53)        (53)        -        -        -        -  

Trade and other payables

     (26 442)        (26 643)        (25 424)        (314)        (507)        (96)        (302)  
       (115 272)        (182 015)        (30 121)        (4 481)        (7 046)        (14 359)        (126 008)  
                                                                

Derivative financial liabilities

                                                              

Foreign exchange derivatives

     (166)        (166)        (166)        -        -        -        -  

Cross currency interest rate swaps

     (273)        (293)        (147)        (35)        (32)        (56)        (23)  

Commodity derivatives

     (34)        (34)        (34)        -        -        -        -  

Equity derivatives

     (5 412)        (5 420)        (5 420)        -        -        -        -  
       (5 885)        (5 913)        (5 767)        (35)        (32)        (56)        (23)  

Of which: related to cash flow hedges

     (203)        (203)        (170)        -        -        (29)        (4)  
     31 December 2020  

Million US dollar

   Carrying
amount1
     Contractual
cash
flows
    

Less
than

1 year

     1-2 years      2-3 years      3-5 years      More
than 5
years
 
                                                                

Non-derivative financial liabilities

                                                              

Secured bank loans

     (702)        (735)        (675)        (14)        (12)        (10)        (24)  

Commercial papers

     (1 522)        (1 522)        (1 522)        -        -        -        -  

Unsecured bank loans

     (294)        (299)        (299)        -        -        -        -  

Unsecured bond issues

     (93 725)        (165 812)        (3 582)        (4 057)        (3 823)        (16 557)        (137 793)  

Unsecured other loans

     (83)        (115)        (13)        (8)        (6)        (57)        (31)  

Lease liabilities

     (2 234)        (2 455)        (460)        (425)        (315)        (424)        (831)  

Bank overdraft

     (5)        (5)        (5)        -        -        -        -  

Trade and other payables

     (24 496)        (24 688)        (22 906)        (1 103)        (135)        (197)        (347)  
       (123 061)        (195 631)        (29 462)        (5 607)        (4 291)        (17 245)        (139 026)  
                                                                

Derivative financial liabilities

                                                              

Foreign exchange derivatives

     (696)        (696)        (696)        -        -        -        -  

Cross currency interest rate swaps

     (709)        (852)        (8)        (575)        (98)        (132)        (39)  

Commodity derivatives

     (26)        (26)        (26)        -        -        -        -  

Equity derivatives

     (5 373)        (5 372)        (4 455)        (917)        -        -        -  
       (6 803)        (6 946)        (5 184)        (1 492)        (98)        (132)        (39)  
                                                                

Of which: related to cash flow hedges

     (418)        (418)        (353)        -        -        (65)        -  

 

1 

“Carrying amount” refers to net book value as recognized in the balance sheet at each reporting date.

 

AB InBev – Financial Report 2021 | 93


CAPITAL MANAGEMENT

AB InBev continuously optimizes its capital structure to maximize shareholder value while keeping the financial flexibility to execute strategic projects. AB InBev’s capital structure policy and framework aims to optimize shareholder value through cash flow distribution to the company from its subsidiaries, while maintaining an investment-grade rating and minimizing investments with returns below AB InBev’s weighted average cost of capital. Besides the statutory minimum equity funding requirements that apply to the company’s subsidiaries in the different countries, AB InBev is not subject to any externally imposed capital requirements. Management uses the same debt/equity classifications as applied in the company’s IFRS reporting to analyze the capital structure.

FAIR VALUE

The following table summarizes for each type of derivative the fair values recognized as assets or liabilities in the balance sheet:

 

     Assets      Liabilities      Net  

Million US dollar

   31 December
2021
     31 December
2020
     31 December
2021
     31 December
2020
     31 December
2021
     31 December
2020
 
                                                       

Foreign currency

                                                     

Forward exchange contracts

     238        480        (129)        (691)        109        (211)  

Foreign currency futures

     -        36        (37)        (5)        (37)        31  
                                                       

Interest rate

                                                     

Interest rate swaps

     38        80        -        -        38        80  

Cross currency interest rate swaps

     111        107        (273)        (709)        (162)        (602)  
                                                       

Commodities

                                                     

Aluminum swaps

     178        170        (20)        (10)        158        160  

Sugar futures

     13        10        -        -        13        10  

Energy

     29        9        (2)        (7)        27        2  

Other commodity derivatives

     62        46        (13)        (8)        50        37  
                                                       

Equity

                                                     

Equity derivatives

     -        27        (5 412)        (5 373)        (5 412)        (5 346)  
       669        965        (5 886)        (6 804)        (5 216)        (5 839)  

Of which:

                                                     

Non-current

     48        138        (100)        (1 759)        (52)        (1 621)  

Current

     621        827        (5 786)        (5 046)        (5 164)        (4 218)  

The following table summarizes the carrying amount and the fair value of the fixed rate interest-bearing financial liabilities as recognized on the balance sheet. Floating rate interest-bearing financial liabilities, trade and other receivables and trade and other payables, including derivatives financial instruments, have been excluded from the analysis as their carrying amount is a reasonable approximation of their fair value:

 

Interest-bearing financial liabilities

Million US dollar

     31 December 2021      31 December 2020  
     Carrying amount1      Fair value      Carrying amount1      Fair value  

Fixed rate

                                     

Australian dollar

       (324      (366      (846      (964

Brazilian real

       (420      (419      (578      (578

Canadian dollar

       (626      (605      (613      (633

Euro

       (21 654      (23 801      (26 092      (29 809

Pound sterling

       (3 611      (3 913      (3 655      (4 301

US dollar

      
(59
399
 
     (75 261     
(62
340
 
     (81 771

Other

       (486      (471      (479      (480
         (86 520      (104 836      (94 602      (118 536

  

 

1 

“Carrying amount” refers to net book value as recognized in the balance sheet at each reporting date.

 

AB InBev – Financial Report 2021 | 94


The table sets out the fair value hierarchy based on the degree to which significant market inputs are observable:

 

Fair value hierarchy 31 December 2021

Million US dollar

   Quoted (unadjusted)
prices - level 1
     Observable market
inputs - level 2
     Unobservable market
inputs - level 3
 
                            

Financial Assets

                          

Held for trading (non-derivatives)

     -        9        -  

Derivatives at fair value through profit and loss

     -        155        -  

Derivatives in a cash flow hedge relationship

     58        352        -  

Derivatives in a fair value hedge relationship

     -        17        -  

Derivatives in a net investment hedge relationship

     -        87        -  
       58        620        -  

Financial Liabilities

                          

Deferred consideration on acquisitions at fair value

     -        -        832  

Derivatives at fair value through profit and loss

     -        5 611        -  

Derivatives in a cash flow hedge relationship

     52        141        -  

Derivatives in a net investment hedge relationship

     -        82        -  
       52        5 834        832  

Fair value hierarchy 31 December 2020

Million US dollar

   Quoted (unadjusted)
prices - level 1
     Observable market
inputs - level 2
     Unobservable market
inputs - level 3
 
                            

Financial Assets

                          

Held for trading (non-derivatives)

     -        11        -  

Derivatives at fair value through profit and loss

     -        457        -  

Derivatives in a cash flow hedge relationship

     29        343        -  

Derivatives in a fair value hedge relationship

     -        80        -  

Derivatives in a net investment hedge relationship

     -        57        -  
       29        948        -  

Financial Liabilities

                          

Deferred consideration on acquisitions at fair value

     -        -        1 251  

Derivatives at fair value through profit and loss

     -        6 119        -  

Derivatives in a cash flow hedge relationship

     46        353        -  

Derivatives in a net investment hedge relationship

     -        287        -  
       46        6 759        1 251  

 

Non-derivative financial liabilities

As part of the 2012 shareholders agreement between Ambev and ELJ, following the acquisition of Cervecería Nacional Dominicana S.A. (“CND”), a forward-purchase contract (combination of a put option and purchased call option) was put in place which may result in Ambev acquiring additional shares in CND. In July 2020, Ambev and ELJ amended the Shareholders’ Agreement to extend their partnership and change the terms and the exercise date of the call and put options. ELJ currently holds 15% of CND and the put option is exercisable in 2022, 2023, 2024 and 2026. As at 31 December 2021, the put option on the remaining shares held by ELJ was valued at 589m US dollar (31 December 2020: 671m US dollar) and recognized as a deferred consideration on acquisitions at fair value in the “level 3” category above.

HEDGING RESERVES

The company’s hedging reserves disclosed in Note 22 relate to the following instruments:

 

Million US dollar    Foreign
currency
     Commodities      Others      Total hedging
reserves
 
                                     

As per 1 January 2021

     20        274        84        376  

Change in fair value of hedging instrument recognized in OCI

     766        123        -        888  

Reclassified to profit or loss / cost of inventory

     (107)        (703)        27        (783)  

As per 31 December 2021

     679        (306)        111        481  
Million US dollar    Foreign
currency
     Commodities      Others      Total hedging
reserves
 
                                     

As per 1 January 2020

     174        117        107        397  

Change in fair value of hedging instrument recognized in OCI

     353        31        -        384  

Reclassified to profit or loss / cost of inventory

     (507)        126        (23)        (404)  

As per 31 December 2020

     20        274        84        376  

 

AB InBev – Financial Report 2021 | 95


OFFSETTING FINANCIAL ASSETS AND LIABILITIES

The following financial assets and liabilities are subject to offsetting, enforceable master netting agreements and similar agreements:

 

     December 2021  

Million US dollar

   Gross amount      Net amount recognized
in the statement of
financial position1
     Other
offsetting
agreements2
     Total
net
amount
 
                                     

Derivative assets

     670        670        (651)        19  

Derivative liabilities

     (5 886)        (5 886)        651        (5 235)  
     31 December 2020  

Million US dollar

   Gross amount      Net amount recognized
in the statement of
financial position1
     Other
offsetting
agreements2
     Total
net
amount
 
                                     

Derivative assets

     965        965        (954)        11  

Derivative liabilities

     (6 804)        (6 804)        954        (5 851)  

29. Collateral and contractual commitments for the acquisition of property, plant and equipment, loans to customers and other

 

Million US dollar

   31 December 2021      31 December 2020  
                   

Collateral given for own liabilities

     310        391  

Contractual commitments to purchase property, plant and equipment

     449        528  

Contractual commitments to acquire loans to associates/customers

     142        150  

Other commitments

     1 943        1 953  

The collateral given for own liabilities of 310m US dollar as at 31 December 2021 contains 168m US dollar cash guarantees (31 December 2020: 391m US dollar collateral given for own liabilities contained 184m US dollar of cash guarantees). Such cash deposits are a customary feature associated with litigations in Brazil: in accordance with Brazilian laws and regulations a company may or must (depending on the circumstances) place a deposit with a bank designated by the court or provide other security such as collateral on property, plant and equipment. With regard to judicial cases, AB InBev has made the appropriate provisions in accordance with IAS 37 Provisions, Contingent Liabilities and Contingent Assets – see also Note 26 Provisions. In the company’s balance sheet, the cash guarantees are presented as part of other receivables – see Note 19 Trade and other receivables. The remaining part of collateral given for own liabilities of 142m US dollar as at 31 December 2021 (31 December 2020: 207m US dollar) contains collateral on AB InBev’s property in favor of the excise tax authorities, the amount of which is determined by the level of the monthly excise taxes due, inventory levels and transportation risk, and collateral on its property, plant and equipment with regard to outstanding loans. To the extent that AB InBev would not respect its obligations under the related outstanding contracts or would lose the pending judicial cases, the collateralized assets would be used to settle AB InBev’s obligations.

AB InBev has entered into commitments to purchase property, plant and equipment for 449m US dollar at 31 December 2021 (31 December 2020: 528m US dollar).

In a limited number of countries AB InBev has committed itself to acquire loans to associates/customers from banks at their notional amount if the associates/customers do not respect their reimbursement commitments towards the banks. The total outstanding amount of such loans is 142m US dollar at 31 December 2021 (31 December 2020: 150m US dollar).

Other commitments amount to 1 943m US dollar at 31 December 2021 and mainly cover guarantees given to pension funds, rental and other guarantees (31 December 2020: 1 953m US dollar).

In order to fulfil AB InBev’s commitments under various outstanding stock option plans, AB InBev entered into stock lending arrangements for up to 30 million of its own ordinary shares. AB InBev shall pay any dividend equivalent, after tax in respect of the loaned securities. This payment will be reported through equity as dividend. As of 31 December 2021, 30 million loaned securities were used to fulfil stock option plan commitments.

 

1 Net amount recognized in the statement of financial position after taking into account offsetting agreements that meet the offsetting criteria as per IFRS rules.

2 Other offsetting agreements include collateral and other guarantee instruments, as well as offsetting agreements that do not meet the offsetting criteria as per IFRS rules.

 

AB InBev – Financial Report 2021 | 96


As at 31 December 2021, the M&A related commitments existed as discussed below.

Cervecería Nacional Dominicana S.A. (“CND”)

As part of the 2012 shareholders agreement between Ambev and E. León Jimenes S.A. (“ELJ”), following the acquisition of Cervecería Nacional Dominicana S.A. (“CND”), a put and call option is in place which may result in Ambev acquiring additional shares in CND. In January 2018 Ambev increased its participation in CND from 55% to 85%. As of 31 December 2021, the put option for the remaining shares held by ELJ was valued 0.6 billion US dollar (31 December 2020: 0.7 billion US dollar). The corresponding liability is presented as a non-current liability and recognized as a deferred consideration on acquisitions at fair value in “level 3” category. See also note 28 Risks arising from financial instruments.

30. Contingencies

The company has contingencies for which, in the opinion of management and its legal counsel, the risk of loss is possible but not probable and therefore no provisions have been recorded. Due to their nature, such legal proceedings and tax matters involve inherent uncertainties including, but not limited to, court rulings, negotiations between affected parties and governmental actions, and as a consequence AB InBev’s management cannot at this stage estimate the likely timing of resolution of these matters. The most significant contingencies are discussed below. Amounts have been converted to US dollar at the closing rate of the respective period.

AMBEV TAX MATTERS

As of 31 December 2021 and 31 December 2020, AB InBev’s material tax proceedings are related to Ambev and its subsidiaries. Estimates of amounts of possible loss are as follows:

 

Million US dollar

   31 December 2021      31 December 2020  
                   

Income tax and social contribution

     9 723        10 372  

Value-added and excise taxes

     4 285        4 483  

Other taxes

     663        727  
       14 671        15 582  

The most significant tax proceedings of Ambev are discussed below.

INCOME TAX AND SOCIAL CONTRIBUTION

Foreign Earnings

Since 2005, Ambev and certain of its subsidiaries have been receiving assessments from the Brazilian Federal Tax Authorities relating to the profits of its foreign subsidiaries. The cases are being challenged at both the administrative and judicial levels of the courts in Brazil.

The administrative proceedings have resulted in partially favorable decisions, which are still subject to review by the Administrative Court. In the judicial proceedings, Ambev has received favorable injunctions that suspend the enforceability of the tax credit, as well as favorable first level decisions, which remain subject to review by the second-level judicial court.

The updated assessed amount related to this uncertain tax position as of 31 December 2021 is approximately 7.5 billion Brazilian real (1.3 billion US dollar) and Ambev has not recorded any provisions in connection therewith as it considers the chance of loss to be possible. For proceedings where it considers the chance of loss to be probable, Ambev has recorded a provision in the total amount of 54 million Brazilian real (10 million US dollar).

Goodwill InBev Holding

In December 2011, Ambev received a tax assessment related to the goodwill amortization resulting from the InBev Holding Brasil S.A. merger with Ambev. At the administrative level, Ambev received partially favorable decisions at both the Lower and Upper Administrative Court. Ambev filed judicial proceedings to discuss the unfavorable portion of the decisions of the Lower and the Upper Administrative Court and requested injunctions to suspend the enforceability of the remaining tax credit, which were granted.

In June 2016, Ambev received a new tax assessment charging the remaining value of the goodwill amortization and filed a defense. Ambev received partially favorable decisions at the first level administrative court and Lower Administrative Court. Ambev filed a Special Appeal which was partially admitted and awaits judgment by the Upper Administrative Court. For the unfavorable portion of the decision which became final at the administrative level, Ambev filed a judicial proceeding requesting an injunction to suspend the enforceability of the remaining tax credit, which was granted.

 

AB InBev – Financial Report 2021 | 97


The updated assessed amount related to this uncertain tax position as of 31 December 2021 is approximately 10.4 billion Brazilian real (1.9 billion US dollar) and Ambev has not recorded any provisions for this matter as it considers the chances of loss to be possible. In the event Ambev is required to pay these amounts, AB InBev will reimburse the amount proportional to the benefit received by AB InBev pursuant to the merger protocol as well as the related costs.

Goodwill Beverage Associate Holding (BAH)

In October 2013, Ambev received a tax assessment related to the goodwill amortization resulting from the merger of Beverage Associates Holding Limited (“BAH”) into Ambev. The decision from the first level administrative court was unfavorable to Ambev. Ambev filed an appeal to the Lower Administrative Court against the decision, which was partially granted. Ambev and the tax authorities filed Special Appeals to the Upper Administrative Court, which are awaiting judgment.

In April and August 2018, Ambev received new tax assessments charging the remaining value of the goodwill amortization and filed defenses. In April 2019, the first level administrative court rendered unfavorable decisions to Ambev. As a result thereof, Ambev appealed to the Lower Administrative Court. In November and December 2019, Ambev received partially favorable decisions at the Lower Administrative Court and filed Special Appeals to the Upper Administrative Court. The Special Appeals filed in both tax assessments are awaiting judgment by the Upper Administrative Court.

The updated assessed amount related to this uncertain tax position as of 31 December 2021 is approximately 2.3 billion Brazilian real (0.4 billion US dollar). Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

Goodwill CND Holdings

In November 2017, Ambev received a tax assessment related to the goodwill amortization in calendar years 2012 to 2016 resulting from the merger of CND Holdings into Ambev. The decision from the first level administrative court was unfavorable to Ambev. Ambev filed an appeal to the Lower Administrative Court. In February 2020, the Lower Administrative Court rendered a partially favorable decision. Ambev and the tax authorities filed Special Appeals to the Upper Administrative Court. The Special Appeal filed by Ambev was partially admitted and is awaiting judgment.

The updated assessed amount related to this uncertain tax position as of 31 December 2021 is approximately 0.9 billion Brazilian real (0.2 billion US dollar). Ambev has not recorded any provisions for this matter as it considers the chances of loss to be possible.

Disallowance of financial expenses

In 2015, 2016 and 2020, Ambev received tax assessments related to the disallowance of alleged non-deductible expenses and the deduction of certain losses mainly associated to financial investments and loans. Ambev presented defenses and, in November 2019, received a favorable decision at the first level administrative court regarding the 2016 case, which is subject to mandatory review by the Lower Administrative Court. In June 2021, Ambev received a partially favorable decision for the 2020 case at the first level administrative court and filed an appeal to the Lower Administrative Court. The favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court. The 2015 case is still pending decision by the first level administrative court.

The updated assessed amount related to this uncertain tax position as of 31 December 2021 is approximately 5.0 billion Brazilian real (0.9 billion US dollar). Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

Disallowance of tax paid abroad

Since 2014, Ambev has been receiving tax assessments from the Brazilian Federal Tax Authorities, for calendar years as of 2007, related to the disallowance of deductions associated with alleged unproven taxes paid abroad by its subsidiaries and has been filing defenses. The cases are being challenged at both the administrative and judicial levels. In November 2019, the Lower Administrative Court rendered a favorable decision to Ambev in one of the cases (related to the 2010 tax period), which became definitive.

In January 2020, the Lower Administrative Court rendered unfavorable decisions regarding four of these assessments related to the periods of 2015 and 2016. In these cases, Ambev filed Special Appeals to the Upper Administrative Court which are pending judgment. With respect to the cases related to the periods of 2015 and 2016, tax assessments were filed to charge isolated fines due to the lack of monthly prepayments of income tax as a result of allegedly undue deductions of taxes paid abroad. In 2021, Ambev received unfavorable decisions from the first level administrative court in two of these assessments with respect to both the 2015 and 2016 isolated fine cases, and filed appeals in connection therewith, which are pending judgment by the Lower Administrative Court. There is a third tax assessment charging such isolated fine that awaits judgment by the first level administrative court.

The other cases are still awaiting final decisions at both administrative and judicial courts.

 

AB InBev – Financial Report 2021 | 98


The updated assessed amount as of 31 December 2021 is approximately 11.3 billion Brazilian real (2.0 billion US dollar). Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

This uncertain tax position continued to be applied by the Company impacting calendar years following those assessed (2018-2021). In a scenario Ambev is questioned on this matter for future periods, on the same basis and under the same arguments as the aforementioned tax assessments, Ambev management estimates that the outcome of such potential further assessments would be similar to the already assessed periods.

Presumed Profit

In April 2016, Arosuco (a subsidiary of Ambev) received a tax assessment regarding the use of the “presumed profit” method for the calculation of income tax and the social contribution on net profits instead of the “real profit” method. In September 2017, Arosuco received an unfavorable first level administrative decision and filed an appeal. In January 2019, the Lower Administrative Court rendered a favorable decision to Arosuco, which became definitive.

In March 2019, Ambev received a new tax assessment regarding the same subject and filed a defense. In October 2019, Arosuco received an unfavorable first level administrative decision and filed an appeal.

The updated assessed amount related to this uncertain tax position as of 31 December 2021 is approximately 0.5 billion Brazilian real (0.1 billion US dollar). Arosuco has not recorded any provisions for this matter as it considers the chance of loss to be possible.

Deductibility of IOC expenses

In November 2019, Ambev received a tax assessment from the Brazilian Federal Tax Authorities related to the interest on capital (“IOC”) deduction in 2014. The assessment refers primarily to the accounting and corporate effects of the restructuring carried out by Ambev in 2013 and the impact on the increase in the deductibility of IOC expenses. In August 2020, Ambev received a partially favorable decision at the first level administrative Court and filed an Appeal to the Lower Administrative Court, which awaits judgement. The favorable portion of the decision if subject to mandatory review by the Lower Administrative Court.

In December 2020, Ambev received a new tax assessment related to the deduction of the IOC in 2015 and 2016. The defense against such new tax assessment was filed by Ambev in January 2021. In June 2021, Ambev received a partially favorable decision and filed an appeal to the Lower Administrative Court, which also awaits judgment. Similar to the first tax assessment, the favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court.

The updated assessed amount as of 31 December 2021 is approximately 10.5 billion Brazilian real (1.9 billion US dollar). Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

The uncertain tax position continued to be adopted by Ambev as it also distributed IOC in the years following the assessed period (2017-2021) and deducted such amounts from its Corporate Income Taxes taxable basis. Therefore, in a scenario where the IOC deductibility would also be questioned for the period after 2016, on the same basis and arguments as the aforementioned tax assessments, Ambev management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

Disallowance on Income Tax deduction

In January 2020, Arosuco, a subsidiary of Ambev, received a tax assessment from the Brazilian Federal Tax Authorities regarding the disallowance of the income tax reduction benefit provided for in Provisional Measure No. 2199-14/2001, for calendar years 2015 to 2018, and an administrative defense was filed. In October 2020, the first level administrative Court rendered an unfavorable decision to Arosuco. Arosuco filed an appeal against the aforementioned decision and awaits judgment by the Lower Administrative Court. The updated assessed amount as of 31 December 2021 is approximately 2.1 billion Brazilian real (0.4 billion US dollar). Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

This uncertain tax position continued to be applied by the Company impacting calendar years following those assessed (2019-2021) in which it benefited from the income tax reduction provided for in Provisional Measure No. 2199-14/2001. In a scenario Arosuco is questioned on this matter for future periods, on the same basis and arguments as the aforementioned tax assessment, Arosuco management estimates that the outcome of such potential further assessments would be consistent to the already assessed periods.

ICMS VALUE ADDED TAX, EXCISE TAX (“IPI”) AND TAXES ON NET SALES

Manaus Free Trade Zone – IPI / Social contributions

In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/ or zero-rated from excise tax (“IPI”) and social contributions (“PIS/COFINS”). With respect to IPI, Ambev’s subsidiaries

 

AB InBev – Financial Report 2021 | 99


have been registering IPI presumed tax credits upon the acquisition of exempted goods manufactured therein. Since 2009, Ambev has been receiving a number of tax assessments from the Brazilian Federal Tax Authorities relating to the disallowance of such credits.

Ambev and its subsidiaries have also been receiving charges from the Brazilian Federal Tax Authorities in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI excise tax credits that are under discussion in these proceedings and (ii) PIS/COFINS amounts allegedly due on Arosuco’s remittance to Ambev subsidiaries.

In April 2019, the Federal Supreme Court (“STF”) announced its judgment on Extraordinary Appeal No. 592.891/SP and 596.614/SP, with binding effects, deciding on the rights of taxpayers registering IPI excise tax presumed credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, Ambev reclassified part of the amounts related to the IPI cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF. The cases are being challenged at both the administrative and judicial levels.

Ambev management estimates the possible loss related to these assessments to be approximately 4.9 billion Brazilian real (0.9 billion US dollar) as of 31 December 2021. Ambev has not recorded any provision in connection therewith.

IPI Suspension

In 2014 and 2015, Ambev received tax assessments from the Brazilian Federal Tax Authorities relating to IPI allegedly due over remittances of manufactured goods to other related factories. The cases are being challenged at both the administrative and judicial levels. In 2020, Ambev received a final partial favorable decision at the administrative level in one of the cases. The cases which are being challenged at the judicial level are still at an initial stage.

Ambev management estimates the possible loss related to these assessments to be approximately 1.6 billion Brazilian real (0.3 billion US dollar) as of 31 December 2021. Ambev has not recorded any provision in connection therewith.

ICMS tax credits

Ambev is currently challenging tax assessments issued by the states of São Paulo, Rio de Janeiro, Minas Gerais, among others, questioning the legality of ICMS tax credits arising from transactions with companies that have tax incentives granted by other states. The cases are being challenged at both the administrative and judicial level of the courts. On August 2020, the STF issued a binding decision (Extraordinary Appeal No. 628.075) ruling that tax credits granted by the states in the context of the ICMS tax war shall be consider unlawful. The decision also recognized that the states should abide by the tax incentives validation process provided for in Complementary Law No. 160/17. This decision is subject to appeal and does not change the likelihood of loss in Ambev´s tax assessments.

Ambev management estimates the possible losses related to these assessments to be approximately 2.0 billion Brazilian real (0.4 billion US dollar) as of 31 December 2021. Ambev has not recorded any provision in connection therewith.

ICMS-ST Trigger

Over the years, Ambev has received tax assessments to charge supposed ICMS differences considered due when the price of the products sold by Ambev is above the fixed price table basis established by the relevant states, cases in which the state tax authorities understand that the calculation basis should be based on a value-added percentage over the actual prices and not the fixed table price. Ambev is currently challenging those charges before the courts. The cases are being challenged at both the administrative and judicial levels.

Ambev management estimates the total possible loss related to this issue to be approximately 8.4 billion Brazilian real (1.5 billion US dollar) as of 31 December 2021. Ambev has not recorded any provisions for this matter as it considers the chance of loss to be possible.

SOCIAL CONTRIBUTIONS

Since 2015, Ambev has received tax assessments issued by the Brazilian Federal Tax Authorities relating to PIS/COFINS amounts allegedly due over bonus products granted to its customers. The cases are being challenged at both the administrative and judicial levels of the courts. In 2019 and 2020, Ambev received final favorable decisions at the administrative level in some of these cases and favorable decisions in other cases that are still subject to review. At the judicial level, one case is pending decision by the second level judicial court after the first level judicial court rendered an unfavorable decision to Ambev.

Ambev management estimates the possible loss related to these assessments to be approximately 1.8 billion Brazilian real (0.3 billion US dollar) as of 31 December 2021. No related provision has been made.

 

AB InBev – Financial Report 2021 | 100


AB INBEV’S AUSTRALIAN BUSINESS TAX MATTERS

SAB Australia Pty Limited (“SAB Australia”), a former subsidiary of AB InBev, received a tax assessment for the 2012 to 2014 income tax years for 0.4 billion Australian dollar (0.3 billion US dollar) related to the interest deductions of SAB’s acquisition of the Foster’s group (the “Foster’s acquisition”). AB InBev is disputing the 2012 to 2014 assessment and remains confident of the positions it has adopted. The company paid 47 million US dollar related to the tax assessment pending conclusion of the matter and recorded a provision of 0.1 billion US dollar in connection therewith as of 31 December 2021. The Australia disposal was concluded on 1 June 2020 with pre-transaction income tax liabilities being subject to an indemnity by AB InBev.

The Australian tax authorities have also notified SAB Australia that it has commenced an audit of the 2015 to 2020 income tax years. The focus of the audit is the tax treatment of the funding arrangements associated with the Foster’s acquisition.

OTHER TAX MATTERS

In February 2015, the European Commission opened an in-depth state aid investigation into the Belgian excess profit ruling system. On 11 January 2016, the European Commission adopted a negative decision finding that the Belgian excess profit ruling system constitutes an aid scheme incompatible with the internal market and ordering Belgium to recover the incompatible aid from a number of aid beneficiaries. The Belgian authorities contacted the companies that had benefitted from the system and advised each company of the amount of incompatible aid that is potentially subject to recovery. The European Commission’s decision was appealed to the European Union’s General Court by Belgium on 22 March 2016 and by AB InBev on 12 July 2016. On 14 February 2019, the European General Court concluded that the Belgian excess profit ruling system does not constitute illegal state aid. The European Commission appealed the judgment to the European Court of Justice. The public hearing in the framework of the appeal proceedings took place on 24 September 2020 and AB InBev was heard as an intervening party.

On 3 December 2020, the Advocate General (AG) of the European Court of Justice presented her non-binding opinion on the appeal procedure related to the 11 January 2016 opening decision, stating that, contrary to the 14 February 2019 judgment of the European General Court, the Belgian excess profit ruling system would fulfil the legal requirements for an “aid scheme”. In the initial European General Court judgment, the court limited itself to finding the Belgian excess profit rulings were not an “aid scheme”, but did not consider whether they constituted State aid. Consequently, the AG advised the European Court of Justice to refer the case back to the European General Court to review whether the Belgian excess profit rulings constitute State aid. On 16 September 2021, the European Court of Justice agreed with the AG and concluded that the excess profit ruling system constitutes an aid scheme and set aside the judgment of the European General Court. The case has been referred back to the European General Court to decide whether the Belgian excess profit ruling system constitutes illegal State aid as well as the other remaining open issues in the appeal.

Following the initial annulment of the European Commission’s decision by the European General Court in 2019, the European Commission opened new state aid investigations into the individual Belgian tax rulings, including the one issued to AB InBev in September 2019, to remedy the concerns that had led to the annulment. These investigations relate to the same rulings that were the subject of the European Commission’s decision issued on 11 January 2016. AB InBev has filed its observations in respect of the opening decisions with the European Commission. On 28 October 2021, the European Commission stayed the new state aid investigations into the individual Belgian tax rulings pending final resolution of the case.

In addition, the Belgian tax authorities have also questioned the validity and the actual application of the excess profit ruling that was issued in favor of AB InBev and have refused the actual tax exemption which it confers. AB InBev has filed a court claim against such decision before the Brussels court of first instance which ruled in favor of AB InBev on 21 June 2019, and again on 9 July 2021 for subsequent years. The Belgian tax authorities appealed both judgments.

In January 2019, AB InBev deposited 68m euro (77m US dollar) on a blocked account. Depending on the final outcome of the European Court procedures on the Belgian excess profit ruling system, as well as the pending Belgian court cases, this amount will either be slightly modified, or released back to the company or paid over to the Belgian State. In connection with the European Court procedures, AB InBev recognized a provision of 68m euro (77m US dollar) in 2020.    

WARRANTS

Certain holders of warrants issued by Ambev in 1996 for exercise in 2003 proposed lawsuits to subscribe correspondent shares for an amount lower than Ambev considers as established upon the warrant issuance. In case Ambev loses the totality of these lawsuits, the issuance of 172,831,574 shares would be necessary. Ambev would receive in consideration funds that are materially lower than the current market value. This could result in a dilution of about 1% to all Ambev shareholders. Furthermore, the holders of these warrants are claiming that they should receive the dividends relative to these shares since 2003, approximately 1.0 billion Brazilian real (0.2 billion US dollar) in addition to legal fees. Ambev

 

AB InBev – Financial Report 2021 | 101


disputes these claims and intends to continue to vigorously defend these cases. All six lawsuits were ruled favorably to Ambev by the Superior Court of Justice (“STJ”). Three cases were dismissed by the STJ’s Special Court and will no longer be remitted to the STJ’s lower court for a new judgment. Although the motions for clarification that were filed against the STJ’s Special Court decision were dismissed, new appeals have been filed in three of these cases with the Brazilian Supreme Court (“STF”), which will decide if the appeals meet the constitutional requirements for admissibility, particularly the requirement for a constitutional issue of general repercussion. In parallel, in one of these cases (Previ/Funcef), the plaintiffs have instituted a claim requesting suspension of the effects of the decision that dismissed the motion for clarification until the appeal is decided. The claim is pending, but has no practical effect on the case. In addition, the Reporting Justice of this case (Previ/Funcef) has suspended the appeal to STF and ordered for the case to be remitted to STF’s Conciliation and Mediation Center, although Ambev has previously informed the court that it has no interest in any settlement discussion with the plaintiffs. The fourth case was ruled favorably to Ambev by the STJ’s Special Court and the judgment became final. The fifth case was remitted to the STJ’s lower court for a new judgment and the sixth case was ruled favorably to Ambev and the decision became final. Considering all of these facts, Ambev and its external counsels strongly believe that the chance of loss in these cases is remote.

 

AB InBev – Financial Report 2021 | 102


31. Non-controlling interests

As at 31 December 2021 and 2020, material non-controlling interests relate to Ambev, a Brazilian listed subsidiary in which AB InBev has 61.79% ownership, and Budweiser APAC, an Asia Pacific listed subsidiary in which AB InBev has 87.22% ownership. The tables below provide summarized information derived from the consolidated financial statements of Ambev and Budweiser APAC as of 31 December 2021 and 2020, in accordance with IFRS.

Summarized financial information of Ambev and Budweiser APAC, in which the company has material non-controlling interests, is as follows:

 

     Ambev      Budweiser APAC  
  Million US dollar    31 December 2021      31 December 2020      31 December 2021      31 December 2020  

            

                                   

  Summarized balance sheet information

                                   

  Current assets

     6 922        6 801        3 161        2 332  

  Non-current assets

     17 915        17 291        13 464        13 857  

  Current liabilities

     6 965        6 442        4 691        4 637  

  Non-current liabilities

     2 817        3 188        851        809  

  Equity attributable to equity holders

     14 809        14 204        11 013        10 685  

  Non-controlling interests

     246        257        70        58  
     Ambev      Budweiser APAC  
  Million US dollar    2021      2020      2021      2020  

            

                                   

  Summarized income statement and

                                   

  other comprehensive income information

                                   

  Revenue

     13 570        11 373        6 788        5 588  

  Net income

     2 444        2 286        981        537  

            

                                   

  Attributable to:

                                   

  Equity holders

     2 360        2 217        950        514

  Non-controlling interests

     84        69        31        23  

            

                                   

  Net income

     2 444        2 286        981        537  

  Other comprehensive income

     629        1 467        (289)        635  

  Total comprehensive income

     3 074        3 753        692        1 172  

            

                                   

  Attributable to:

                                   

  Equity holders

     2 970        3 647        660        1 147  

  Non-controlling interests

     104        106        32        25  

            

                                   

  Summarized cash flow information

                                   

  Cash flow from operating activities

     4 266        3 673        1 903        1 301  

  Cash flow from investing activities

     (1 441)        (1 325)        (731)        (572)  

  Cash flow from financing activities

     (2 988)        (1 676)        (464)        (432)  

  Net increase/(decrease) in cash and cash equivalents

     (163)        673        708        297  

Dividends paid by Ambev and its subsidiaries to non-controlling interests (i.e., to entities outside the AB InBev Group) amounted to 0.8 billion US dollar and 0.7 billion US dollar for 2021 and 2020, respectively. In 2021, Budweiser APAC and its subsidiaries paid a final dividend related to the financial year 2020 to non-controlling interests amounting to 67m US dollar (2020: 59m US dollar).

On 31 December 2020, the company completed the issuance of a 49.9% minority stake in its US-based metal container operations to Apollo Global Management, Inc. (“Apollo”) for net proceeds of 3.0 billion USD. AB InBev retained operational control of its US-based metal container operations. The transaction was reported in the equity statement.

Other non-controlling interests not deemed individually material by the company mainly related to the company’s operations in Africa in association with the Castel Group (e.g., Botswana, Ghana, Mozambique, Nigeria, Tanzania, Uganda and Zambia), as well as non-controlling interests recognized in respect of the company’s subsidiaries in Colombia, Ecuador and Peru.

 

AB InBev – Financial Report 2021 | 103


32. Related parties

TRANSACTIONS WITH DIRECTORS AND EXECUTIVE COMMITTEE MEMBERS (KEY MANAGEMENT PERSONNEL)

AB InBev’s Executive Committee members’ compensation consists of short-term employee benefits (primarily salaries) and post-employment benefits from pension plans of their respective country – see also Note 24 Employee Benefits. Key management personnel are also eligible for the company’s share option; restricted stock and/or share swap program (see Note 25 Share-based Payments). Total directors and Executive Committee compensation included in the income statement can be detailed as follows:

 

     2021      2020  
  Million US dollar    Directors      Executive
Committee1
     Directors      Executive
Committee
 
                                            

  Short-term employee benefits

     2        24        2        4  

  Termination benefits

     -        -        -        2  

  Share-based payment

     -        33        -        7  
       2        57        2        13  

Directors’ compensation consists mainly of directors’ fees.

During 2021, AB InBev entered into the following transactions:

 

   

The acquisition, through Grupo Modelo and its subsidiaries, of information technology and infrastructure services for a consideration of approximately 1m US dollar from a company in which one of the company’s Board Member had significant influence as of 31 December 2021 (2020: 1m US dollar).

 

   

The lease of commercial premises from and the sale of malt-based beverages and beer to companies in which one of the company’s Board Member had a significant influence as of 31 December 2021. The transactions happened mainly through AB InBev’s subsidiary Bavaria S.A. for an aggregated consideration of approximately 19m US dollar (2020: 13m US dollar). The outstanding balance of these transactions as of 31 December 2021 amounts to 3m US dollar (31 December 2020: 3m US dollar).

JOINTLY CONTROLLED ENTITIES

Significant interests in joint ventures include three entities in Brazil, one in Mexico and one in Canada. None of these joint ventures are material to the company. Aggregate amounts of AB InBev’s interest are as follows:

 

  Million US dollar    2021      2020  

            

                 

  Non-current assets

     8        8  

  Current assets

     2        2  

  Non-current liabilities

     9        9  

  Current liabilities

     2        12  

  Result from operations

     (3)        3  

  Profit attributable to equity holders of AB InBev

     (2)        3  

TRANSACTIONS WITH ASSOCIATES

Significant interests in associates are shown in note 16 Investments in associates. AB InBev’s transactions with associates were as follows:

 

  Million US dollar    2021      2020  

            

                 

  Gross profit

     58        (118)  

  Current assets

     57        55  

  Current liabilities

     99        115  

TRANSACTIONS WITH PENSION PLANS

AB InBev’s transactions with pension plans mainly comprise (12)m US dollar other expense to pension plans in the US in 2021 (2020: (12)m US dollar).

 

                                                     

1 The 2021 Executive Committee members’ compensation includes the cost reported for AB InBev’s former CEO up to 30 June 2021 and the costs for the newly appointed CEO for the full year 2021.

 

AB InBev – Financial Report 2021 | 104


33. Events after the balance sheet date

On 10 January 2022, Anheuser-Busch InBev SA/NV (AB InBev) announced that its wholly-owned subsidiary Anheuser-Busch InBev Finance Inc. (“ABIFI”) will exercise its respective option to redeem the outstanding principal amounts for an aggregate principal amount of 3.1 billion US dollar of the following series of notes:

 

  Date of
  redemption
   Issuer
(abbreviated)
   Title of series of notes
issued redeemed
   Currency   

Original
principal amount
outstanding

(in million)

  

Principal amount
redeemed

(in million)

                          

  9 February 2022

   ABIFI    3.650% Notes due 2026    USD    1 633    1 633

  1 March 2022

   ABIFI    4.915% Notes due 2046    USD    1 470    1 470

 

  AB InBev – Financial Report 2021    105  


34. AB InBev companies

Listed below are the most important AB InBev companies. A complete list of the company’s investments is available at AB InBev NV, Brouwerijplein 1, B-3000 Leuven, Belgium.

LIST OF MOST IMPORTANT FULLY CONSOLIDATED COMPANIES

 

  Name and registered office of fully consolidated companies   

% of economic interest

as at

31 December 2021

 
          

ARGENTINA

        

CERVECERIA Y MALTERIA QUILMES SAICA Y G - Charcas 5160 - C1425BOF - Buenos Aires

     61.64%  
          

BELGIUM

        

AB-INBEV N.V - Grand Place 1 - 1000 - Brussel

     Consolidating  

BRASSERIE DE L’ABBAYE DE LEFFE S.A. - Place de l’Abbaye, 1 - 5500 - Dinant

     98.54%  

BROUWERIJ VAN HOEGAARDEN N.V. - Stoopkensstraat 46 - 3320 - Hoegaarden

     100.00%  

COBREW N.V - Brouwerijplein 1 - 3000 - Leuven

     100.00%  

INBEV BELGIUM BV/SRL - Boulevard Industriel 21 - 1070 - Brussel

     100.00%  
          

BOTSWANA

        

KGALAGADI BREWERIES (PTY) LIMITED - Plot 20768, Kudu Road, Broadhurst Industrial Estate – Gaborone1

     31.06%  
          

BOLIVIA

        

CERVECERÍA BOLIVIANA NACIONAL S.A. - Av. Montes 400 and Calle Chuquisaca No. 121, Zona Challapampa - La Paz

     52.73%  
          

BRAZIL

        

AMBEV S.A. - Rua Dr. Renato Paes de Barros, 1017 - 3° floor - Itaim Bibi - CEP 04530-001 - Sao Paulo

     61.79%  
          

CANADA

        

LABATT BREWING COMPANY LIMITED - 207 Queen’s Quay West, Suite 299 - M5J 1A7 - Toronto

     61.79%  
          

CHILE

        

CERVECERIA CHILE S.A. - Av. Presidente Eduardo Frei Montalva 9600, Quilicura - 8700000 - Santiago de Chile

     61.79%  
          

CHINA

        

ANHEUSER-BUSCH INBEV (CHINA) SALES CO. LTD. - Shangshou, Qin Duan Kou, Hanyang Area - 430051 - Wuhan City, Hubei Province

     87.22%  

ANHEUSER-BUSCH INBEV (WUHAN) BREWERY CO. LTD. - Shangshou, Qin Duan Kou, Hanyang Area - 430051 - Wuhan City, Hubei Province

     84.66%  

ANHEUSER-BUSCH INBEV (FOSHAN) BREWERY CO. LTD. - 1 Budweiser Avenue, Southwest St., Sanshui District - 528132 - Foshan City, Guangdong

     87.22%  

ANHEUSER-BUSCH INBEV HARBIN BREWERY CO. LTD. - 9 Hapi Road, Pingfang district - 150066 - Harbin City, Heilongijang Province

     87.22%  

ANHEUSER-BUSCH INBEV (TANGSHAN) BREWERY CO. LTD. - 18, Yingbin Road - 063300 - Tangshan City, Hebei Province

     87.22%  

ANHEUSER-BUSCH INBEV SEDRIN BREWERY CO. LTD. - No.1 West Xuejin Avenue,Hanjiang District - 351111 - Putian City, Fujian Province

     87.22%  

ANHEUSER-BUSCH INBEV SEDRIN (ZHANGZHOU) BREWERY CO. LTD. - Lantian Economic District - 363005 - Zhangzhou City, Fujian Province

     87.22%  

ANHEUSER-BUSCH INBEV (TAIZHOU) BREWERY CO. LTD. - 159 Qi Xia East Road, Chengguan Town, Tiantai County - 317200 - Taizhou Cithy, Zhejiang Province

     87.22%  

ANHEUSER-BUSCH INBEV SEDRIN (NANCHANG) BREWERY CO. LTD. - 1188 Jinsha Avenue, Economic District - Nanchang City, Jiangxi Province

     87.22%  

SIPING GINSBER DRAFT BEER CO. LTD. - Xianmaquan, Tiedong Area - Siping City, Jilin Province

     87.22%  

ANHEUSER-BUSCH INBEV (NANTONG) BREWERY CO. LTD. - 666 Zhaoxia Road - Nantong City, Jiangsu Province

     87.22%  

ANHEUSER-BUSCH INBEV (SICHUAN) BREWERY CO. LTD. - No. 1, AB InBev Avenue, Cheng Nan Industry Park, Economic Development Area - 641300 - Ziyang City, Sichuan Province

     87.22%  

ANHEUSER-BUSCH INBEV (HENAN) BREWERY CO. LTD. - No. 1 Budweiser Avenue, Industry Park, Tangzhuang Town - 453100 - Weihui City, Henan Province

     87.22%  

 

                                                 

1 The group’s shares entitle the holder to twice the voting rights.

 

AB InBev – Financial Report 2021 | 106


  Name and registered office of fully consolidated companies    % of economic interest
as at 31 December
2021
 
          

INBEV JINLONGQUAN (HUBEI) BREWERY CO. LTD. - 89 Jin Long Quan Avenue - Jingmen City, Hubei Province

     52.33%  

ANHEUSER-BUSCH INBEV (SUQIAN) BREWERY CO. LTD. - No 1 Qujiang Road, Suyu Industry Park - Suqian City, Jiangsu Province

     87.22%  

ANHEUSER-BUSCH INBEV SEDRIN BREWERY CO. LTD. - No.1 West Xuejin Avenue, Hanjiang District - 351111 - Putian City, Fujian Province

     87.22%  

ANHEUSER-BUSCH INBEV (WENZHOU) BREWERY CO. LTD. - No. 5108 Management Office, MingZhu Road, Binghai District, Development Zone - 325025 - Wenzhou City, Zhejiang Province

     87.22%  

BLUE GIRL BEER (GUANGZHOU) COMPANY LIMITED - Units 2101,21/F, Tower A, China International Centre, 33 Zhongshan San Road - 510000 - Guangzhou City

     56.69%  
          

COLOMBIA

        

ZX VENTURES COLOMBIA S.A.S. - Carrera 53 A, No 127 - 35 - 110221 - Bogota

     100.00%  

BAVARIA & CIA S.A.S. - Carrera 53 A, No 127 - 35 - 110221 - Bogota

     99.16%  

KOPPS COMERCIAL S.A.S. - Carrera 53 A, No 127 - 35 - 110221 - Bogota

     100.00%  

CERVECERIA DEL VALLE - Calle 15, No. 25 A37 Autopista, Cali-Yumbo - 760507 - Yumbo

     100.00%  

CERVECERIA UNION - Cra 50 A #38-39, Itagui - 55412 - Itaguí

     99.14%  
          

CZECH REPUBLIC

        

PIVOVAR SAMSON A.S. - Lidická 458 - 370 01 - České Budějovice

     100.00%  

ANHEUSER-BUSCH INBEV CZECH S.R.O. - Vyskočilova 1422/1A - 140 00 - Praha 4-Michle

     100.00%  
          

DOMINICAN REPUBLIC

        

CERVECERIA NACIONAL DOMINICANA S.A. - Autopista 30 de Mayo Km 61/2, Distrito Nacional - A.P. 1086 - Santo Domingo1

     52.52%  
          

ECUADOR

        

CERVECERÍA NACIONAL (CN) S.A. - Via a daule km 16,5 y calle cobre s/n - Guayaquil, Guayas

     95.58%  
          

EL SALVADOR

        

INDUSTRIAS LA CONSTANCIA S.A. DE C.V. - Avenida Independencia, No 526 - San Salvador

     100.00%  
          

FRANCE

        

AB INBEV FRANCE S.A.S. - Immeuble Crystal, 38, Place Vauban - C.P. 59110 - La Madeleine

     100.00%  
          

GERMANY

        

BRAUEREI BECK GMBH & CO. KG - Am Deich 18/19 - 28199 - Bremen

     100.00%  

BRAUEREI DIEBELS GMBH & CO. KG - Brauerei-Diebels-Straße 1 - 47661 - Issum

     100.00%  

HAAKE-BECK AG - Am Deich 18/19 - 28199 - Bremen

     99.96%  

HASSERÖDER BRAUEREI GMBH. - Auerhahnring 1 - 38855 - Wernigerode

     100.00%  

ANHEUSER-BUSCH INBEV GERMANY HOLDING GMBH. - Am Deich 18/19 - 28199 - Bremen

     100.00%  

SPATEN-FRANZISKANER-BRÄU GMBH. - Marsstrasse 46 + 48 - 80335 - München

     100.00%  

ANHEUSER-BUSCH INBEV DEUTSCHLAND GMBH & CO. KG - Am Deich 18/19 - 28199 - Bremen

     100.00%  

LÖWENBRÄU AG - Nymphenburger Str. 7 - 80335 - München

     100.00%  
          

GHANA

        

ACCRA BREWERY PLC - Farra Avenue 20 1st Floor, Pkf Building - P.O. Box GP1219 - Accra

     59.89%  
          

GRAND DUCHY OF LUXEMBOURG

        

BRASSERIE DE LUXEMBOURG MOUSEL - DIEKIRCH - Rue de la Brasserie, 1 - L-9214 - Diekirch

     95.82%  
          

HONDURAS

        

CERVECERÍA HONDUREÑA S.A. DE C.V. - Blvd. Del Norte, Carretera Salida a Puerto Cortes - San Pedro Sula

     99.60%  
          

HONG KONG

        

BUDWEISER BREWING COMPANY APAC LIMITED - Suites 3012-16, Tower Two, Times Square, 1 Matheson Street, Causeway Bay - Hong Kong

     87.22%  

 

                                                 

1 85% owned by Ambev S.A.

 

  AB InBev – Financial Report 2021    107  


  Name and registered office of fully consolidated companies    % of economic interest
as at 31 December
2021
 
          

INDIA

        

CROWN BEERS INDIA LIMITED. - 510/511, Minerva House, Sarojini Devi Road - 500003 - Secunderabad, Telangana

     87.22%  

ANHEUSER BUSCH INBEV INDIA LIMITED. - Unit No.301-302, Dynasty Business Park, 3rd Floor Andheri - Kurla Road, Andheri (East) - 400059 - Mumbai, Maharashtra

     87.05%  
          

ITALY

        

ANHEUSER-BUSH INBEV ITALIA S.P.A. - Via Fratelli Castiglioni, 8 - 20214 - Milano

     100.00%  
          

MEXICO

        

CERVECERIA MODELO DE MEXICO S. DE R.L. DE C.V. - Cerrada de Palomas 22, Piso 6, Reforma Social - C.P. 11650 - Mexico City, CD MX

     100.00%  

COMPANIA CERVECERA DE ZACATECAS S. DE R.L. DE C.V. - Blvd. Antonino Fernandez Rodriguez n° 100 - C.P. 98500 - Calera de Victor Rosales, Zacatecas

     100.00%  
          

MOZAMBIQUE

        

CERVEJAS DE MOÇAMBIQUE SA - Rua do Jardim 1329 - Maputo

     51.47%  
          

THE NETHERLANDS

        

INBEV NEDERLAND N.V. - Ceresstraat 1 - 4811 CA - Breda

     100.00%  

INTERBREW INTERNATIONAL B.V. - Ceresstraat 1 - 4811 CA - Breda

     100.00%  

AB INBEV AFRICA B.V. - Ceresstraat 1 - 4811 CA - Breda

     62.00%  
          

NIGERIA

        

INTERNATIONAL BREWERIES PLC - 22/36 Glover Road, Lagos, Ikoyi, Nigeria - Lagos1

     43.00%  
          

PANAMA

        

CERVECERÍA NACIONAL S DE RL - Ave. Ricardo J. Alfaro, Corregimiento de Betania, Distrito de Panamá, - Panama City

     61.79%  
          

PARAGUAY

        

CERVECERÍA PARAGUAYA S.A. - Ruta Villeta km 30 N 3045 - 2660 - Ypané

     53.98%  
          

PERU

        

COMPANIA CERVECERA AMBEV PERU S.A.C. - Av. Los Laureles Mza. A Lt. 4 del Centro Poblado Menor Santa Maria de Huachipa - Lurigancho (Chosica) - 15 - Lima

     97.22%  

UNIÓN DE CERVECERÍAS PERUANAS BACKUS Y JOHNSTON S.A.A. - 3986 Av. Nicolas Ayllon, Ate - 3 - Lima

     93.78%  
          

SPAIN

        

COMPAÑÍA CERVECERA DE CANARIAS, S.A. - Av Ángel Romero, 18 - 38009 - Santa Cruz de Tenerife

     51.03%  
          

SOUTH AFRICA

        

SABSA HOLDINGS LTD PUBLIC LIMITED COMPANY - 65 Park Lane, Sandown - 2001 - Johannesburg

     100.00%  

THE SOUTH AFRICAN BREWERIES (PTY) LTD LIMITED BY SHARES - 65 Park Lane, Sandown - 2146 - Johannesburg

     100.00%  
          

SOUTH KOREA

        

ORIENTAL BREWERY CO. LTD. - 8F, ASEM Tower, 517, Yeongdong-daero, Gangnam-gu - 06164 - Seoul

     87.22%  
          

SWITZERLAND

        

ANHEUSER-BUSCH INBEV PROCUREMENT GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG (GMBH) - Suurstoffi 22 - 6343 - Rotkreuz

     100.00%  
          

TANZANIA

        

TANZANIA BREWERIES PLC - Uhuru Street, Plot 79, Block AA - P.O. Box 9013 - Dar es Salaam1

     39.65%  
          

UGANDA

        

NILE BREWERIES LTD - Plot M90 Yusuf Lule Road, Njeru - P.O. Box 762 - Jinja - Eastern Uganda

     61.64%  

 

                                                         

1 The company is consolidated due to the group’s majority shareholdings and ability to control the operations.

 

AB InBev – Financial Report 2021 | 108


  Name and registered office of fully consolidated companies   

% of economic interest
as at

31 December 2021

 
          

UNITED KINGDOM

        

ABI SAB GROUP HOLDING LIMITED - Bureau, 90 Fetter Lane - EC4A 1EN - London

     100.00%  

ABI UK HOLDING 1 LIMITED - Bureau, 90 Fetter Lane - EC4A 1EN - London

     100.00%  

AB INBEV UK LIMITED - Bureau, 90 Fetter Lane - EC4A 1EN - London

     100.00%  

AB INBEV HOLDINGS LIMITED - Bureau, 90 Fetter Lane - EC4A 1EN - London

     100.00%  

AB INBEV INTERNATIONAL BRANDS LIMITED - Bureau, 90 Fetter Lane - EC4A 1EN - London

     100.00%  

ZX VENTURES LIMITED - Bureau, 90 Fetter Lane - EC4A 1EN - London

     100.00%  
          

UNITED STATES

        

ANHEUSER-BUSCH COMPANIES, LLC. - One Busch Place - MO 63118 - St. Louis

     100.00%  

ANHEUSER-BUSCH INTERNATIONAL, INC. - One Busch Place - MO 63118 - St. Louis

     100.00%  

ANHEUSER-BUSCH PACKAGING GROUP, INC. - One Busch Place - MO 63118 - St. Louis

     100.00%  

ANHEUSER-BUSCH, LLC. - One Busch Place - MO 63118 - St. Louis

     100.00%  

ANHEUSER-BUSCH NORTH AMERICAN HOLDING CORPORATION - C/O THE CORPORATION TRUST COMPANY, INC. - 1209 Orange Street - DE 19801 - Wilmington

     100.00%  

METAL CONTAINER CORPORATION, INC. - One Busch Place - MO 63118 - St. Louis

     50.10%  
          

URUGUAY

        

CERVECERIA Y MALTERIA PAYSANDU S.A. - Cesar Cortinas, 2037 - C.P. 11500 - Montevideo

     61.75%  
          

VIETNAM

        

ANHEUSER-BUSCH INBEV VIETNAM BREWERY COMPANY LIMITED - 2 VSIP II-A, Street No. 28 - Singapore II-A Industrial Park, Vinh Tan Ward - Tan Uyen Town, Binh Duong Province

     87.22%  
          

ZAMBIA

        

ZAMBIAN BREWERIES - Plot No 6438, Mungwi Road - P.O. Box 31293 - Lusaka

     54.00%  

LIST OF MOST IMPORTANT ASSOCIATES AND JOINT VENTURES

 

  Name and registered office of associates and joint ventures   

% of economic interest
as at

31 December 2021

 

FRANCE

        

SOCIÉTÉ DES BRASSERIES ET GLACIÈRES INTERNATIONALES S.A - 49 rue François 1er - Paris

     20.00%  
          

GIBRALTAR

        

B.I.H. BRASSERIES INTERNATIONALES HOLDING LIMITED LIMITED - ICC Building, 10th Floor, Main Street

     20.00%  

B.I.H. BRASSERIES INTERNATIONALES HOLDING (ANGOLA) LIMITED - Suite 10/3, International Commercial Centre, 2A Main Street

     27.00%  
          

TURKEY

        

ANADOLU EFES BIRACILIK VE MALT SANAYII A.S. - Bahçelievler Mahallesi, Sehit Ibrahim Koparir Caddesi No. 4, Bahçelievler - Istanbul

     24.00%  
          

ZIMBABWE

        

DELTA CORPORATION LIMITED - Sable House, Northridge Close, Borrowdale - P.O. Box BW 343 - Harare

     25.42%  
          

RUSSIA

        

AB INBEV EFES JSC - 28 Moskovskaya street, Moscow region - 141607 - Klin

     50.00%  

 

AB InBev – Financial Report 2021 | 109


Information to our shareholders

Earnings, dividends, share and share price

 

      2021      2020      2019      2018
restated
     2017
restated
 

            

                                            

  Cash flow from operating activities (US dollar per share)

     7.37        5.45        6.75        7.18        7.56  

  Normalized earnings per share (US dollar per share)

     2.85        1.91        4.08        3.16        3.75  

  Dividend (euro per share)

     0.5        0.5        1.3        1.8        3.6  

            

                                            

  Share price high (euro per share)

     65.34        74.49        92.71        96.7        110.1  

  Share price low (euro per share)

     47.00        30.97        57.47        56.84        92.88  

  Year-end share price (euro per share)

     53.17        57.01        72.71        57.7        93.13  

            

                                            

  Weighted average number of ordinary and restricted shares (million shares)

     2 007      1 998      1 984      1 975      1 971

  Diluted weighted average number of ordinary and restricted shares (million shares)

     2 045      2 037      2 026      2 014      2 010

  Volume of shares traded (million shares)

     416      587      452      496      349

Information on the auditors’ assignments and related fees

AB InBev’s Statutory auditor is PwC Bedrijfsrevisoren BV, represented by Koen Hens, audit partner.

Base fees for auditing the annual financial statements of AB InBev and its subsidiaries are determined by the shareholders meeting after review and approval by the company’s Audit Committee and Board of Directors.

Fees for 2021 in relation to services provided by PwC Bedrijfsrevisoren BV amounted to 2 617k US dollar (2020: 2 866k US dollar), which was composed of audit services for the annual financial statements of 2 512k US dollar (2020: 2 603k US dollar) and audit related services of 105k US dollar (2020: 262k US dollar).

Fees for 2021 in relation to services provided by other offices in the PwC network amounted to 16 198k US dollar (2020: 17 134k US dollar), which was composed of audit services for the annual financial statements of 13 191k US dollar (2020: 13 301k US dollar), tax services of 2 648k US dollar (2020: 3 317k US dollar), audit related services amounting to 281k US Dollar (2020: 111k US dollar) and other services amounting 78k US dollar (2020: 404k US dollar), all of which have been pre-approved by the company’s Audit Committee.

Financial calendar

 

  Publication of 2021 results    24 February 2022
  Annual report 2021 available on www.ab-inbev.com    24 February 2022
  General shareholders meeting    27 April 2022
  Dividend: ex-coupon date    3 May 2022
  Publication of first quarter results    5 May 2022
  Publication of half year results    28 July 2022
  Publication of third quarter results    27 October 2022

 

AB InBev – Financial Report 2021 | 110


Investor relations contact

 

Investors

  Media
     

Shaun Fullalove

 

Kate Laverge

Tel: +1 212 573 9287

 

Tel: +1 917 940 7421

E-mail: shaun.fullalove@ab-inbev.com

 

E-mail: kate.laverge@ab-inbev.com

     

Marya Glukhova

  Ana Zenatti

Tel: +32 16 276 888

 

Tel: +1 646 249 5440

E-mail: mariya.glukhova@ab-inbev.com

 

E-mail: ana.zenatti@ab-inbev.com

     

Cyrus Nentin

   

Tel: +1 646 746 9673

   

E-mail: cyrus.nentin@ab-inbev.com

   

 

AB InBev – Financial Report 2021 | 111


Excerpt from the AB InBev NV/SA separate (non-consolidated) financial statements prepared in accordance with Belgian GAAP

 

 

The following information is extracted from the separate Belgian GAAP financial statements of AB InBev NV/SA per 31 December 2021. These separate financial statements, together with the management report of the Board of Directors to the general assembly of shareholders as well as the auditor’s report, will be filed with the National Bank of Belgium within the legally foreseen time limits. These documents are also available on request from: AB InBev NV/SA, Brouwerijplein 1, 3000 Leuven.

It should be noted that only the consolidated financial statements as set forth above present a true and fair view of the financial position and performance of the AB InBev group.

Since AB InBev NV/SA is essentially a holding company, which recognizes its investments at cost in its non-consolidated financial statements, these separate financial statements present no more than a limited view of the financial position of AB InBev NV/SA. For this reason, the Board of Directors deemed it appropriate to publish only an abbreviated version of the non-consolidated balance sheet and income statement prepared in accordance with Belgian GAAP as at and for the year ended 31 December 2021.

The statutory auditor has confirmed that his audit procedures are substantially complete and that the abbreviated non-consolidated balance sheet and income statement of AB InBev NV/SA prepared in accordance with Belgian GAAP for the year ended 31 December 2021 are consistent, in all material respects, with the accounts from which they have been derived.

Abbreviated non-consolidated balance sheet

 

  Million euro

     2021                        2020  
                   

  ASSETS

                 

  Non-current assets

                 

  Intangible assets

     638        528  

  Property, plant and equipment

     140        97  

  Financial assets

     115 719        115 712  
       116 497        116 337  
                   

  Current assets

     15 957        18 937  
                   

  Total assets

     132 454        135 274  
                   

  Equity and liabilities

                 

  Equity

                 

  Issued capital

     1 239        1 239  

  Share premium

     13 186        13 186  

  Legal reserve

     124        124  

  Reserves not available for distribution

     1 998        3 454  

  Reserves available for distribution

     33 009        33 009  

  Profit carried forward

     25 745        19 691  
       75 301        70 703  
                   

  Provisions and deferred taxes

     98        100  
                   

  Non-current liabilities

     43 523        45 486  
                   

  Current liabilities

     13 532        18 985  
                   

  Total equity and liabilities

     132 454        135 274  

 

AB InBev – Financial Report 2021 | 112


Abbreviated non-consolidated income statement

 

  Million euro    2021      2020  

            

                 

  Operating income

     1 154        1 167  

  Operating expenses

     (1 202)        (1 183)  

  Operating result

     (48)        (16)  

            

                 

  Financial result

     5 636        104  

            

                 

  Result for the year available for appropriation

     5 588        88  

 

AB InBev – Financial Report 2021 | 113


Glossary

 

 

AGGREGATED WEIGHTED NOMINAL TAX RATE

The aggregated weighted nominal tax rate is based on the statutory corporate income tax rates applicable in the various countries.

DILUTED EPS

Profit attributable to equity holders of AB InBev divided by the fully diluted weighted average number of ordinary and restricted shares.

DILUTED WEIGHTED AVERAGE NUMBER OF ORDINARY AND RESTRICTED SHARES

Weighted average number of ordinary and restricted shares adjusted by the effect of dilutive share options and restricted stock units.

EBIT

Profit from operations.

EBITDA

Profit from operations plus depreciation, amortization and impairment.

EMEA

Europe and Africa.

EPS

Profit attributable to equity holders of AB InBev divided by the weighted average number of ordinary and restricted shares.

FVOCI

Fair value through other comprehensive income.

FVPLI

Fair value through profit or loss.

FTE’s

Full-time equivalent on a permanent or temporary basis, excluding outsourced personnel.

INVESTED CAPITAL

Includes property, plant and equipment, goodwill and intangible assets, investments in associates and equity securities, working capital, provisions, employee benefits and deferred taxes.

MARKETING EXPENSES

Include all costs relating to the support and promotion of the brands. They include among others operating costs (payroll, office costs, etc.) of the marketing department, advertising costs (agency costs, media costs, etc.), sponsoring and events, and surveys and market research.

NET CAPEX

Acquisitions of property, plant and equipment and of intangible assets, minus proceeds from sale.

NET DEBT

Non-current and current interest-bearing loans and borrowings and bank overdrafts, minus debt securities and cash and cash equivalents.

NON-UNDERLYING ITEMS

Items of income or expense which do not occur regularly as part of the normal activities of the company.

NORMALIZED

The term “normalized” refers to performance measures (EBITDA, EBIT, Profit, EPS, effective tax rate) before non-underlying items and profit from discontinued operations. Non-underlying items are items of income or expense which do not occur regularly as part of the normal activities of the company and which warrant separate disclosure because they are important for the understanding of the underlying results of the company due to their size or nature. AB InBev believes that the

 

AB InBev – Financial Report 2021 | 114


communication and explanation of normalized measures is essential for readers of its financial statements to understand fully the sustainable performance of the company. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the company’s performance.

NORMALIZED DILUTED EPS

Diluted EPS adjusted for non-underlying items and profit from discontinued operations.

NORMALIZED EBIT

Profit from operations adjusted for non-underlying items.

NORMALIZED EBITDA

Profit from operations adjusted for non-underlying items, plus depreciation, amortization and impairment.

NORMALIZED EFFECTIVE TAX RATE

Effective tax rate adjusted for non-underlying items.

NORMALIZED EPS

EPS adjusted for non-underlying items and profit from discontinued operations.

NORMALIZED PROFIT

Profit adjusted for non-underlying items and profit from discontinued operations.

NORMALIZED PROFIT FROM OPERATIONS

Profit from operations adjusted for non-underlying items.

PAY OUT RATIO

Gross dividend per share multiplied by the estimated number of ordinary shares outstanding at the dividend record date, divided by normalized profit attributable to equity holders of AB InBev.

RE-MEASUREMENTS OF POST-EMPLOYEE BENEFITS

Comprised of actuarial gains and losses, the effect of the asset ceiling (excluding net interest) and the return on plan assets (excluding net interest).

REVENUE

Gross revenue less excise taxes and discounts.

SALES EXPENSES

Include all costs relating to the selling of the products. They include among others the operating costs (payroll, office costs, etc.) of the sales department and the sales force.

SG&A AND SELLING, GENERAL & ADMINISTRATIVE EXPENSES

Sales, marketing, distribution and administrative expenses

SCOPE

Financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scopes. A scope represents the impact of acquisitions and divestitures, the start-up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year-over-year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business.

UNDERLYING EPS

Profit before non-underlying items, discontinued operations, mark-to-market gains/losses on certain derivatives related to the hedging of share-based payment programs and hyperinflation impacts, attributable to equity holders of AB InBev divided by the weighted average number of ordinary and restricted shares.

WEIGHTED AVERAGE NUMBER OF ORDINARY AND RESTRICTED SHARES

Number of shares outstanding at the beginning of the period, adjusted by the number of shares cancelled, repurchased or issued during the period multiplied by a time-weighing factor.

WORKING CAPITAL

Includes inventories, trade and other receivables and trade and other payables, both current and non-current.

 

AB InBev – Financial Report 2021 | 115